|
G
|
Abca3
|
ATP binding cassette subfamily A member 3
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of ABCA3 mRNA; Bleomycin results in decreased expression of ABCA3 protein
|
CTD |
PMID:34425168 |
|
NCBI chr10:13,886,948...13,944,286
Ensembl chr10:13,887,083...13,944,285
|
|
G
|
Ace
|
angiotensin I converting enzyme
|
multiple interactions decreases expression
|
EXP
|
angiotensin I (1-7) inhibits the reaction [Bleomycin results in decreased expression of ACE protein]
|
CTD |
PMID:20581171 |
|
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942
|
|
G
|
Ace2
|
angiotensin converting enzyme 2
|
multiple interactions decreases expression
|
EXP
|
angiotensin I (1-7) inhibits the reaction [Bleomycin results in decreased expression of ACE2 mRNA]
|
CTD |
PMID:20581171 |
|
NCBI chr X:33,925,458...33,972,851
Ensembl chr X:33,925,458...33,971,596
|
|
G
|
Acta2
|
actin alpha 2, smooth muscle
|
increases expression multiple interactions decreases expression
|
ISO EXP
|
Bleomycin results in increased expression of ACTA2 mRNA; Bleomycin results in increased expression of ACTA2 protein (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone inhibits the reaction [Bleomycin results in increased expression of ACTA2 mRNA]; (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein]; 12-(3-adamantan-1-ylureido)dodecanoic acid inhibits the reaction [Bleomycin results in increased expression of ACTA2 mRNA]; 12-(3-adamantan-1-ylureido)dodecanoic acid inhibits the reaction [Bleomycin results in increased expression of and results in increased phosphorylation of ACTA2 protein]; 2-((dimethylamino)methyl)-9-hydroxythieno(2,3-c)isoquinolin-5(4H)-one inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein]; 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein]]; [Arsenic Trioxide co-treated with Bleomycin] results in decreased expression of ACTA2 mRNA; [Bleomycin co-treated with Soot] results in increased expression of ACTA2 protein; Bleomycin results in increased expression of and results in increased phosphorylation of ACTA2 protein; Calcitriol inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein]; CCR2 gene mutant form inhibits the reaction [Bleomycin results in increased expression of ACTA2 mRNA]; CEBPB protein affects the reaction [Bleomycin results in increased expression of ACTA2 mRNA]; celastrol inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein]; Curcumin inhibits the reaction [Bleomycin results in increased expression of ACTA2 mRNA]; Dexamethasone inhibits the reaction [Bleomycin results in increased expression of ACTA2 mRNA]; Dexamethasone inhibits the reaction [Bleomycin results in increased expression of and results in increased phosphorylation of ACTA2 protein]; Diazoxide inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein]; honokiol inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein]; icaritin inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein]; lenabasum inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein]; loganin inhibits the reaction [Bleomycin results in increased expression of ACTA2 mRNA]; loganin inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein]; MIR100HG mRNA affects the reaction [Bleomycin results in increased expression of ACTA2 mRNA]; MIR100HG mRNA affects the reaction [Bleomycin results in increased expression of ACTA2 protein]; MIR182 affects the reaction [Bleomycin results in increased expression of ACTA2 protein]; MKLN1 mRNA alternative form affects the reaction [Bleomycin results in increased expression of ACTA2 protein]; morroniside inhibits the reaction [Bleomycin results in increased expression of ACTA2 mRNA]; morroniside inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein]; Thioctic Acid inhibits the reaction [Bleomycin results in increased expression of ACTA2 mRNA] allyl sulfide inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein]; andrographolide inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein]; montelukast inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein]; pachymic acid inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein]; protocatechualdehyde inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein] Bleomycin results in decreased expression of ACTA2 protein Ephedrine inhibits the reaction [Bleomycin results in increased expression of ACTA2 mRNA]; Ephedrine inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein]; yupingfeng inhibits the reaction [Bleomycin results in increased expression of ACTA2 mRNA]; yupingfeng inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein]
|
CTD |
PMID:14609568 PMID:17177178 PMID:21381050 PMID:23656969 PMID:24762191 PMID:25582705 PMID:25648892 PMID:26520185 PMID:27153807 PMID:27704718 PMID:28694203 PMID:31302203 PMID:31706003 PMID:31884830 PMID:31901889 PMID:32032644 PMID:34153405 PMID:34425168 PMID:35187969 PMID:35267148 PMID:35279615 PMID:35472619 PMID:35716765 PMID:37163307 PMID:37399107 PMID:37778983 PMID:37783230 PMID:37898439 PMID:38460002 More...
|
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503
|
|
G
|
Actg1
|
actin, gamma 1
|
increases expression
|
ISO
|
Bleomycin results in increased expression of ACTG1 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr10:106,118,106...106,120,951
Ensembl chr10:106,118,108...106,120,951
|
|
G
|
Actn1
|
actinin, alpha 1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of ACTN1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 6:104,731,485...104,826,312
Ensembl chr 6:104,731,485...104,826,172
|
|
G
|
Actn4
|
actinin alpha 4
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of ACTN4 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 1:93,310,294...93,379,369
Ensembl chr 1:93,310,278...93,379,320
|
|
G
|
Actr10
|
actin related protein 10
|
increases expression
|
ISO
|
Bleomycin results in increased expression of ACTR10 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 6:95,182,082...95,208,325
Ensembl chr 6:95,182,111...95,209,021
|
|
G
|
Actr3b
|
actin related protein 3B
|
increases expression
|
ISO
|
Bleomycin results in increased expression of ACTR3B mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 4:9,995,553...10,089,422
Ensembl chr 4:9,996,155...10,089,553
|
|
G
|
Adam17
|
ADAM metallopeptidase domain 17
|
multiple interactions
|
ISO
|
Bleomycin results in increased expression of and results in increased activity of ADAM17 protein
|
CTD |
PMID:22687607 |
|
NCBI chr 6:46,601,583...46,663,690
Ensembl chr 6:46,601,583...46,649,344
|
|
G
|
Adra1b
|
adrenoceptor alpha 1B
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of ADRA1B mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr10:28,756,461...28,874,831
Ensembl chr10:28,756,461...28,814,347
|
|
G
|
Ager
|
advanced glycosylation end product-specific receptor
|
multiple interactions decreases expression
|
EXP
|
protocatechualdehyde inhibits the reaction [Bleomycin results in decreased expression of AGER protein]
|
CTD |
PMID:25582705 PMID:25933445 |
|
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685
|
|
G
|
Agtr1a
|
angiotensin II receptor, type 1a
|
multiple interactions increases expression
|
EXP
|
angiotensin I (1-7) inhibits the reaction [Bleomycin results in increased expression of AGTR1 protein]
|
CTD |
PMID:20581171 |
|
NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660
|
|
G
|
Ahsg
|
alpha-2-HS-glycoprotein
|
increases expression
|
EXP
|
Bleomycin results in increased expression of AHSG protein
|
CTD |
PMID:25933445 |
|
NCBI chr11:91,625,975...91,632,583
Ensembl chr11:91,625,975...91,634,039
|
|
G
|
Aifm1
|
apoptosis inducing factor, mitochondria associated 1
|
multiple interactions
|
ISO
|
5-hydroxydecanoic acid inhibits the reaction [baicalein inhibits the reaction [Bleomycin affects the expression of and affects the localization of AIFM1 protein]]; 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Bleomycin affects the expression of and affects the localization of AIFM1 protein]]; baicalein inhibits the reaction [Bleomycin affects the expression of and affects the localization of AIFM1 protein]; Bleomycin affects the expression of and affects the localization of AIFM1 protein; Diazoxide inhibits the reaction [Bleomycin affects the expression of and affects the localization of AIFM1 protein]
|
CTD |
PMID:37783230 |
|
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:132,528,107...132,567,237
|
|
G
|
Akt1
|
AKT serine/threonine kinase 1
|
increases phosphorylation
|
ISO
|
Bleomycin results in increased phosphorylation of AKT1 protein
|
CTD |
PMID:22687607 PMID:26520185 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
G
|
Alb
|
albumin
|
increases expression
|
EXP
|
Bleomycin results in increased expression of ALB protein
|
CTD |
PMID:25933445 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
G
|
Aldh1a1
|
aldehyde dehydrogenase 1 family, member A1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of ALDH1A1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500
|
|
G
|
Aldoc
|
aldolase, fructose-bisphosphate C
|
multiple interactions
|
ISO
|
[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of ALDOC protein
|
CTD |
PMID:29733421 |
|
NCBI chr10:63,715,544...63,719,133
Ensembl chr10:63,715,489...63,719,133
|
|
G
|
Angptl3
|
angiopoietin-like 3
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of ANGPTL3 protein Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of ANGPTL3 protein]; lenabasum inhibits the reaction [Bleomycin results in increased expression of ANGPTL3 protein]
|
CTD |
PMID:30825431 |
|
NCBI chr 5:118,818,494...118,825,531
Ensembl chr 5:118,818,499...118,826,444
|
|
G
|
Ankrd1
|
ankyrin repeat domain 1
|
increases expression
|
ISO
|
Bleomycin results in increased expression of ANKRD1 mRNA
|
CTD |
PMID:26345256 |
|
NCBI chr 1:243,228,460...243,237,014
Ensembl chr 1:243,228,448...243,263,751
|
|
G
|
Anp32e
|
acidic nuclear phosphoprotein 32 family member E
|
increases expression
|
EXP
|
Bleomycin results in increased expression of ANP32E protein
|
CTD |
PMID:25933445 |
|
NCBI chr 2:186,161,520...186,177,984
Ensembl chr 2:186,161,532...186,177,986
|
|
G
|
Anxa2
|
annexin A2
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of ANXA2 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 8:78,986,252...79,022,638
Ensembl chr 8:78,986,242...79,022,631
|
|
G
|
Anxa3
|
annexin A3
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of ANXA3 protein
|
CTD |
PMID:25933445 |
|
NCBI chr14:13,031,675...13,085,678
Ensembl chr14:13,023,762...13,085,849
|
|
G
|
Anxa4
|
annexin A4
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of ANXA4 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 4:120,741,750...120,798,534
Ensembl chr 4:120,741,750...120,798,513
|
|
G
|
Anxa5
|
annexin A5
|
increases expression
|
EXP
|
Bleomycin results in increased expression of ANXA5 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:121,242,136...121,281,400
|
|
G
|
Anxa6
|
annexin A6
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of ANXA6 protein
|
CTD |
PMID:25933445 |
|
NCBI chr10:39,602,106...39,657,183
Ensembl chr10:39,602,106...39,657,359
|
|
G
|
Anxa7
|
annexin A7
|
multiple interactions
|
ISO
|
[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of ANXA7 protein
|
CTD |
PMID:29733421 |
|
NCBI chr15:3,869,180...3,897,827
Ensembl chr15:3,870,974...3,898,891
|
|
G
|
Aqp1
|
aquaporin 1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of AQP1 mRNA
|
CTD |
PMID:15782499 |
|
NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504
|
|
G
|
Areg
|
amphiregulin
|
increases expression
|
ISO
|
Bleomycin results in increased expression of AREG mRNA
|
CTD |
PMID:26817844 |
|
NCBI chr14:17,256,384...17,265,641
Ensembl chr14:17,256,384...17,265,641
|
|
G
|
Arg1
|
arginase 1
|
increases expression decreases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of ARG1 mRNA; Bleomycin results in increased expression of ARG1 protein Bleomycin results in decreased expression of ARG1 protein Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of ARG1 protein]
|
CTD |
PMID:26345256 PMID:26526764 PMID:30825431 PMID:33647319 |
|
NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713
|
|
G
|
Atf4
|
activating transcription factor 4
|
multiple interactions increases expression
|
EXP
|
pachymic acid inhibits the reaction [Bleomycin results in increased expression of ATF4 protein]
|
CTD |
PMID:37163307 |
|
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739
|
|
G
|
Atm
|
ATM serine/threonine kinase
|
multiple interactions increases phosphorylation
|
ISO
|
2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Bleomycin promotes the reaction [resveratrol results in increased phosphorylation of ATM protein]]; 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Bleomycin results in increased phosphorylation of ATM protein]; 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [resveratrol promotes the reaction [Bleomycin results in increased phosphorylation of ATM protein]]; Bleomycin promotes the reaction [resveratrol results in increased phosphorylation of ATM protein]; resveratrol promotes the reaction [Bleomycin results in increased phosphorylation of ATM protein]
|
CTD |
PMID:24933654 |
|
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:62,727,291...62,828,629
|
|
G
|
Atp5f1b
|
ATP synthase F1 subunit beta
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of ATP5F1B protein
|
CTD |
PMID:25933445 |
|
NCBI chr 7:1,100,058...1,106,461
Ensembl chr 7:1,099,860...1,106,462
|
|
G
|
Atp5if1
|
ATP synthase inhibitory factor subunit 1
|
increases expression
|
EXP
|
Bleomycin results in increased expression of ATP5IF1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 5:150,022,960...150,026,677
Ensembl chr 5:150,022,960...150,026,677
|
|
G
|
Atp5me
|
ATP synthase membrane subunit e
|
multiple interactions
|
ISO
|
[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in increased expression of ATP5ME protein
|
CTD |
PMID:29733421 |
|
NCBI chr14:1,464,788...1,465,989
Ensembl chr14:1,464,800...1,465,988
|
|
G
|
Atp5po
|
ATP synthase peripheral stalk subunit OSCP
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of ATP5PO protein
|
CTD |
PMID:29733421 |
|
NCBI chr11:44,651,171...44,657,483
Ensembl chr11:44,651,173...44,657,520
|
|
G
|
Atp6v1a
|
ATPase H+ transporting V1 subunit A
|
multiple interactions decreases expression
|
ISO
|
[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of ATP6V1A protein Bleomycin results in decreased expression of ATP6V1A protein
|
CTD |
PMID:29733421 |
|
NCBI chr11:70,066,800...70,120,603
Ensembl chr11:70,035,134...70,120,603
|
|
G
|
Avpr1a
|
arginine vasopressin receptor 1A
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of AVPR1A mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr 7:59,999,743...60,003,667
Ensembl chr 7:59,999,738...60,003,837
|
|
G
|
Basp1
|
brain abundant, membrane attached signal protein 1
|
increases expression
|
EXP
|
Bleomycin results in increased expression of BASP1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 2:77,546,628...77,594,297
Ensembl chr 2:77,546,092...77,597,178
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions increases expression
|
EXP ISO
|
allyl sulfide inhibits the reaction [Bleomycin results in increased expression of BAX protein]; Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of BAX mRNA]; Phytochemicals inhibits the reaction [Bleomycin results in increased expression of BAX mRNA] Bleomycin results in increased expression of BAX mRNA; Bleomycin results in increased expression of BAX protein 5-hydroxydecanoic acid inhibits the reaction [baicalein inhibits the reaction [Bleomycin results in increased expression of BAX protein]]; 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Bleomycin results in increased expression of BAX protein]]; baicalein inhibits the reaction [Bleomycin results in increased expression of BAX protein]; Bleomycin inhibits the reaction [Azacitidine results in increased expression of BAX mRNA]; Diazoxide inhibits the reaction [Bleomycin results in increased expression of BAX protein]
|
CTD |
PMID:23656969 PMID:26093215 PMID:32278510 PMID:37783230 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
multiple interactions increases expression decreases expression
|
EXP ISO
|
[Bleomycin co-treated with Bee Venoms] results in decreased expression of BCL2 mRNA; allyl sulfide promotes the reaction [Bleomycin results in increased expression of BCL2 protein]; Phytochemicals inhibits the reaction [Bleomycin results in decreased expression of BCL2 mRNA] [Polyphenols co-treated with Bleomycin] results in increased expression of BCL2 mRNA; [Tea co-treated with Bleomycin] results in increased expression of BCL2 mRNA 5-hydroxydecanoic acid inhibits the reaction [baicalein inhibits the reaction [Bleomycin results in decreased expression of BCL2 protein]]; 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Bleomycin results in decreased expression of BCL2 protein]]; baicalein inhibits the reaction [Bleomycin results in decreased expression of BCL2 protein]; Bleomycin inhibits the reaction [Azacitidine results in decreased expression of BCL2 mRNA]; Bleomycin inhibits the reaction [Azacitidine results in decreased expression of BCL2 protein]; Diazoxide inhibits the reaction [Bleomycin results in decreased expression of BCL2 protein]
|
CTD |
PMID:23656969 PMID:24822179 PMID:26093215 PMID:26800624 PMID:32278510 PMID:37783230 More...
|
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
G
|
Bcl2l1
|
Bcl2-like 1
|
multiple interactions decreases expression
|
ISO
|
thymoquinone inhibits the reaction [Bleomycin results in decreased expression of BCL2L1 mRNA]
|
CTD |
PMID:34818114 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
G
|
Bcl6b
|
BCL6B, transcription repressor
|
multiple interactions
|
ISO
|
[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of BCL6B mRNA
|
CTD |
PMID:29733421 |
|
NCBI chr10:55,439,566...55,444,631
Ensembl chr10:55,432,382...55,444,631
|
|
G
|
Bik
|
BCL2-interacting killer
|
increases expression
|
ISO
|
Bleomycin results in increased expression of BIK mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 7:116,552,303...116,571,317
Ensembl chr 7:116,552,303...116,571,317
|
|
G
|
Birc2
|
baculoviral IAP repeat-containing 2
|
decreases response to substance increases expression
|
ISO EXP
|
BIRC2 protein results in decreased susceptibility to Bleomycin Bleomycin results in increased expression of BIRC2 protein
|
CTD |
PMID:10815900 PMID:15371238 |
|
NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:13,253,706...13,271,911
|
|
G
|
Birc5
|
baculoviral IAP repeat-containing 5
|
increases expression
|
ISO
|
Bleomycin results in increased expression of BIRC5 mRNA
|
CTD |
PMID:26345256 |
|
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155
|
|
G
|
Blmh
|
bleomycin hydrolase
|
affects response to substance
|
ISO
|
BLMH gene polymorphism affects the susceptibility to Bleomycin
|
CTD |
PMID:12082022 |
|
NCBI chr10:62,270,170...62,313,349
Ensembl chr10:62,270,033...62,313,345
|
|
G
|
Bmp7
|
bone morphogenetic protein 7
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of BMP7 mRNA
|
CTD |
PMID:29408570 |
|
NCBI chr 3:182,059,318...182,135,273
Ensembl chr 3:182,052,337...182,135,137
|
|
G
|
Bscl2
|
BSCL2 lipid droplet biogenesis associated, seipin
|
increases expression
|
ISO
|
Bleomycin results in increased expression of BSCL2 mRNA
|
CTD |
PMID:22003191 |
|
NCBI chr 1:215,160,764...215,172,540
Ensembl chr 1:215,160,957...215,172,536
|
|
G
|
C1qb
|
complement C1q B chain
|
increases expression
|
ISO
|
Bleomycin results in increased expression of C1QB mRNA
|
CTD |
PMID:26345256 |
|
NCBI chr 5:154,402,276...154,407,827
Ensembl chr 5:154,402,279...154,407,840
|
|
G
|
Ca1
|
carbonic anhydrase 1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of CA1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 2:88,550,681...88,593,454
Ensembl chr 2:88,495,475...88,593,454
|
|
G
|
Calca
|
calcitonin-related polypeptide alpha
|
increases expression
|
ISO
|
Bleomycin results in increased expression of CALCA mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529
|
|
G
|
Cald1
|
caldesmon 1
|
increases expression
|
EXP
|
Bleomycin results in increased expression of CALD1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 4:64,232,906...64,414,085
Ensembl chr 4:64,233,171...64,414,085
|
|
G
|
Calml3
|
calmodulin-like 3
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of CALML3 protein
|
CTD |
PMID:25933445 |
|
NCBI chr17:71,329,438...71,333,068
Ensembl chr17:71,319,943...71,335,682
|
|
G
|
Calr
|
calreticulin
|
increases expression
|
EXP
|
Bleomycin results in increased expression of CALR protein
|
CTD |
PMID:25933445 |
|
NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236
|
|
G
|
Calu
|
calumenin
|
increases expression
|
EXP
|
Bleomycin results in increased expression of CALU protein
|
CTD |
PMID:25933445 |
|
NCBI chr 4:58,914,456...58,941,957
Ensembl chr 4:58,914,421...58,941,956
|
|
G
|
Car2
|
carbonic anhydrase 2
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of CA2 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:88,462,872...88,478,064
|
|
G
|
Carhsp1
|
calcium regulated heat stable protein 1
|
increases expression
|
EXP
|
Bleomycin results in increased expression of CARHSP1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr10:7,453,602...7,467,218
Ensembl chr10:7,452,978...7,467,770
|
|
G
|
Casp3
|
caspase 3
|
multiple interactions increases activity increases expression increases cleavage
|
EXP ISO
|
[Bleomycin co-treated with Bee Venoms] results in increased expression of CASP3 mRNA; allyl sulfide inhibits the reaction [Bleomycin results in increased expression of CASP3 protein]; Bleomycin results in increased cleavage of and results in increased activity of CASP3 protein; Phytochemicals inhibits the reaction [Bleomycin results in increased expression of CASP3 mRNA] Bleomycin results in increased activity of CASP3 protein Bleomycin results in increased expression of CASP3 mRNA; Bleomycin results in increased expression of CASP3 protein [Polyphenols co-treated with Bleomycin] results in increased expression of CASP3 mRNA; [Tea co-treated with Bleomycin] results in increased expression of CASP3 mRNA 5-hydroxydecanoic acid inhibits the reaction [baicalein inhibits the reaction [Bleomycin results in increased cleavage of CASP3 protein]]; baicalein inhibits the reaction [Bleomycin results in increased cleavage of CASP3 protein]
|
CTD |
PMID:15371238 PMID:22687607 PMID:23656969 PMID:24822179 PMID:26093215 PMID:26800624 PMID:37783230 More...
|
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Casp8
|
caspase 8
|
multiple interactions
|
ISO
|
[Polyphenols co-treated with Bleomycin] results in increased expression of CASP8 mRNA; [Tea co-treated with Bleomycin] results in increased expression of CASP8 mRNA
|
CTD |
PMID:26800624 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
|
|
G
|
Casp9
|
caspase 9
|
multiple interactions increases activity increases expression
|
EXP ISO
|
Bleomycin results in increased cleavage of and results in increased activity of CASP9 protein; pachymic acid inhibits the reaction [Bleomycin results in increased expression of CASP9 protein] Bleomycin results in increased activity of CASP9 protein [Polyphenols co-treated with Bleomycin] results in increased expression of CASP9 mRNA; [Tea co-treated with Bleomycin] results in increased expression of CASP9 mRNA
|
CTD |
PMID:15371238 PMID:22687607 PMID:26800624 PMID:37163307 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
G
|
Cast
|
calpastatin
|
increases expression
|
EXP
|
Bleomycin results in increased expression of CAST protein
|
CTD |
PMID:25933445 |
|
NCBI chr 2:5,707,633...5,817,213
Ensembl chr 2:5,707,640...5,817,180
|
|
G
|
Cat
|
catalase
|
increases response to substance multiple interactions increases expression decreases activity
|
ISO EXP
|
CAT protein results in increased susceptibility to Bleomycin Bleomycin results in decreased expression of and results in decreased activity of CAT protein; caffeic acid phenethyl ester inhibits the reaction [Bleomycin results in decreased expression of CAT protein]; Oils, Volatile inhibits the reaction [Bleomycin results in decreased activity of CAT protein] Bleomycin results in increased expression of CAT protein IL1A protein promotes the reaction [Bleomycin results in increased expression of CAT protein]; IL1B protein promotes the reaction [Bleomycin results in increased expression of CAT protein]; TNF protein promotes the reaction [Bleomycin results in increased expression of CAT protein] celastrol inhibits the reaction [Bleomycin results in decreased activity of CAT protein]; pachymic acid inhibits the reaction [Bleomycin results in decreased activity of CAT protein]
|
CTD |
PMID:8317554 PMID:10751631 PMID:23570914 PMID:26768587 PMID:28850077 PMID:30106319 PMID:37163307 More...
|
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
G
|
Cav1
|
caveolin 1
|
decreases expression multiple interactions
|
EXP ISO
|
Bleomycin results in decreased expression of CAV1 protein Bleomycin results in decreased expression of CAV1 mRNA; Bleomycin results in decreased expression of CAV1 protein yupingfeng inhibits the reaction [Bleomycin results in decreased expression of CAV1 mRNA]; yupingfeng inhibits the reaction [Bleomycin results in decreased expression of CAV1 protein]
|
CTD |
PMID:25933445 PMID:37898439 |
|
NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740
|
|
G
|
Cavin2
|
caveolae associated protein 2
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of CAVIN2 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 9:57,794,007...57,806,024
Ensembl chr 9:57,794,019...57,806,024
|
|
G
|
Cbx8
|
chromobox 8
|
decreases expression multiple interactions
|
ISO
|
Bleomycin results in decreased expression of CBX8 mRNA Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of CBX8 mRNA]; lenabasum inhibits the reaction [Bleomycin results in decreased expression of CBX8 mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr10:104,793,062...104,795,500
Ensembl chr10:104,793,062...104,795,500
|
|
G
|
Cckar
|
cholecystokinin A receptor
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of CCKAR mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr14:61,505,270...61,513,618
Ensembl chr14:61,505,270...61,513,618
|
|
G
|
Ccl11
|
C-C motif chemokine ligand 11
|
increases expression decreases response to substance multiple interactions decreases expression
|
ISO
|
Bleomycin results in increased expression of CCL11 mRNA; Bleomycin results in increased expression of CCL11 protein CCL11 gene mutant form results in decreased susceptibility to Bleomycin CCL11 protein promotes the reaction [Bleomycin results in increased expression of CCL2 mRNA]; CCL11 protein promotes the reaction [Bleomycin results in increased expression of TGFB1 mRNA] Bleomycin results in decreased expression of CCL11 mRNA
|
CTD |
PMID:16314464 PMID:29720568 |
|
NCBI chr10:67,525,975...67,530,576
Ensembl chr10:67,525,862...67,530,575
|
|
G
|
Ccl12
|
C-C motif chemokine ligand 12
|
increases expression multiple interactions decreases expression
|
ISO
|
Bleomycin results in increased expression of CCL12 mRNA [CCL12 protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of CCN2 mRNA]; [CCL12 protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; [CCL12 protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of TGFB2 mRNA]; [CCL12 protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of TGFBR1 mRNA]; [CCL12 protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of TGFBR2 mRNA]; CCL12 protein affects the reaction [Dinoprostone inhibits the reaction [Bleomycin results in increased expression of TGFB3 mRNA]]; Dinoprostone inhibits the reaction [Bleomycin results in increased expression of CCL12 mRNA] Bleomycin results in decreased expression of CCL12 mRNA
|
CTD |
PMID:28434932 PMID:29720568 |
|
NCBI chr10:67,567,876...67,569,426
Ensembl chr10:67,567,876...67,569,426
|
|
G
|
Ccl17
|
C-C motif chemokine ligand 17
|
increases expression
|
ISO
|
Bleomycin results in increased expression of CCL17 mRNA; Bleomycin results in increased expression of CCL17 protein
|
CTD |
PMID:26345256 PMID:29175452 |
|
NCBI chr19:10,208,120...10,218,340
Ensembl chr19:10,208,120...10,209,895
|
|
G
|
Ccl2
|
C-C motif chemokine ligand 2
|
increases expression multiple interactions decreases expression
|
ISO EXP
|
Bleomycin results in increased expression of CCL2 mRNA; Bleomycin results in increased expression of CCL2 protein Calcitriol inhibits the reaction [Bleomycin results in increased expression of CCL2 mRNA]; Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of CCL2 mRNA]; CCL11 protein promotes the reaction [Bleomycin results in increased expression of CCL2 mRNA]; CEBPB protein affects the reaction [Bleomycin results in increased expression of CCL2 mRNA]; N-((3-(aminomethyl)phenyl)methyl)ethanimidamide inhibits the reaction [Bleomycin results in increased expression of CCL2 mRNA]; Rosiglitazone inhibits the reaction [Bleomycin results in increased expression of CCL2 protein]; SPL-334 inhibits the reaction [Bleomycin results in increased expression of CCL2 protein]; tetrathiomolybdate inhibits the reaction [Bleomycin results in increased expression of CCL2 mRNA]; tetrathiomolybdate inhibits the reaction [Bleomycin results in increased expression of CCL2 protein] Bleomycin results in decreased expression of CCL2 mRNA [Bleomycin co-treated with Tobacco Smoke Pollution] results in increased expression of CCL2 protein
|
CTD |
PMID:15541506 PMID:16314464 PMID:17177178 PMID:19147827 PMID:26209236 PMID:26520185 PMID:26526764 PMID:29720568 PMID:30033591 PMID:32828905 PMID:33516805 PMID:35112775 More...
|
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
G
|
Ccl3
|
C-C motif chemokine ligand 3
|
increases expression multiple interactions decreases expression
|
ISO EXP
|
Bleomycin results in increased expression of CCL3 mRNA Calcitriol inhibits the reaction [Bleomycin results in increased expression of CCL3 mRNA] Bleomycin results in decreased expression of CCL3 mRNA [Bleomycin co-treated with Tobacco Smoke Pollution] affects the expression of CCL3 protein Bleomycin results in decreased expression of CCL3 protein
|
CTD |
PMID:26520185 PMID:29720568 PMID:32828905 PMID:33516805 |
|
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439
|
|
G
|
Ccl4
|
C-C motif chemokine ligand 4
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of CCL4 mRNA
|
CTD |
PMID:29720568 |
|
NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722
|
|
G
|
Ccl5
|
C-C motif chemokine ligand 5
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of CCL5 mRNA SLCO2A1 gene mutant form promotes the reaction [Bleomycin results in increased expression of CCL5 mRNA]
|
CTD |
PMID:32828905 |
|
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884
|
|
G
|
Ccl7
|
C-C motif chemokine ligand 7
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of CCL7 mRNA
|
CTD |
PMID:29720568 |
|
NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,514,091...67,515,947
|
|
G
|
Ccl9
|
C-C motif chemokine ligand 9
|
increases expression
|
ISO
|
Bleomycin results in increased expression of CCL6 protein
|
CTD |
PMID:29175452 |
|
NCBI chr10:68,863,994...68,868,928
Ensembl chr10:68,863,995...68,868,877
|
|
G
|
Ccn2
|
cellular communication network factor 2
|
multiple interactions increases expression
|
ISO
|
[CCL12 protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of CCN2 mRNA]; [HIF1A protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of CCN2 mRNA]; [MMP3 protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of CCN2 mRNA]; bufotalin inhibits the reaction [Bleomycin results in increased expression of CCN2 protein]; honokiol inhibits the reaction [Bleomycin results in increased expression of CCN2 protein]; lenabasum inhibits the reaction [Bleomycin results in increased expression of CCN2 protein]; OGG1 protein affects the reaction [Bleomycin results in increased expression of CCN2 protein]; OGG1 protein inhibits the reaction [TH5487 inhibits the reaction [Bleomycin results in increased expression of CCN2 protein]]; OGG1 protein promotes the reaction [Bleomycin results in increased expression of CCN2 protein]; pirfenidone inhibits the reaction [Bleomycin results in increased expression of CCN2 protein]; Simvastatin inhibits the reaction [Bleomycin results in increased expression of CCN2 mRNA]; Simvastatin inhibits the reaction [Bleomycin results in increased expression of CCN2 protein]; TH5487 inhibits the reaction [Bleomycin results in increased expression of CCN2 protein] Bleomycin results in increased expression of CCN2 mRNA; Bleomycin results in increased expression of CCN2 protein
|
CTD |
PMID:19080365 PMID:26817844 PMID:27153807 PMID:28434932 PMID:32032644 PMID:35654123 PMID:38158113 More...
|
|
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976
|
|
G
|
Ccng1
|
cyclin G1
|
increases expression
|
ISO
|
Bleomycin results in increased expression of CCNG1 mRNA
|
CTD |
PMID:26345256 |
|
NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,677,885...25,683,766
|
|
G
|
Ccr2
|
C-C motif chemokine receptor 2
|
multiple interactions decreases response to substance increases expression
|
ISO
|
CCR2 gene mutant form inhibits the reaction [Bleomycin results in increased expression of ACTA2 mRNA]; CCR2 gene mutant form inhibits the reaction [Bleomycin results in increased expression of COL1A1 mRNA]; CCR2 gene mutant form inhibits the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; CCR2 gene mutant form inhibits the reaction [Bleomycin results in increased expression of TNF mRNA] CCR2 gene mutant form results in decreased susceptibility to Bleomycin Bleomycin results in increased expression of CCR2 mRNA
|
CTD |
PMID:14609568 PMID:29033951 |
|
NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:132,611,410...132,620,059
|
|
G
|
Ccr3
|
C-C motif chemokine receptor 3
|
increases expression
|
ISO
|
Bleomycin results in increased expression of CCR3 mRNA; Bleomycin results in increased expression of CCR3 protein
|
CTD |
PMID:16314464 |
|
NCBI chr 8:132,463,533...132,511,601
Ensembl chr 8:132,463,788...132,511,593
|
|
G
|
Ccr5
|
C-C motif chemokine receptor 5
|
affects expression increases expression multiple interactions
|
ISO
|
Bleomycin affects the expression of CCR5 mRNA Bleomycin results in increased expression of CCR5 mRNA Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of CCR5 mRNA]; lenabasum inhibits the reaction [Bleomycin results in increased expression of CCR5 mRNA]
|
CTD |
PMID:26345256 PMID:30825431 |
|
NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:132,629,683...132,637,594
|
|
G
|
Cct8
|
chaperonin containing TCP1 subunit 8
|
multiple interactions
|
ISO
|
[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of CCT8 protein
|
CTD |
PMID:29733421 |
|
NCBI chr11:40,196,619...40,208,328
Ensembl chr11:40,196,619...40,208,328
|
|
G
|
Cd14
|
CD14 molecule
|
increases expression
|
ISO
|
Bleomycin results in increased expression of CD14 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292
|
|
G
|
Cd2
|
Cd2 molecule
|
increases expression
|
ISO
|
Bleomycin results in increased expression of CD2 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 2:191,399,510...191,412,659
Ensembl chr 2:191,399,510...191,413,665
|
|
G
|
Cd33
|
CD33 molecule
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of CD33 mRNA Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of CD33 mRNA]; lenabasum inhibits the reaction [Bleomycin results in increased expression of CD33 mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr 1:103,071,985...103,086,687
Ensembl chr 1:103,072,375...103,086,291
|
|
G
|
Cd34
|
CD34 molecule
|
multiple interactions decreases expression
|
ISO
|
Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of CD34 protein]
|
CTD |
PMID:30825431 |
|
NCBI chr13:109,008,786...109,029,317
Ensembl chr13:109,008,623...109,029,315
|
|
G
|
Cd36
|
CD36 molecule
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of CD36 mRNA
|
CTD |
PMID:29408570 |
|
NCBI chr 4:18,209,088...18,302,142
|
|
G
|
Cd44
|
CD44 molecule
|
multiple interactions increases expression
|
ISO
|
honokiol inhibits the reaction [Bleomycin results in increased expression of CD44 protein]
|
CTD |
PMID:32032644 |
|
NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424
|
|
G
|
Cd83
|
CD83 molecule
|
increases expression
|
ISO
|
Bleomycin results in increased expression of CD83 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr17:21,093,281...21,113,223
Ensembl chr17:21,093,281...21,113,047
|
|
G
|
Cd86
|
CD86 molecule
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of CD86 mRNA
|
CTD |
PMID:29720568 |
|
NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361
|
|
G
|
Cdc20
|
cell division cycle 20
|
increases expression
|
ISO
|
Bleomycin results in increased expression of CDC20 mRNA
|
CTD |
PMID:26345256 |
|
NCBI chr 5:137,251,596...137,255,799
Ensembl chr 5:137,251,596...137,255,799
|
|
G
|
Cdh1
|
cadherin 1
|
multiple interactions decreases expression
|
ISO EXP
|
12-(3-adamantan-1-ylureido)dodecanoic acid inhibits the reaction [Bleomycin results in decreased expression of CDH1 mRNA]; 12-(3-adamantan-1-ylureido)dodecanoic acid inhibits the reaction [Bleomycin results in decreased expression of CDH1 protein]; Dexamethasone inhibits the reaction [Bleomycin results in decreased expression of CDH1 mRNA]; Dexamethasone inhibits the reaction [Bleomycin results in decreased expression of CDH1 protein]; geranylgeranylacetone inhibits the reaction [Bleomycin results in decreased expression of CDH1 mRNA]; geranylgeranylacetone inhibits the reaction [Bleomycin results in decreased expression of CDH1 protein]; Grape Seed Extract inhibits the reaction [Bleomycin results in decreased expression of CDH1 mRNA]; Grape Seed Extract inhibits the reaction [Bleomycin results in decreased expression of CDH1 protein]; honokiol inhibits the reaction [Bleomycin results in decreased expression of CDH1 protein]; MIR100HG mRNA affects the reaction [Bleomycin results in decreased expression of CDH1 mRNA]; MIR100HG mRNA affects the reaction [Bleomycin results in decreased expression of CDH1 protein]; MKLN1 mRNA alternative form affects the reaction [Bleomycin results in decreased expression of CDH1 protein]; OGG1 protein affects the reaction [Bleomycin results in decreased expression of CDH1 protein]; OGG1 protein inhibits the reaction [TH5487 inhibits the reaction [Bleomycin results in decreased expression of CDH1 protein]]; pirfenidone inhibits the reaction [Bleomycin results in decreased expression of CDH1 protein]; TH5487 inhibits the reaction [Bleomycin results in decreased expression of CDH1 protein] Bleomycin results in decreased expression of CDH1 mRNA; Bleomycin results in decreased expression of CDH1 protein Ephedrine inhibits the reaction [Bleomycin results in decreased expression of CDH1 mRNA]; Ephedrine inhibits the reaction [Bleomycin results in decreased expression of CDH1 protein]
|
CTD |
PMID:28300665 PMID:28694203 PMID:32032644 PMID:34425168 PMID:35472619 PMID:35654123 PMID:37126650 PMID:37307957 PMID:37778983 PMID:38460002 More...
|
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
|
|
G
|
Cdh2
|
cadherin 2
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of CDH2 protein OGG1 protein affects the reaction [Bleomycin results in increased expression of CDH2 protein]; OGG1 protein inhibits the reaction [TH5487 inhibits the reaction [Bleomycin results in increased expression of CDH2 protein]]; pirfenidone inhibits the reaction [Bleomycin results in increased expression of CDH2 protein]; TH5487 inhibits the reaction [Bleomycin results in increased expression of CDH2 protein]
|
CTD |
PMID:35654123 |
|
NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288
|
|
G
|
Cdk8
|
cyclin-dependent kinase 8
|
multiple interactions increases expression
|
ISO
|
MKLN1 mRNA alternative form affects the reaction [Bleomycin results in increased expression of CDK8 protein]
|
CTD |
PMID:38460002 |
|
NCBI chr12:13,851,024...13,919,017
Ensembl chr12:13,851,024...13,917,992
|
|
G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
increases expression
|
ISO
|
Bleomycin results in increased expression of CDKN1A mRNA
|
CTD |
PMID:26345256 PMID:29720568 PMID:32554301 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
G
|
Cebpb
|
CCAAT/enhancer binding protein beta
|
increases expression decreases response to substance multiple interactions increases response to substance
|
ISO
|
Bleomycin results in increased expression of CEBPB mRNA CEBPB gene mutant form results in decreased susceptibility to Bleomycin CEBPB protein affects the reaction [Bleomycin results in increased expression of ACTA2 mRNA]; CEBPB protein affects the reaction [Bleomycin results in increased expression of CCL2 mRNA]; CEBPB protein affects the reaction [Bleomycin results in increased expression of IL1B mRNA]; CEBPB protein affects the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; CEBPB protein affects the reaction [Bleomycin results in increased expression of TNF mRNA] CEBPB protein results in increased susceptibility to Bleomycin
|
CTD |
PMID:17177178 PMID:21998664 |
|
NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072
|
|
G
|
Cemip2
|
cell migration inducing hyaluronidase 2
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of CEMIP2 mRNA
|
CTD |
PMID:33770205 |
|
NCBI chr 1:228,756,826...228,834,313
Ensembl chr 1:228,757,466...228,832,906
|
|
G
|
Cenpe
|
centromere protein E
|
multiple interactions decreases expression
|
ISO
|
Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of CENPE mRNA]; lenabasum inhibits the reaction [Bleomycin results in decreased expression of CENPE mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr 2:226,310,970...226,369,636
Ensembl chr 2:226,300,798...226,369,636
|
|
G
|
Cert1
|
ceramide transporter 1
|
increases expression
|
ISO
|
Bleomycin results in increased expression of CERT1 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 2:29,617,202...29,721,734
Ensembl chr 2:29,617,023...29,721,729
|
|
G
|
Ces1d
|
carboxylesterase 1D
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of CES1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr19:30,046,494...30,085,039
Ensembl chr19:30,046,449...30,085,449
|
|
G
|
Cfl1
|
cofilin 1
|
increases expression
|
EXP
|
Bleomycin results in increased expression of CFL1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:212,226,121...212,231,353
|
|
G
|
Chek2
|
checkpoint kinase 2
|
increases phosphorylation multiple interactions
|
ISO
|
Bleomycin results in increased phosphorylation of CHEK2 protein resveratrol promotes the reaction [Bleomycin results in increased phosphorylation of CHEK2 protein]
|
CTD |
PMID:24933654 |
|
NCBI chr12:51,448,838...51,481,159
Ensembl chr12:51,449,140...51,480,667
|
|
G
|
Chrnb2
|
cholinergic receptor nicotinic beta 2 subunit
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of CHRNB2 mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr 2:177,479,091...177,487,306
Ensembl chr 2:177,479,091...177,491,326
|
|
G
|
Ckb
|
creatine kinase B
|
increases expression
|
EXP
|
Bleomycin results in increased expression of CKB protein
|
CTD |
PMID:25933445 |
|
NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478
|
|
G
|
Clcn5
|
chloride voltage-gated channel 5
|
increases expression
|
EXP
|
Bleomycin results in increased expression of CLCN5 mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr X:17,857,260...18,011,844
Ensembl chr X:17,857,260...18,011,844
|
|
G
|
Cldn4
|
claudin 4
|
increases expression
|
ISO
|
Bleomycin results in increased expression of CLDN4 mRNA
|
CTD |
PMID:26345256 |
|
NCBI chr12:27,388,160...27,389,958
Ensembl chr12:27,387,981...27,389,958
|
|
G
|
Clic4
|
chloride intracellular channel 4
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of CLIC4 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 5:152,737,371...152,797,118
Ensembl chr 5:152,737,371...152,797,118
|
|
G
|
Clic5
|
chloride intracellular channel 5
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of CLIC5 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 9:24,208,455...24,310,964
Ensembl chr 9:24,208,456...24,358,780
|
|
G
|
Cltc
|
clathrin heavy chain
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of CLTC protein
|
CTD |
PMID:25933445 |
|
NCBI chr10:72,014,984...72,073,308
Ensembl chr10:72,014,986...72,070,691
|
|
G
|
Cnr1
|
cannabinoid receptor 1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of CNR1 mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:53,204,260...53,239,252
|
|
G
|
Col11a2
|
collagen type XI alpha 2 chain
|
increases expression
|
ISO
|
Bleomycin results in increased expression of COL11A2 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr20:4,788,829...4,818,492
Ensembl chr20:4,788,829...4,817,648
|
|
G
|
Col14a1
|
collagen type XIV alpha 1 chain
|
increases expression
|
ISO
|
Bleomycin results in increased expression of COL14A1 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 7:88,611,827...88,826,939
Ensembl chr 7:88,611,828...88,826,938
|
|
G
|
Col18a1
|
collagen type XVIII alpha 1 chain
|
increases expression
|
ISO
|
Bleomycin results in increased expression of COL18A1 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr20:11,473,645...11,582,111
Ensembl chr20:11,473,645...11,582,112
|
|
G
|
Col1a1
|
collagen type I alpha 1 chain
|
multiple interactions increases expression decreases expression
|
ISO EXP
|
5-hydroxydecanoic acid inhibits the reaction [baicalein inhibits the reaction [Bleomycin results in increased expression of COL1A1 protein]]; 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Bleomycin results in increased expression of COL1A1 protein]]; [Bleomycin co-treated with Soot] results in increased expression of COL1A1 protein; Arsenic Trioxide inhibits the reaction [Bleomycin results in increased expression of COL1A1 mRNA]; Arsenic Trioxide inhibits the reaction [Bleomycin results in increased expression of COL1A1 protein]; baicalein inhibits the reaction [Bleomycin results in increased expression of COL1A1 protein]; CCR2 gene mutant form inhibits the reaction [Bleomycin results in increased expression of COL1A1 mRNA]; Dexamethasone inhibits the reaction [Bleomycin results in increased expression of COL1A1 mRNA]; Dexamethasone inhibits the reaction [Bleomycin results in increased expression of COL1A1 protein]; Diazoxide inhibits the reaction [Bleomycin results in increased expression of COL1A1 protein]; Enalapril inhibits the reaction [Bleomycin results in increased expression of COL1A1 mRNA]; geranylgeranylacetone inhibits the reaction [Bleomycin results in increased expression of COL1A1 mRNA]; geranylgeranylacetone inhibits the reaction [Bleomycin results in increased expression of COL1A1 protein]; Grape Seed Extract inhibits the reaction [Bleomycin results in increased expression of COL1A1 mRNA]; Grape Seed Extract inhibits the reaction [Bleomycin results in increased expression of COL1A1 protein]; icaritin inhibits the reaction [Bleomycin results in increased expression of COL1A1 mRNA]; Rosiglitazone inhibits the reaction [Bleomycin results in increased expression of COL1A1 mRNA]; S1PR5 protein affects the reaction [Bleomycin results in increased expression of COL1A1 mRNA]; Thioctic Acid inhibits the reaction [Bleomycin results in increased expression of COL1A1 mRNA] 1-hydroxyalantolactone inhibits the reaction [Bleomycin results in increased expression of COL1A1 protein]; Curcumin inhibits the reaction [Bleomycin results in increased expression of COL1A1 mRNA]; Curcumin inhibits the reaction [Bleomycin results in increased expression of COL1A1 protein]; Hydrocortisone inhibits the reaction [Bleomycin results in increased expression of COL1A1 mRNA]; Hydrocortisone inhibits the reaction [Bleomycin results in increased expression of COL1A1 protein]; Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of COL1A1 mRNA]; Phytochemicals inhibits the reaction [Bleomycin results in increased expression of COL1A1 mRNA] Bleomycin results in increased expression of COL1A1 mRNA; Bleomycin results in increased expression of COL1A1 protein Bleomycin results in decreased expression of COL1A1 protein MIR101-1 mRNA inhibits the reaction [Bleomycin results in increased expression of COL1A1 mRNA]
|
CTD |
PMID:12003776 PMID:14609568 PMID:17434272 PMID:19147827 PMID:24762191 PMID:25933445 PMID:26093215 PMID:26345256 PMID:28300665 PMID:28726637 PMID:29033951 PMID:31302203 PMID:34153405 PMID:34425168 PMID:34758440 PMID:35187969 PMID:37307957 PMID:37399107 PMID:37783230 More...
|
|
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
|
|
G
|
Col1a2
|
collagen type I alpha 2 chain
|
increases expression multiple interactions decreases expression
|
ISO EXP
|
Bleomycin results in increased expression of COL1A2 mRNA; Bleomycin results in increased expression of COL1A2 protein geranylgeranylacetone inhibits the reaction [Bleomycin results in increased expression of COL1A2 mRNA]; geranylgeranylacetone inhibits the reaction [Bleomycin results in increased expression of COL1A2 protein]; MIR100HG mRNA affects the reaction [Bleomycin results in increased expression of COL1A2 protein]; Rosiglitazone inhibits the reaction [Bleomycin results in increased expression of COL1A2 mRNA] Bleomycin results in decreased expression of COL1A2 protein pachymic acid inhibits the reaction [Bleomycin results in increased expression of COL1A2 protein]
|
CTD |
PMID:19147827 PMID:25933445 PMID:35472619 PMID:37163307 PMID:37307957 |
|
NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995
|
|
G
|
Col22a1
|
collagen type XXII alpha 1 chain
|
increases expression
|
ISO
|
Bleomycin results in increased expression of COL22A1 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 7:105,619,776...105,857,246
Ensembl chr 7:105,619,757...105,856,960
|
|
G
|
Col24a1
|
collagen type XXIV alpha 1 chain
|
increases expression
|
ISO
|
Bleomycin results in increased expression of COL24A1 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 2:236,872,583...237,129,768
Ensembl chr 2:236,872,265...237,129,447
|
|
G
|
Col3a1
|
collagen type III alpha 1 chain
|
decreases expression increases expression multiple interactions
|
EXP ISO
|
Bleomycin results in decreased expression of COL3A1 protein Bleomycin results in increased expression of COL3A1 mRNA; Bleomycin results in increased expression of COL3A1 protein MIR101-1 mRNA inhibits the reaction [Bleomycin results in increased expression of COL3A1 mRNA] honokiol inhibits the reaction [Bleomycin results in increased expression of COL3A1 protein]
|
CTD |
PMID:25933445 PMID:26817844 PMID:28726637 PMID:32032644 |
|
NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232
|
|
G
|
Col4a4
|
collagen type IV alpha 4 chain
|
increases expression
|
ISO
|
Bleomycin results in increased expression of COL4A4 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 9:91,281,324...91,323,577
Ensembl chr 9:91,203,670...91,323,577
|
|
G
|
Col5a1
|
collagen type V alpha 1 chain
|
decreases expression increases expression
|
EXP ISO
|
Bleomycin results in decreased expression of COL5A1 protein Bleomycin results in increased expression of COL5A1 mRNA
|
CTD |
PMID:25933445 PMID:36087614 |
|
NCBI chr 3:31,606,475...31,755,097
Ensembl chr 3:31,606,486...31,753,020
|
|
G
|
Col5a2
|
collagen type V alpha 2 chain
|
increases expression
|
ISO
|
Bleomycin results in increased expression of COL5A2 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 9:54,940,768...55,090,151
Ensembl chr 9:54,940,764...55,090,150
|
|
G
|
Col5a3
|
collagen type V alpha 3 chain
|
increases expression
|
ISO
|
Bleomycin results in increased expression of COL5A3 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 8:27,580,768...27,626,002
Ensembl chr 8:27,580,768...27,626,122
|
|
G
|
Col6a3
|
collagen type VI alpha 3 chain
|
increases expression
|
ISO
|
Bleomycin results in increased expression of COL6A3 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 9:98,809,171...98,887,060
Ensembl chr 9:98,809,171...98,886,990
|
|
G
|
Col9a2
|
collagen type IX alpha 2 chain
|
increases expression
|
ISO
|
Bleomycin results in increased expression of COL9A2 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 5:139,892,798...139,910,131
Ensembl chr 5:139,892,798...139,909,855
|
|
G
|
Colq
|
collagen like tail subunit of asymmetric acetylcholinesterase
|
increases expression
|
ISO
|
Bleomycin results in increased expression of COLQ mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr16:6,738,251...6,830,492
Ensembl chr16:6,738,251...6,793,501
|
|
G
|
Comp
|
cartilage oligomeric matrix protein
|
multiple interactions
|
ISO
|
[S1PR5 protein affects the susceptibility to Bleomycin] which affects the expression of COMP protein
|
CTD |
PMID:29033951 |
|
NCBI chr16:19,081,172...19,089,548
Ensembl chr16:19,081,172...19,089,605
|
|
G
|
Cp
|
ceruloplasmin
|
multiple interactions increases expression
|
ISO
|
tetrathiomolybdate inhibits the reaction [Bleomycin results in increased expression of CP protein]
|
CTD |
PMID:12624602 |
|
NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:104,368,456...104,427,087
|
|
G
|
Crip2
|
cysteine-rich protein 2
|
affects expression
|
EXP
|
Bleomycin affects the expression of CRIP2 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 6:138,042,175...138,047,121
Ensembl chr 6:138,041,906...138,047,120
|
|
G
|
Csf2
|
colony stimulating factor 2
|
increases expression decreases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of CSF2 mRNA; Bleomycin results in increased expression of CSF2 protein Bleomycin results in decreased expression of CSF2 mRNA 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [Bleomycin results in increased expression of CSF2 mRNA]; Apigenin inhibits the reaction [Bleomycin results in increased expression of CSF2 mRNA]; methyl caffeate inhibits the reaction [Bleomycin results in increased expression of CSF2 mRNA]
|
CTD |
PMID:18684396 PMID:28299617 PMID:29720568 PMID:32554301 |
|
NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031
|
|
G
|
Csf2rb
|
colony stimulating factor 2 receptor subunit beta
|
increases expression
|
ISO
|
Bleomycin results in increased expression of CSF2RB2 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 7:111,756,950...111,782,089
Ensembl chr 7:111,757,405...111,784,654
|
|
G
|
Csf3
|
colony stimulating factor 3
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of CSF3 mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:84,157,211...84,159,860
|
|
G
|
Csrp1
|
cysteine and glycine-rich protein 1
|
increases expression
|
EXP
|
Bleomycin results in increased expression of CSRP1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr13:49,709,928...49,731,141
Ensembl chr13:49,709,914...49,731,139
|
|
G
|
Ctsa
|
cathepsin A
|
affects expression
|
ISO
|
Bleomycin affects the expression of CTSA mRNA
|
CTD |
PMID:26345256 |
|
NCBI chr 3:173,988,443...173,994,320
Ensembl chr 3:173,988,460...173,995,539
|
|
G
|
Ctsb
|
cathepsin B
|
affects expression
|
ISO
|
Bleomycin affects the expression of CTSB mRNA
|
CTD |
PMID:26345256 |
|
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478
|
|
G
|
Ctsh
|
cathepsin H
|
affects expression
|
ISO
|
Bleomycin affects the expression of CTSH mRNA
|
CTD |
PMID:26345256 |
|
NCBI chr 8:99,488,756...99,507,639
Ensembl chr 8:99,488,874...99,509,181
|
|
G
|
Ctss
|
cathepsin S
|
increases expression
|
ISO
|
Bleomycin results in increased expression of CTSS mRNA
|
CTD |
PMID:19101991 |
|
NCBI chr 2:185,775,316...185,803,440
Ensembl chr 2:185,775,296...185,803,440
|
|
G
|
Cx3cl1
|
C-X3-C motif chemokine ligand 1
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of CX3CL1 protein Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of CX3CL1 protein]; lenabasum inhibits the reaction [Bleomycin results in increased expression of CX3CL1 protein]
|
CTD |
PMID:30825431 |
|
NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,233,329...10,242,999
|
|
G
|
Cxcl1
|
C-X-C motif chemokine ligand 1
|
multiple interactions increases expression
|
ISO
|
5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [Bleomycin results in increased expression of CXCL1 mRNA]; Apigenin inhibits the reaction [Bleomycin results in increased expression of CXCL1 mRNA]
|
CTD |
PMID:28299617 PMID:32554301 |
|
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811
|
|
G
|
Cxcl10
|
C-X-C motif chemokine ligand 10
|
increases expression decreases expression multiple interactions
|
ISO EXP
|
Bleomycin results in increased expression of CXCL10 mRNA; Bleomycin results in increased expression of CXCL10 protein Bleomycin results in decreased expression of CXCL10 mRNA [Bleomycin co-treated with Tobacco Smoke Pollution] results in increased expression of CXCL10 protein
|
CTD |
PMID:26345256 PMID:29720568 PMID:33516805 PMID:36087614 |
|
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
|
|
G
|
Cxcl12
|
C-X-C motif chemokine ligand 12
|
increases expression
|
ISO
|
Bleomycin results in increased expression of CXCL12 mRNA
|
CTD |
PMID:29720568 |
|
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627
|
|
G
|
Cxcl13
|
C-X-C motif chemokine ligand 13
|
affects expression
|
ISO
|
Bleomycin affects the expression of CXCL13 mRNA
|
CTD |
PMID:26345256 |
|
NCBI chr14:13,912,858...13,917,920
Ensembl chr14:13,912,858...13,917,920
|
|
G
|
Cxcl14
|
C-X-C motif chemokine ligand 14
|
increases expression
|
ISO
|
Bleomycin results in increased expression of CXCL14 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr17:8,323,150...8,331,176
Ensembl chr17:8,323,143...8,331,172
|
|
G
|
Cxcl2
|
C-X-C motif chemokine ligand 2
|
increases expression increases secretion multiple interactions
|
ISO EXP
|
Bleomycin results in increased expression of CXCL2 protein Bleomycin results in increased secretion of CXCL2 protein Bleomycin results in increased expression of CXCL2 mRNA 3-aminobenzamide inhibits the reaction [Bleomycin results in increased secretion of CXCL2 protein]; Calcitriol inhibits the reaction [Bleomycin results in increased expression of CXCL2 mRNA]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Bleomycin results in increased secretion of CXCL2 protein]; TRPM2 gene mutant form inhibits the reaction [Bleomycin results in increased secretion of CXCL2 protein] [Bleomycin co-treated with Tobacco Smoke Pollution] results in increased expression of CXCL2 protein
|
CTD |
PMID:18684396 PMID:22687607 PMID:26520185 PMID:26600069 PMID:33516805 |
|
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
|
|
G
|
Cxcl3
|
C-X-C motif chemokine ligand 3
|
multiple interactions increases secretion increases expression
|
ISO
|
TRPM2 gene mutant form inhibits the reaction [Bleomycin results in increased secretion of CXCL1 protein] Bleomycin results in increased expression of CXCL1 protein 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [Bleomycin results in increased expression of CXCL1 mRNA]; Apigenin inhibits the reaction [Bleomycin results in increased expression of CXCL1 mRNA]
|
CTD |
PMID:26600069 PMID:28299617 PMID:32554301 PMID:36087614 |
|
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624
|
|
G
|
Cxcl9
|
C-X-C motif chemokine ligand 9
|
increases expression
|
ISO
|
Bleomycin results in increased expression of CXCL9 protein
|
CTD |
PMID:29175452 |
|
NCBI chr14:16,007,166...16,012,077
Ensembl chr14:16,007,204...16,014,299
|
|
G
|
Cxcr1
|
C-X-C motif chemokine receptor 1
|
increases expression
|
ISO
|
Bleomycin results in increased expression of CXCR1 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 9:83,216,040...83,220,225
Ensembl chr 9:83,215,292...83,226,872
|
|
G
|
Cyba
|
cytochrome b-245 alpha chain
|
multiple interactions increases expression
|
ISO
|
Thioctic Acid inhibits the reaction [Bleomycin results in increased expression of CYBA mRNA]
|
CTD |
PMID:35187969 |
|
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214
|
|
G
|
Cycs
|
cytochrome c, somatic
|
affects localization
|
EXP
|
Bleomycin affects the localization of CYCS protein
|
CTD |
PMID:15371238 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816 Ensembl chr18:80,982,668...80,984,816
|
|
G
|
Dbi
|
diazepam binding inhibitor
|
increases expression
|
EXP
|
Bleomycin results in increased expression of DBI protein
|
CTD |
PMID:25933445 |
|
NCBI chr13:33,794,231...33,802,632
Ensembl chr13:33,759,845...33,821,450
|
|
G
|
Ddit3
|
DNA-damage inducible transcript 3
|
increases expression multiple interactions
|
EXP
|
Bleomycin results in increased expression of DDIT3 protein pachymic acid inhibits the reaction [Bleomycin results in increased expression of DDIT3 protein]
|
CTD |
PMID:37163307 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
G
|
Des
|
desmin
|
increases expression
|
EXP
|
Bleomycin results in increased expression of DES protein
|
CTD |
PMID:25933445 |
|
NCBI chr 9:84,299,626...84,307,344
Ensembl chr 9:84,298,447...84,307,347
|
|
G
|
Dlat
|
dihydrolipoamide S-acetyltransferase
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of DLAT protein
|
CTD |
PMID:29733421 |
|
NCBI chr 8:59,875,537...59,900,947
Ensembl chr 8:59,868,214...59,900,818 Ensembl chr 1:59,868,214...59,900,818
|
|
G
|
Dld
|
dihydrolipoamide dehydrogenase
|
increases expression
|
EXP ISO
|
Bleomycin results in increased expression of DLD protein
|
CTD |
PMID:25933445 PMID:29733421 |
|
NCBI chr 6:53,631,686...53,655,059
Ensembl chr 6:53,619,631...53,652,354
|
|
G
|
Dlk1
|
delta like non-canonical Notch ligand 1
|
increases expression
|
ISO
|
Bleomycin results in increased expression of DLK1 protein
|
CTD |
PMID:29175452 |
|
NCBI chr 6:134,192,491...134,199,779
Ensembl chr 6:134,192,518...134,200,529
|
|
G
|
Dll4
|
delta like canonical Notch ligand 4
|
multiple interactions decreases expression
|
ISO
|
Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of DLL4 protein]; lenabasum promotes the reaction [Bleomycin results in decreased expression of DLL4 protein]
|
CTD |
PMID:30825431 |
|
NCBI chr 3:126,770,945...126,780,769
Ensembl chr 3:126,770,794...126,780,763
|
|
G
|
Dnm1l
|
dynamin 1-like
|
increases expression
|
ISO
|
Bleomycin results in increased expression of DNM1L protein
|
CTD |
PMID:37126650 |
|
NCBI chr11:98,084,049...98,135,663
Ensembl chr11:98,085,397...98,137,420
|
|
G
|
Dnmt1
|
DNA methyltransferase 1
|
affects response to substance
|
ISO
|
DNMT1 protein affects the susceptibility to Bleomycin
|
CTD |
PMID:17991895 |
|
NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119
|
|
G
|
Dpep1
|
dipeptidase 1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of DPEP1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr19:68,118,270...68,143,781
Ensembl chr19:68,118,453...68,143,775
|
|
G
|
Ech1
|
enoyl-CoA hydratase 1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of ECH1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 1:93,241,076...93,248,314
Ensembl chr 1:93,241,734...93,248,440
|
|
G
|
Edn1
|
endothelin 1
|
multiple interactions increases expression
|
EXP
|
Phytochemicals inhibits the reaction [Bleomycin results in increased expression of EDN1 mRNA]
|
CTD |
PMID:26093215 |
|
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
|
|
G
|
Eef1a1
|
eukaryotic translation elongation factor 1 alpha 1
|
increases expression
|
ISO
|
Bleomycin results in increased expression of EEF1A1 protein
|
CTD |
PMID:29733421 |
|
NCBI chr 8:88,221,839...88,225,688
Ensembl chr 8:88,221,843...88,225,072
|
|
G
|
Egr1
|
early growth response 1
|
increases expression multiple interactions affects expression
|
ISO
|
Bleomycin results in increased expression of EGR1 mRNA rosiglitazone inhibits the reaction [Bleomycin results in increased expression of EGR1 mRNA] Bleomycin affects the expression of EGR1 mRNA
|
CTD |
PMID:19147827 PMID:26345256 |
|
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
|
|
G
|
Egr2
|
early growth response 2
|
affects expression
|
ISO
|
Bleomycin affects the expression of EGR2 mRNA
|
CTD |
PMID:26345256 |
|
NCBI chr20:21,050,149...21,055,201
Ensembl chr20:21,050,149...21,057,748
|
|
G
|
Ehd1
|
EH-domain containing 1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of EHD1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 1:213,009,113...213,031,488
Ensembl chr 1:213,008,049...213,031,485
|
|
G
|
Ehd2
|
EH-domain containing 2
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of EHD2 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 1:85,767,757...85,786,974
Ensembl chr 1:85,768,667...85,786,943
|
|
G
|
Eif5a
|
eukaryotic translation initiation factor 5A
|
increases expression
|
EXP
|
Bleomycin results in increased expression of EIF5A protein
|
CTD |
PMID:25933445 |
|
NCBI chr10:55,138,821...55,143,272
Ensembl chr10:55,138,823...55,143,330
|
|
G
|
Eln
|
elastin
|
increases expression
|
ISO
|
Bleomycin results in increased expression of ELN mRNA
|
CTD |
PMID:26817844 |
|
NCBI chr12:27,604,983...27,648,413
Ensembl chr12:27,604,680...27,648,413
|
|
G
|
Emcn
|
endomucin
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of EMCN mRNA Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of EMCN mRNA]; lenabasum inhibits the reaction [Bleomycin results in increased expression of EMCN mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr 2:228,564,445...228,644,370
Ensembl chr 2:228,564,430...228,645,155
|
|
G
|
Eng
|
endoglin
|
multiple interactions increases expression
|
ISO
|
Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of ENG protein]
|
CTD |
PMID:30825431 |
|
NCBI chr 3:36,332,190...36,370,324
Ensembl chr 3:36,326,202...36,370,933
|
|
G
|
Epx
|
eosinophil peroxidase
|
increases expression
|
EXP
|
Bleomycin results in increased expression of EPX protein
|
CTD |
PMID:26093215 |
|
NCBI chr10:73,164,096...73,175,180
Ensembl chr10:73,164,096...73,175,180
|
|
G
|
Errfi1
|
ERBB receptor feedback inhibitor 1
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of ERRFI1 mRNA
|
CTD |
PMID:33770205 |
|
NCBI chr 5:166,606,841...166,620,124
Ensembl chr 5:166,606,834...166,620,432
|
|
G
|
Espl1
|
extra spindle pole bodies like 1, separase
|
multiple interactions decreases expression
|
ISO
|
Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of ESPL1 mRNA]; lenabasum inhibits the reaction [Bleomycin results in decreased expression of ESPL1 mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr 7:135,302,460...135,329,570
Ensembl chr 7:135,302,716...135,329,570
|
|
G
|
Ets1
|
ETS proto-oncogene 1, transcription factor
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of ETS1 mRNA
|
CTD |
PMID:28726637 |
|
NCBI chr 8:39,303,936...39,426,022
Ensembl chr 8:39,303,925...39,426,021
|
|
G
|
Ets2
|
ETS proto-oncogene 2, transcription factor
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of ETS2 mRNA
|
CTD |
PMID:28726637 |
|
NCBI chr11:48,491,057...48,507,843
Ensembl chr11:48,491,394...48,507,842
|
|
G
|
Ezr
|
ezrin
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of EZR protein
|
CTD |
PMID:25933445 |
|
NCBI chr 1:49,373,033...49,416,573
Ensembl chr 1:49,373,035...49,416,573
|
|
G
|
F2rl1
|
F2R like trypsin receptor 1
|
multiple interactions increases expression
|
EXP
|
allyl sulfide inhibits the reaction [Bleomycin results in increased expression of F2RL1 mRNA]; allyl sulfide inhibits the reaction [Bleomycin results in increased expression of F2RL1 protein] Bleomycin results in increased expression of F2RL1 mRNA; Bleomycin results in increased expression of F2RL1 protein
|
CTD |
PMID:23656969 |
|
NCBI chr 2:28,507,003...28,519,954
Ensembl chr 2:28,507,003...28,519,954
|
|
G
|
Fabp4
|
fatty acid binding protein 4
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of FABP4 mRNA
|
CTD |
PMID:29408570 |
|
NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972
|
|
G
|
Faslg
|
Fas ligand
|
increases expression
|
ISO
|
Bleomycin results in increased expression of FASLG mRNA
|
CTD |
PMID:11350791 |
|
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
|
|
G
|
Fgf1
|
fibroblast growth factor 1
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of FGF1 protein Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of FGF1 protein]
|
CTD |
PMID:30825431 |
|
NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,939,870...30,961,393
|
|
G
|
Fgf2
|
fibroblast growth factor 2
|
increases expression multiple interactions
|
EXP ISO
|
Bleomycin results in increased expression of FGF2 protein protocatechualdehyde inhibits the reaction [Bleomycin results in increased expression of FGF2 protein] Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of FGF2 protein]
|
CTD |
PMID:25582705 PMID:30825431 |
|
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493
|
|
G
|
Fgf21
|
fibroblast growth factor 21
|
decreases expression multiple interactions
|
ISO
|
Bleomycin results in decreased expression of FGF21 protein Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of FGF21 protein]
|
CTD |
PMID:30825431 |
|
NCBI chr 1:105,219,825...105,221,376
Ensembl chr 1:105,219,825...105,232,056
|
|
G
|
Fgf7
|
fibroblast growth factor 7
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of FGF7 protein Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of FGF7 protein]; lenabasum inhibits the reaction [Bleomycin results in increased expression of FGF7 protein]
|
CTD |
PMID:30825431 |
|
NCBI chr 3:133,734,557...133,786,678
Ensembl chr 3:133,734,673...133,786,328
|
|
G
|
Fhl1
|
four and a half LIM domains 1
|
increases expression
|
EXP
|
Bleomycin results in increased expression of FHL1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr X:139,592,794...139,652,290
Ensembl chr X:139,592,604...139,652,282
|
|
G
|
Fkbp10
|
FKBP prolyl isomerase 10
|
increases expression
|
ISO
|
Bleomycin results in increased expression of FKBP10 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr10:85,845,801...85,858,361
Ensembl chr10:85,844,703...85,858,355
|
|
G
|
Fn1
|
fibronectin 1
|
increases expression multiple interactions
|
EXP ISO
|
Bleomycin results in increased expression of FN1 protein [Bleomycin co-treated with Soot] results in increased expression of FN1 protein; Dexamethasone inhibits the reaction [Bleomycin results in increased expression of FN1 mRNA]; Dexamethasone inhibits the reaction [Bleomycin results in increased expression of FN1 protein]; geranylgeranylacetone inhibits the reaction [Bleomycin results in increased expression of FN1 mRNA]; geranylgeranylacetone inhibits the reaction [Bleomycin results in increased expression of FN1 protein]; Grape Seed Extract inhibits the reaction [Bleomycin results in increased expression of FN1 mRNA]; Grape Seed Extract inhibits the reaction [Bleomycin results in increased expression of FN1 protein]; honokiol inhibits the reaction [Bleomycin results in increased expression of FN1 protein]; MIR182 affects the reaction [Bleomycin results in increased expression of FN1 protein]; OGG1 protein affects the reaction [Bleomycin results in increased expression of FN1 protein]; OGG1 protein inhibits the reaction [TH5487 inhibits the reaction [Bleomycin results in increased expression of FN1 protein]]; OGG1 protein promotes the reaction [Bleomycin results in increased expression of FN1 protein]; pirfenidone inhibits the reaction [Bleomycin results in increased expression of FN1 protein]; Soot promotes the reaction [Bleomycin results in increased expression of FN1 mRNA]; TH5487 inhibits the reaction [Bleomycin results in increased expression of FN1 protein]; Thioctic Acid inhibits the reaction [Bleomycin results in increased expression of FN1 mRNA] Bleomycin results in increased expression of FN1 mRNA; Bleomycin results in increased expression of FN1 protein pachymic acid inhibits the reaction [Bleomycin results in increased expression of FN1 protein]
|
CTD |
PMID:25071917 PMID:25933445 PMID:26345256 PMID:26817844 PMID:28300665 PMID:31302203 PMID:31884830 PMID:32032644 PMID:34460027 PMID:35187969 PMID:35267148 PMID:35654123 PMID:37163307 PMID:37307957 PMID:37399107 More...
|
|
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137
|
|
G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
increases activity multiple interactions
|
ISO
|
Bleomycin results in increased activity of FOS protein Bleomycin results in increased expression of [JUN protein binds to FOS protein]
|
CTD |
PMID:12003776 PMID:37399107 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
G
|
Foxp3
|
forkhead box P3
|
increases expression
|
ISO
|
Bleomycin results in increased expression of FOXP3 mRNA
|
CTD |
PMID:29033951 |
|
NCBI chr X:17,580,380...17,601,181
Ensembl chr X:17,580,380...17,595,894
|
|
G
|
Foxq1
|
forkhead box Q1
|
increases expression
|
ISO
|
Bleomycin results in increased expression of FOXQ1 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr17:33,121,454...33,124,087
Ensembl chr17:33,121,545...33,123,720
|
|
G
|
Foxr1
|
forkhead box R1
|
increases expression
|
ISO
|
Bleomycin results in increased expression of FOXR1 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 8:53,657,388...53,669,424
Ensembl chr 8:53,657,256...53,669,629
|
|
G
|
Fshb
|
follicle stimulating hormone subunit beta
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of FSHB protein thymoquinone inhibits the reaction [Bleomycin results in increased expression of FSHB protein]
|
CTD |
PMID:34818114 |
|
NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:114,003,262...114,007,072
|
|
G
|
Fshr
|
follicle stimulating hormone receptor
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of FSHR mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr 6:10,952,329...11,160,288
Ensembl chr 6:10,952,329...11,160,288
|
|
G
|
Fubp1
|
far upstream element binding protein 1
|
increases expression
|
EXP
|
Bleomycin results in increased expression of FUBP1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 2:243,819,529...243,846,544
Ensembl chr 2:243,819,218...243,846,428
|
|
G
|
Fzd6
|
frizzled class receptor 6
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of FZD6 mRNA MIR101-1 mRNA inhibits the reaction [Bleomycin results in increased expression of FZD6 mRNA]
|
CTD |
PMID:28726637 |
|
NCBI chr 7:71,939,916...71,971,685
Ensembl chr 7:71,939,973...71,971,680
|
|
G
|
Gabra4
|
gamma-aminobutyric acid type A receptor subunit alpha 4
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of GABRA4 mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr14:36,944,747...37,021,652
Ensembl chr14:36,944,388...37,021,648
|
|
G
|
Gabrb2
|
gamma-aminobutyric acid type A receptor subunit beta 2
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of GABRB2 mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr10:27,438,127...27,657,680
Ensembl chr10:27,438,238...27,655,171
|
|
G
|
Gabrg2
|
gamma-aminobutyric acid type A receptor subunit gamma 2
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of GABRG2 mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,876,926...26,965,523
|
|
G
|
Gabrr1
|
gamma-aminobutyric acid type A receptor subunit rho 1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of GABRR1 mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr 5:52,320,475...52,357,549
Ensembl chr 5:52,320,475...52,357,549
|
|
G
|
Ganab
|
glucosidase II alpha subunit
|
multiple interactions
|
ISO
|
[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of GANAB protein
|
CTD |
PMID:29733421 |
|
NCBI chr 1:215,222,918...215,242,808
Ensembl chr 1:215,222,995...215,243,036
|
|
G
|
Gas6
|
growth arrest specific 6
|
increases expression
|
ISO
|
Bleomycin results in increased expression of GAS6 protein
|
CTD |
PMID:29175452 |
|
NCBI chr16:82,747,676...82,778,090
Ensembl chr16:82,747,345...82,778,088
|
|
G
|
Gata3
|
GATA binding protein 3
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of GATA3 mRNA S1PR5 protein affects the reaction [Bleomycin results in increased expression of GATA3 mRNA]
|
CTD |
PMID:29033951 |
|
NCBI chr17:73,544,234...73,575,670
Ensembl chr17:73,553,548...73,575,670
|
|
G
|
Gc
|
GC, vitamin D binding protein
|
increases expression
|
EXP
|
Bleomycin results in increased expression of GC protein
|
CTD |
PMID:25933445 |
|
NCBI chr14:18,916,255...18,951,670
Ensembl chr14:18,916,246...18,951,673
|
|
G
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit
|
multiple interactions decreases expression
|
ISO
|
caffeic acid phenethyl ester inhibits the reaction [Bleomycin results in decreased expression of GCLC protein]
|
CTD |
PMID:23570914 |
|
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
|
|
G
|
Gda
|
guanine deaminase
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of GDA protein
|
CTD |
PMID:25933445 |
|
NCBI chr 1:228,333,401...228,408,901
Ensembl chr 1:228,333,364...228,409,348
|
|
G
|
Glb1
|
galactosidase, beta 1
|
increases activity
|
ISO
|
Bleomycin results in increased activity of GLB1 protein
|
CTD |
PMID:32554301 |
|
NCBI chr 8:122,963,718...123,036,326
Ensembl chr 8:122,963,718...123,036,326
|
|
G
|
Gpi
|
glucose-6-phosphate isomerase
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of GPI protein
|
CTD |
PMID:25933445 |
|
NCBI chr 1:95,965,389...95,996,932
Ensembl chr 1:95,965,396...95,993,261
|
|
G
|
Gpx1
|
glutathione peroxidase 1
|
affects expression
|
EXP
|
Bleomycin affects the expression of GPX1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
G
|
Gria2
|
glutamate ionotropic receptor AMPA type subunit 2
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of GRIA2 mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:168,247,496...168,367,616
|
|
G
|
Grik3
|
glutamate ionotropic receptor kainate type subunit 3
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of GRIK3 mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr 5:143,052,442...143,268,873
Ensembl chr 5:143,052,442...143,268,873
|
|
G
|
Grpr
|
gastrin releasing peptide receptor
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of GRPR mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr X:34,630,238...34,670,245
Ensembl chr X:34,630,229...34,670,245
|
|
G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
multiple interactions increases phosphorylation
|
ISO
|
[2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of GSK3B protein] which results in decreased susceptibility to Bleomycin; [Bleomycin results in increased phosphorylation of GSK3B protein] inhibits the reaction [GSK3B protein binds to and results in increased stability of NFKBIA protein]
|
CTD |
PMID:19429264 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
|
|
G
|
Gsn
|
gelsolin
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of GSN protein
|
CTD |
PMID:25933445 |
|
NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:38,982,671...39,035,850
|
|
G
|
Gsr
|
glutathione-disulfide reductase
|
decreases activity multiple interactions
|
EXP
|
Bleomycin results in decreased activity of GSR protein celastrol inhibits the reaction [Bleomycin results in decreased activity of GSR protein]
|
CTD |
PMID:26768587 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
G
|
Gstm1
|
glutathione S-transferase mu 1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of GSTM1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569
|
|
G
|
H1f0
|
H1.0 linker histone
|
affects expression
|
EXP
|
Bleomycin affects the expression of H1F0 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 7:112,473,280...112,475,140
Ensembl chr 7:112,473,222...112,475,006
|
|
G
|
H1f4
|
H1.4 linker histone, cluster member
|
affects expression
|
EXP
|
Bleomycin affects the expression of H1F4 protein
|
CTD |
PMID:25933445 |
|
NCBI chr17:41,914,425...41,915,206
Ensembl chr17:41,914,431...41,916,129
|
|
G
|
H2ax
|
H2A.X variant histone
|
increases expression
|
ISO
|
Bleomycin results in increased expression of H2AX protein
|
CTD |
PMID:25130544 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
G
|
Hadha
|
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of HADHA protein
|
CTD |
PMID:25933445 |
|
NCBI chr 6:31,907,801...31,947,434
Ensembl chr 6:31,907,291...31,947,698
|
|
G
|
Havcr1
|
hepatitis A virus cellular receptor 1
|
increases expression
|
ISO
|
Bleomycin results in increased expression of HAVCR1 protein
|
CTD |
PMID:29175452 |
|
NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,619,897...31,653,268
|
|
G
|
Hbb
|
hemoglobin subunit beta
|
affects expression
|
EXP
|
Bleomycin affects the expression of HBB protein
|
CTD |
PMID:25933445 |
|
NCBI chr 1:167,662,310...167,663,721
Ensembl chr 1:167,630,245...167,663,873
|
|
G
|
Hbb-b2
|
hemoglobin, beta adult minor chain
|
affects expression
|
EXP
|
Bleomycin affects the expression of HBB-B2 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 1:167,655,583...167,656,963
|
|
G
|
Hbegf
|
heparin-binding EGF-like growth factor
|
increases expression
|
ISO
|
Bleomycin results in increased expression of HBEGF mRNA
|
CTD |
PMID:18684396 |
|
NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,380,337...28,390,220
|
|
G
|
Hcls1
|
hematopoietic cell specific Lyn substrate 1
|
multiple interactions increases expression
|
ISO
|
Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of HCLS1 mRNA]; lenabasum inhibits the reaction [Bleomycin results in increased expression of HCLS1 mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr11:77,322,873...77,346,333
Ensembl chr11:77,322,873...77,346,387
|
|
G
|
Hgf
|
hepatocyte growth factor
|
decreases expression multiple interactions increases secretion increases expression
|
EXP ISO
|
Bleomycin results in decreased expression of HGF mRNA; Bleomycin results in decreased expression of HGF protein Valsartan inhibits the reaction [Bleomycin results in decreased expression of HGF mRNA]; Valsartan inhibits the reaction [Bleomycin results in decreased expression of HGF protein] Bleomycin results in increased secretion of HGF protein Bleomycin results in increased expression of HGF mRNA Berberine inhibits the reaction [Bleomycin results in decreased expression of HGF mRNA]; Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of HGF protein]; lenabasum promotes the reaction [Bleomycin results in decreased expression of HGF protein]
|
CTD |
PMID:16115399 PMID:22687607 PMID:29408570 PMID:30825431 |
|
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851
|
|
G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
multiple interactions increases expression
|
ISO
|
[HIF1A protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of CCN2 mRNA]; [HIF1A protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; [HIF1A protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of TGFB2 mRNA]; [HIF1A protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of TGFBR1 mRNA]; [HIF1A protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of TGFBR2 mRNA]; Dinoprostone inhibits the reaction [Bleomycin results in increased expression of HIF1A mRNA]; HIF1A protein affects the reaction [Dinoprostone inhibits the reaction [Bleomycin results in increased expression of TGFB3 mRNA]]
|
CTD |
PMID:28434932 |
|
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
G
|
Hist1h2bg
|
histone cluster 1, H2bg
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of HIST1H2BG protein
|
CTD |
PMID:25933445 |
|
NCBI chr17:41,999,269...42,000,237
Ensembl chr17:41,998,640...42,000,585
|
|
G
|
Hmces
|
5-hydroxymethylcytosine binding, ES cell specific
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of HMCES mRNA
|
CTD |
PMID:33770205 |
|
NCBI chr 4:121,950,129...121,972,937
Ensembl chr 4:121,950,840...121,972,891
|
|
G
|
Hmgb1
|
high mobility group box 1
|
multiple interactions increases expression
|
EXP ISO
|
protocatechualdehyde inhibits the reaction [Bleomycin results in increased expression of HMGB1 protein] Bleomycin inhibits the reaction [Azacitidine results in decreased expression of and results in increased secretion of HMGB1 protein]; Bleomycin inhibits the reaction [Azacitidine results in decreased expression of HMGB1 mRNA]
|
CTD |
PMID:25582705 PMID:32278510 |
|
NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327 Ensembl chr12:39,039,050...39,041,327
|
|
G
|
Hmox1
|
heme oxygenase 1
|
increases expression multiple interactions decreases expression
|
ISO EXP
|
Bleomycin results in increased expression of HMOX1 protein PPARA protein affects the reaction [Bleomycin results in increased expression of HMOX1 protein] Bleomycin results in increased expression of HMOX1 mRNA Bleomycin results in decreased expression of HMOX1 protein celastrol inhibits the reaction [Bleomycin results in decreased expression of HMOX1 protein]; Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of HMOX1 mRNA]; Phytochemicals inhibits the reaction [Bleomycin results in increased expression of HMOX1 mRNA]
|
CTD |
PMID:16317386 PMID:26093215 PMID:26768587 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
G
|
Hnrnpa2b1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
increases expression
|
EXP
|
Bleomycin results in increased expression of HNRNPA2B1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 4:81,867,354...81,875,886
Ensembl chr 4:81,869,661...81,877,572
|
|
G
|
Hnrnpa3
|
heterogeneous nuclear ribonucleoprotein A3
|
increases expression
|
EXP
|
Bleomycin results in increased expression of HNRNPA3 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 3:80,984,470...80,999,413
Ensembl chr 3:80,985,969...80,996,043
|
|
G
|
Hpx
|
hemopexin
|
increases expression
|
EXP
|
Bleomycin results in increased expression of HPX protein
|
CTD |
PMID:25933445 |
|
NCBI chr 1:169,344,647...169,352,155
Ensembl chr 1:169,344,583...169,352,156
|
|
G
|
Hsp90aa1
|
heat shock protein 90 alpha family class A member 1
|
multiple interactions
|
EXP
|
[Bleomycin co-treated with Cisplatin co-treated with Etoposide] results in increased expression of HSP90AA1 protein
|
CTD |
PMID:24478030 |
|
NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:135,523,616...135,528,499
|
|
G
|
Hsp90b1
|
heat shock protein 90 beta family member 1
|
multiple interactions
|
EXP
|
[Bleomycin co-treated with Cisplatin co-treated with Etoposide] results in increased expression of HSP90B1 protein
|
CTD |
PMID:24478030 |
|
NCBI chr 7:22,997,962...23,012,293
Ensembl chr 7:22,997,962...23,012,293
|
|
G
|
Hspa1a
|
heat shock protein family A (Hsp70) member 1A
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of HSPA1A mRNA geranylgeranylacetone promotes the reaction [Bleomycin results in increased expression of HSPA1A mRNA]
|
CTD |
PMID:37307957 |
|
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979
|
|
G
|
Hspa1b
|
heat shock protein family A (Hsp70) member 1B
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of HSPA1B mRNA geranylgeranylacetone promotes the reaction [Bleomycin results in increased expression of HSPA1B mRNA]
|
CTD |
PMID:37307957 |
|
NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,855,780...3,877,979
|
|
G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
increases expression multiple interactions
|
EXP
|
Bleomycin results in increased expression of HSPA5 protein pachymic acid inhibits the reaction [Bleomycin results in increased expression of HSPA5 protein]
|
CTD |
PMID:25933445 PMID:37163307 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
G
|
Hspb1
|
heat shock protein family B (small) member 1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of HSPB1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301
|
|
G
|
Hspe1
|
heat shock protein family E (Hsp10) member 1
|
increases expression
|
EXP ISO
|
Bleomycin results in increased expression of HSPE1 protein
|
CTD |
PMID:25933445 PMID:29733421 |
|
NCBI chr 9:64,084,327...64,087,415
Ensembl chr 9:64,085,068...64,087,502
|
|
G
|
Htr1f
|
5-hydroxytryptamine receptor 1F
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of HTR1F mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr11:16,089,266...16,090,665
Ensembl chr11:16,081,053...16,274,580
|
|
G
|
Htr5a
|
5-hydroxytryptamine receptor 5A
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of HTR5A mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr 4:8,178,802...8,188,485
Ensembl chr 4:8,178,802...8,200,482
|
|
G
|
Htr5b
|
5-hydroxytryptamine (serotonin) receptor 5B
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of HTR5B mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr13:35,239,662...35,252,586
Ensembl chr13:35,239,662...35,252,586
|
|
G
|
Icam1
|
intercellular adhesion molecule 1
|
increases expression
|
ISO
|
Bleomycin results in increased expression of ICAM1 mRNA
|
CTD |
PMID:29033951 PMID:29720568 |
|
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
G
|
Idh2
|
isocitrate dehydrogenase (NADP(+)) 2
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of IDH2 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:143,439,323...143,467,248
|
|
G
|
Ifitm1
|
interferon induced transmembrane protein 1
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of IFITM1 mRNA Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of IFITM1 mRNA]; lenabasum inhibits the reaction [Bleomycin results in increased expression of IFITM1 mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr 1:205,496,757...205,498,796
Ensembl chr 1:205,496,807...205,498,776
|
|
G
|
Ifng
|
interferon gamma
|
increases expression decreases expression multiple interactions
|
ISO EXP
|
Bleomycin results in increased expression of IFNG mRNA Bleomycin results in decreased expression of IFNG mRNA [SPL-334 co-treated with Bleomycin] results in increased expression of IFNG protein Bleomycin results in decreased expression of IFNG protein [Bleomycin co-treated with Tobacco Smoke Pollution] results in increased expression of IFNG protein
|
CTD |
PMID:11350791 PMID:25071917 PMID:26209236 PMID:29408570 PMID:33516805 PMID:36087614 More...
|
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
G
|
Igf1
|
insulin-like growth factor 1
|
increases expression
|
ISO
|
Bleomycin results in increased expression of IGF1 mRNA
|
CTD |
PMID:1705203 |
|
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
G
|
Ikbip
|
IKBKB interacting protein
|
increases expression
|
ISO
|
Bleomycin results in increased expression of IKBIP mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 7:27,467,097...27,485,776
Ensembl chr 7:27,467,055...27,491,460
|
|
G
|
Il10
|
interleukin 10
|
increases expression multiple interactions increases secretion
|
ISO
|
Bleomycin results in increased expression of IL10 protein yupingfeng inhibits the reaction [Bleomycin results in increased secretion of IL10 protein] bufotalin inhibits the reaction [Bleomycin results in increased expression of IL10 protein]
|
CTD |
PMID:29175452 PMID:37898439 PMID:38158113 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
G
|
Il10ra
|
interleukin 10 receptor subunit alpha
|
increases expression
|
ISO
|
Bleomycin results in increased expression of IL10RA mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 8:54,459,754...54,474,786
Ensembl chr 8:54,459,882...54,475,028
|
|
G
|
Il12b
|
interleukin 12B
|
increases expression
|
ISO
|
Bleomycin results in increased expression of IL12B mRNA; Bleomycin results in increased expression of IL12B protein
|
CTD |
PMID:11350791 |
|
NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194
|
|
G
|
Il12rb2
|
interleukin 12 receptor subunit beta 2
|
increases expression
|
ISO
|
Bleomycin results in increased expression of IL12RB2 mRNA
|
CTD |
PMID:11350791 |
|
NCBI chr 4:97,756,089...97,844,937
Ensembl chr 4:97,756,089...97,844,937
|
|
G
|
Il13
|
interleukin 13
|
decreases response to substance multiple interactions increases expression
|
ISO
|
IL13 gene mutant form results in decreased susceptibility to Bleomycin bufotalin inhibits the reaction [Bleomycin results in increased expression of IL13 protein]; IL13 protein affects the reaction [Bleomycin results in increased expression of RETNLA mRNA]
|
CTD |
PMID:15322207 PMID:38158113 |
|
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:38,290,926...38,293,483
|
|
G
|
Il13ra1
|
interleukin 13 receptor subunit alpha 1
|
multiple interactions increases expression
|
ISO
|
Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of IL13RA1 mRNA]; lenabasum inhibits the reaction [Bleomycin results in increased expression of IL13RA1 mRNA]
|
CTD |
PMID:30825431 PMID:36087614 |
|
NCBI chr X:120,213,670...120,294,777
Ensembl chr X:120,214,075...120,274,461
|
|
G
|
Il17a
|
interleukin 17A
|
multiple interactions increases expression
|
ISO
|
Curcumin inhibits the reaction [Bleomycin results in increased expression of IL17A mRNA]
|
CTD |
PMID:35716765 |
|
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331
|
|
G
|
Il17rd
|
interleukin 17 receptor D
|
increases expression
|
ISO
|
Bleomycin results in increased expression of IL17RD mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr16:2,235,172...2,489,827
Ensembl chr16:2,235,169...2,301,850
|
|
G
|
Il17re
|
interleukin 17 receptor E
|
increases expression
|
ISO
|
Bleomycin results in increased expression of IL17RE mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 4:148,160,384...148,173,830
Ensembl chr 4:148,159,475...148,173,827
|
|
G
|
Il1a
|
interleukin 1 alpha
|
multiple interactions increases expression
|
ISO
|
5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [Bleomycin results in increased expression of IL1A mRNA]; Apigenin inhibits the reaction [Bleomycin results in increased expression of IL1A mRNA]; IL1A protein promotes the reaction [Bleomycin results in increased expression of CAT protein]; IL1A protein promotes the reaction [Bleomycin results in increased expression of SOD1 protein]; IL1A protein promotes the reaction [Bleomycin results in increased expression of SOD2 protein]; methyl caffeate inhibits the reaction [Bleomycin results in increased expression of IL1A mRNA] Bleomycin results in increased expression of IL1A protein
|
CTD |
PMID:8317554 PMID:28299617 PMID:29175452 PMID:32554301 |
|
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
|
|
G
|
Il1b
|
interleukin 1 beta
|
multiple interactions increases expression increases secretion affects expression
|
ISO EXP
|
12-(3-adamantan-1-ylureido)dodecanoic acid inhibits the reaction [Bleomycin results in increased expression of IL1B mRNA]; 12-(3-adamantan-1-ylureido)dodecanoic acid inhibits the reaction [Bleomycin results in increased expression of IL1B protein]; 2-((dimethylamino)methyl)-9-hydroxythieno(2,3-c)isoquinolin-5(4H)-one inhibits the reaction [Bleomycin results in increased expression of IL1B protein]; [Bleomycin co-treated with Cannabidiol analog] results in decreased expression of IL1B mRNA; [Bleomycin co-treated with Rosiglitazone] results in decreased expression of IL1B mRNA; bufotalin inhibits the reaction [Bleomycin results in increased expression of IL1B protein]; Calcitriol inhibits the reaction [Bleomycin results in increased expression of IL1B mRNA]; CEBPB protein affects the reaction [Bleomycin results in increased expression of IL1B mRNA]; Dexamethasone inhibits the reaction [Bleomycin results in increased expression of IL1B mRNA]; Dexamethasone inhibits the reaction [Bleomycin results in increased expression of IL1B protein]; Grape Seed Extract inhibits the reaction [Bleomycin results in increased expression of IL1B mRNA]; honokiol inhibits the reaction [Bleomycin results in increased expression of IL1B protein]; N-((3-(aminomethyl)phenyl)methyl)ethanimidamide inhibits the reaction [Bleomycin results in increased expression of IL1B mRNA]; pirinixic acid inhibits the reaction [Bleomycin results in increased expression of IL1B protein]; PPARA protein affects the reaction [Bleomycin results in increased expression of IL1B protein]; Rosiglitazone inhibits the reaction [Bleomycin results in increased expression of IL1B protein]; SLCO2A1 gene mutant form promotes the reaction [Bleomycin results in increased expression of IL1B mRNA]; TRPM2 gene mutant form inhibits the reaction [Bleomycin results in increased secretion of IL1B protein]; verlukast inhibits the reaction [Bleomycin results in increased expression of IL1B protein]; zileuton inhibits the reaction [Bleomycin results in increased expression of IL1B protein] Bleomycin results in increased expression of IL1B mRNA; Bleomycin results in increased expression of IL1B protein Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of IL1B mRNA]; Phytochemicals inhibits the reaction [Bleomycin results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [Bleomycin results in increased expression of IL1B protein] 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [Bleomycin results in increased expression of IL1B mRNA]; Apigenin inhibits the reaction [Bleomycin results in increased expression of IL1B mRNA]; IL1B protein promotes the reaction [Bleomycin results in increased expression of CAT protein]; IL1B protein promotes the reaction [Bleomycin results in increased expression of SOD1 protein]; IL1B protein promotes the reaction [Bleomycin results in increased expression of SOD2 protein]; methyl caffeate inhibits the reaction [Bleomycin results in increased expression of IL1B mRNA]; yupingfeng inhibits the reaction [Bleomycin results in increased secretion of IL1B protein] Bleomycin affects the expression of IL1B mRNA
|
CTD |
PMID:8317554 PMID:8473757 PMID:16317386 PMID:17035056 PMID:17118201 PMID:17177178 PMID:19147827 PMID:22687607 PMID:26093215 PMID:26520185 PMID:26526764 PMID:26600069 PMID:27704718 PMID:28299617 PMID:28300665 PMID:28694203 PMID:30033591 PMID:32032644 PMID:32554301 PMID:32828905 PMID:35267148 PMID:36087614 PMID:37898439 PMID:38158113 More...
|
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
G
|
Il1rl1
|
interleukin 1 receptor-like 1
|
increases expression
|
ISO
|
Bleomycin results in increased expression of IL1RL1 mRNA; Bleomycin results in increased expression of IL1RL1 protein
|
CTD |
PMID:37399107 |
|
NCBI chr 9:50,157,326...50,222,888
Ensembl chr 9:50,204,551...50,222,891
|
|
G
|
Il2
|
interleukin 2
|
multiple interactions
|
EXP
|
[Bleomycin co-treated with Tobacco Smoke Pollution] results in increased expression of IL2 protein
|
CTD |
PMID:33516805 |
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
|
|
G
|
Il33
|
interleukin 33
|
increases expression
|
ISO
|
Bleomycin results in increased expression of IL33 mRNA; Bleomycin results in increased expression of IL33 protein
|
CTD |
PMID:36087614 PMID:37399107 |
|
NCBI chr 1:237,115,478...237,149,897
Ensembl chr 1:237,115,572...237,150,901
|
|
G
|
Il4
|
interleukin 4
|
increases expression decreases response to substance multiple interactions affects response to substance increases secretion
|
ISO
|
Bleomycin results in increased expression of IL4 mRNA IL4 gene mutant form results in decreased susceptibility to Bleomycin Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of IL4 mRNA]; IL4 protein affects the reaction [Bleomycin results in increased expression of RETNLA mRNA]; Rosiglitazone inhibits the reaction [Bleomycin results in increased expression of IL4 mRNA] IL4 protein affects the susceptibility to Bleomycin Bleomycin results in increased secretion of IL4 protein yupingfeng inhibits the reaction [Bleomycin results in increased secretion of IL4 protein]
|
CTD |
PMID:11554783 PMID:12574379 PMID:15322207 PMID:30033591 PMID:37898439 |
|
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
|
|
G
|
Il6
|
interleukin 6
|
increases expression multiple interactions increases secretion
|
ISO EXP
|
Bleomycin results in increased expression of IL6 mRNA; Bleomycin results in increased expression of IL6 protein 1-hydroxyalantolactone inhibits the reaction [Bleomycin results in increased secretion of IL6 protein]; allyl sulfide inhibits the reaction [Bleomycin results in increased expression of IL6 protein]; Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of IL6 mRNA]; Phytochemicals inhibits the reaction [Bleomycin results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [Bleomycin results in increased expression of IL6 protein] Calcitriol inhibits the reaction [Bleomycin results in increased expression of IL6 mRNA]; Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of IL6 mRNA]; Curcumin inhibits the reaction [Bleomycin results in increased expression of IL6 mRNA]; Curcumin inhibits the reaction [Bleomycin results in increased expression of IL6 protein]; Dexamethasone inhibits the reaction [Bleomycin results in increased expression of IL6 mRNA]; Grape Seed Extract inhibits the reaction [Bleomycin results in increased expression of IL6 mRNA]; honokiol inhibits the reaction [Bleomycin results in increased expression of IL6 protein]; Oils, Volatile inhibits the reaction [Bleomycin results in increased expression of IL6 protein]; Rosiglitazone inhibits the reaction [Bleomycin results in increased expression of IL6 mRNA]; SPL-334 inhibits the reaction [Bleomycin results in increased expression of IL6 protein] 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [Bleomycin results in increased expression of IL6 mRNA]; Apigenin inhibits the reaction [Bleomycin results in increased expression of IL6 mRNA]; astragalin inhibits the reaction [Bleomycin results in increased secretion of IL6 protein]; aurantio-obtusin inhibits the reaction [Bleomycin results in increased secretion of IL6 protein]; caffeic acid inhibits the reaction [Bleomycin results in increased secretion of IL6 protein]; eleutheroside E inhibits the reaction [Bleomycin results in increased secretion of IL6 protein]; Ephedrine inhibits the reaction [Bleomycin results in increased secretion of IL6 protein]; linarin inhibits the reaction [Bleomycin results in increased secretion of IL6 protein]; methyl caffeate inhibits the reaction [Bleomycin results in increased expression of IL6 mRNA]; methyl caffeate inhibits the reaction [Bleomycin results in increased secretion of IL6 protein]; rhoifolin inhibits the reaction [Bleomycin results in increased secretion of IL6 protein]; scoparone inhibits the reaction [Bleomycin results in increased secretion of IL6 protein]
|
CTD |
PMID:17035056 PMID:18684396 PMID:23656969 PMID:25071917 PMID:26093215 PMID:26209236 PMID:26520185 PMID:28299617 PMID:28300665 PMID:28850077 PMID:30033591 PMID:32032644 PMID:32554301 PMID:34758440 PMID:35267148 PMID:35716765 PMID:36087614 PMID:37778983 More...
|
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
G
|
Il7
|
interleukin 7
|
increases expression
|
ISO
|
Bleomycin results in increased expression of IL7 protein
|
CTD |
PMID:36087614 |
|
NCBI chr 2:96,142,523...96,186,282
Ensembl chr 2:96,142,092...96,187,389
|
|
G
|
Insig1
|
insulin induced gene 1
|
multiple interactions decreases expression
|
ISO
|
Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of INSIG1 mRNA]; lenabasum inhibits the reaction [Bleomycin results in decreased expression of INSIG1 mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778
|
|
G
|
Itgb2
|
integrin subunit beta 2
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of ITGB2 mRNA Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of ITGB2 mRNA]; lenabasum inhibits the reaction [Bleomycin results in increased expression of ITGB2 mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr20:11,061,009...11,097,242
Ensembl chr20:11,058,492...11,097,182
|
|
G
|
Jpt1
|
Jupiter microtubule associated homolog 1
|
increases expression
|
EXP
|
Bleomycin results in increased expression of JPT1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr10:101,243,428...101,261,464
Ensembl chr10:101,243,424...101,261,469
|
|
G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
increases activity increases phosphorylation multiple interactions
|
ISO
|
Bleomycin results in increased activity of JUN protein Bleomycin results in increased phosphorylation of JUN protein Bleomycin results in increased expression of [JUN protein binds to FOS protein]; Curcumin inhibits the reaction [Bleomycin results in increased phosphorylation of JUN protein]
|
CTD |
PMID:12003776 PMID:35716765 PMID:37399107 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
|
|
G
|
Keap1
|
Kelch-like ECH-associated protein 1
|
decreases expression multiple interactions increases expression
|
EXP ISO
|
Bleomycin results in decreased expression of KEAP1 protein celastrol inhibits the reaction [Bleomycin results in decreased expression of KEAP1 protein] Ephedrine inhibits the reaction [Bleomycin results in increased expression of KEAP1 protein]
|
CTD |
PMID:26768587 PMID:37778983 |
|
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042
|
|
G
|
Khsrp
|
KH-type splicing regulatory protein
|
increases expression
|
EXP
|
Bleomycin results in increased expression of KHSRP protein
|
CTD |
PMID:25933445 |
|
NCBI chr 9:1,949,557...1,959,400
Ensembl chr 9:1,949,557...1,959,497
|
|
G
|
Kit
|
KIT proto-oncogene receptor tyrosine kinase
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of KIT protein [Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in increased expression of KIT protein
|
CTD |
PMID:29733421 |
|
NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,903,033...32,978,812
|
|
G
|
Kl
|
Klotho
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of KL mRNA
|
CTD |
PMID:29408570 |
|
NCBI chr12:5,326,003...5,367,016
Ensembl chr12:5,325,959...5,367,015
|
|
G
|
Klhl42
|
kelch-like family, member 42
|
increases expression
|
ISO
|
Bleomycin results in increased expression of KLHL42 mRNA
|
CTD |
PMID:33770205 |
|
NCBI chr 4:181,730,343...181,760,899
Ensembl chr 4:181,735,244...181,757,013
|
|
G
|
Kras
|
KRAS proto-oncogene, GTPase
|
multiple interactions
|
ISO
|
[Bleomycin co-treated with 1-nitropyrene] results in increased mutagenesis of KRAS gene
|
CTD |
PMID:12616606 |
|
NCBI chr 4:179,916,255...179,949,613
Ensembl chr 4:179,919,802...179,949,320
|
|
G
|
Krt13
|
keratin 13
|
increases expression
|
ISO
|
Bleomycin results in increased expression of KRT13 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr10:85,552,287...85,556,499
Ensembl chr10:85,552,287...85,556,499
|
|
G
|
Krt19
|
keratin 19
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of KRT19 protein
|
CTD |
PMID:25933445 |
|
NCBI chr10:85,576,235...85,580,952
Ensembl chr10:85,576,235...85,580,952
|
|
G
|
Krt8
|
keratin 8
|
multiple interactions decreases expression
|
ISO
|
Ephedrine inhibits the reaction [Bleomycin results in decreased expression of KRT8 mRNA]; Ephedrine inhibits the reaction [Bleomycin results in decreased expression of KRT8 protein] Bleomycin results in decreased expression of KRT8 mRNA; Bleomycin results in decreased expression of KRT8 protein
|
CTD |
PMID:37778983 |
|
NCBI chr 7:135,002,886...135,010,339
Ensembl chr 7:135,002,894...135,010,403
|
|
G
|
Krt87
|
keratin 87
|
increases expression
|
ISO
|
Bleomycin results in increased expression of KRT87 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 7:134,426,567...134,433,740
Ensembl chr 7:134,426,567...134,433,740
|
|
G
|
Lap3
|
leucine aminopeptidase 3
|
increases expression
|
EXP
|
Bleomycin results in increased expression of LAP3 protein
|
CTD |
PMID:25933445 |
|
NCBI chr14:69,820,907...69,839,891
Ensembl chr14:69,820,908...69,839,891
|
|
G
|
Lasp1
|
LIM and SH3 protein 1
|
increases expression
|
EXP
|
Bleomycin results in increased expression of LASP1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr10:83,290,820...83,331,989
Ensembl chr10:83,290,865...83,331,988
|
|
G
|
Lcn2
|
lipocalin 2
|
increases expression
|
ISO
|
Bleomycin results in increased expression of LCN2 mRNA; Bleomycin results in increased expression of LCN2 protein
|
CTD |
PMID:26345256 |
|
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842
|
|
G
|
Lcp1
|
lymphocyte cytosolic protein 1
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of LCP1 mRNA Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of LCP1 mRNA]; lenabasum inhibits the reaction [Bleomycin results in increased expression of LCP1 mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr15:56,846,375...56,954,090
Ensembl chr15:56,847,433...56,954,092
|
|
G
|
Ldhal1
|
lactate dehydrogenase A like 1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of LDHAL1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 8:38,621,351...38,622,975
|
|
G
|
Lep
|
leptin
|
increases expression
|
ISO
|
Bleomycin results in increased expression of LEP protein
|
CTD |
PMID:29175452 |
|
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661
|
|
G
|
Lgals3
|
galectin 3
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of LGALS3 protein NOS2 protein affects the reaction [Bleomycin results in increased expression of LGALS3 protein]
|
CTD |
PMID:26526764 |
|
NCBI chr15:23,099,795...23,111,731
Ensembl chr15:23,086,841...23,111,737
|
|
G
|
Lgals9
|
galectin 9
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of LGALS9 mRNA Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of LGALS9 mRNA]; lenabasum inhibits the reaction [Bleomycin results in increased expression of LGALS9 mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr10:64,405,044...64,428,249
Ensembl chr10:64,405,044...64,428,070
|
|
G
|
Lhb
|
luteinizing hormone subunit beta
|
multiple interactions increases expression
|
ISO
|
thymoquinone inhibits the reaction [Bleomycin results in increased expression of LHB protein]
|
CTD |
PMID:34818114 |
|
NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:105,037,457...105,038,445
|
|
G
|
Lhfpl6
|
LHFPL tetraspan subfamily member 6
|
multiple interactions decreases expression
|
ISO
|
Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of LHFPL6 mRNA]; lenabasum inhibits the reaction [Bleomycin results in decreased expression of LHFPL6 mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr 2:139,276,810...139,474,740
Ensembl chr 2:139,276,789...139,474,737
|
|
G
|
Lhx1
|
LIM homeobox 1
|
multiple interactions
|
ISO
|
[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of LHX1 mRNA
|
CTD |
PMID:29733421 |
|
NCBI chr10:69,894,288...69,901,076
Ensembl chr10:69,894,288...69,901,076
|
|
G
|
Liph
|
lipase H
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of LIPH mRNA
|
CTD |
PMID:33770205 |
|
NCBI chr11:92,536,724...92,586,117
Ensembl chr11:92,537,860...92,586,120
|
|
G
|
Lmna
|
lamin A/C
|
increases expression
|
EXP
|
Bleomycin results in increased expression of LMNA protein
|
CTD |
PMID:25933445 |
|
NCBI chr 2:176,237,564...176,265,301
Ensembl chr 2:176,237,564...176,288,072
|
|
G
|
Lpxn
|
leupaxin
|
multiple interactions increases expression
|
ISO
|
Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of LPXN mRNA]; lenabasum inhibits the reaction [Bleomycin results in increased expression of LPXN mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr 1:219,353,319...219,387,743
Ensembl chr 1:219,353,708...219,387,742
|
|
G
|
Lyz2
|
lysozyme 2
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of LYZ protein
|
CTD |
PMID:25933445 |
|
NCBI chr 7:54,792,715...54,798,060
Ensembl chr 7:54,792,716...54,798,011
|
|
G
|
Macroh2a1
|
macroH2A.1 histone
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MACROH2A1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr17:8,484,340...8,547,268
Ensembl chr17:8,484,246...8,547,257
|
|
G
|
Map1lc3b
|
microtubule-associated protein 1 light chain 3 beta
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of MAP1LC3B protein modified form Soot inhibits the reaction [Bleomycin results in increased expression of MAP1LC3B protein modified form]
|
CTD |
PMID:31302203 |
|
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358 Ensembl chr16:66,574,407...66,584,358
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions
|
ISO
|
Bleomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein; U 0126 inhibits the reaction [Bleomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein]
|
CTD |
PMID:23570914 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions
|
ISO
|
Bleomycin results in increased phosphorylation of and results in increased activity of MAPK3 protein; U 0126 inhibits the reaction [Bleomycin results in increased phosphorylation of and results in increased activity of MAPK3 protein]
|
CTD |
PMID:23570914 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
G
|
Mapk8
|
mitogen-activated protein kinase 8
|
multiple interactions increases phosphorylation
|
ISO
|
Curcumin inhibits the reaction [Bleomycin results in increased phosphorylation of MAPK8 protein]
|
CTD |
PMID:35716765 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
G
|
Marcks
|
myristoylated alanine rich protein kinase C substrate
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MARCKS protein
|
CTD |
PMID:25933445 |
|
NCBI chr20:42,240,185...42,245,882
Ensembl chr20:42,240,185...42,245,882
|
|
G
|
Mdh2
|
malate dehydrogenase 2
|
decreases expression multiple interactions
|
EXP ISO
|
Bleomycin results in decreased expression of MDH2 protein [Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of MDH2 protein
|
CTD |
PMID:25933445 PMID:29733421 |
|
NCBI chr12:26,530,886...26,543,841
Ensembl chr12:26,530,881...26,543,841
|
|
G
|
Mecp2
|
methyl CpG binding protein 2
|
affects response to substance
|
ISO
|
MECP2 protein affects the susceptibility to Bleomycin
|
CTD |
PMID:21435439 |
|
NCBI chr X:156,932,481...156,995,981
Ensembl chr X:156,941,234...156,943,560
|
|
G
|
Mepce
|
methylphosphate capping enzyme
|
increases expression
|
ISO
|
Bleomycin results in increased expression of MEPCE mRNA
|
CTD |
PMID:33770205 |
|
NCBI chr12:24,548,596...24,553,315
Ensembl chr12:24,548,596...24,553,877
|
|
G
|
Mertk
|
MER proto-oncogene, tyrosine kinase
|
multiple interactions increases phosphorylation
|
ISO
|
Bleomycin affects the localization of and affects the expression of MERTK protein Bleomycin results in increased phosphorylation of MERTK protein
|
CTD |
PMID:22687607 |
|
NCBI chr 3:136,391,936...136,498,366
Ensembl chr 3:136,383,560...136,500,192
|
|
G
|
Mfn1
|
mitofusin 1
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of MFN1 protein
|
CTD |
PMID:37126650 |
|
NCBI chr 2:117,240,525...117,288,017
Ensembl chr 2:117,241,759...117,290,190
|
|
G
|
Mfn2
|
mitofusin 2
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of MFN2 protein
|
CTD |
PMID:37126650 |
|
NCBI chr 5:163,587,463...163,617,363
Ensembl chr 5:163,587,463...163,618,495
|
|
G
|
Mif
|
macrophage migration inhibitory factor
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIF protein
|
CTD |
PMID:25933445 |
|
NCBI chr20:12,767,138...12,791,222
Ensembl chr 4:134,041,774...134,042,121 Ensembl chr20:134,041,774...134,042,121
|
|
G
|
Mir100
|
microRNA 100
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR100 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 8:50,798,295...50,798,374
Ensembl chr 8:50,798,295...50,798,374
|
|
G
|
Mir101-2
|
microRNA 101-2
|
decreases expression
|
EXP ISO
|
Bleomycin results in decreased expression of MIR101B mRNA
|
CTD |
PMID:25933445 PMID:28726637 |
|
NCBI chr 1:236,273,922...236,274,018
Ensembl chr 1:236,273,922...236,274,018
|
|
G
|
Mir101a
|
microRNA 101a
|
multiple interactions decreases expression
|
ISO EXP
|
MIR101-1 mRNA inhibits the reaction [Bleomycin results in increased expression of COL1A1 mRNA]; MIR101-1 mRNA inhibits the reaction [Bleomycin results in increased expression of COL3A1 mRNA]; MIR101-1 mRNA inhibits the reaction [Bleomycin results in increased expression of FZD6 mRNA]; MIR101-1 mRNA inhibits the reaction [Bleomycin results in increased expression of NFATC2 mRNA]; MIR101-1 mRNA inhibits the reaction [Bleomycin results in increased expression of TGFBR1 mRNA] Bleomycin results in decreased expression of MIR101A mRNA
|
CTD |
PMID:25933445 PMID:28726637 |
|
NCBI chr 5:121,081,683...121,081,757
|
|
G
|
Mir106b
|
microRNA 106b
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR106B mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr12:22,157,053...22,157,134
|
|
G
|
Mir107
|
microRNA 107
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR107 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 1:241,750,418...241,750,504
|
|
G
|
Mir10a
|
microRNA 10a
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR10A mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr10:81,779,709...81,779,818
Ensembl chr10:81,779,709...81,779,818
|
|
G
|
Mir10b
|
microRNA 10b
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR10B mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 3:80,035,859...80,035,967
Ensembl chr 3:80,035,859...80,035,967
|
|
G
|
Mir1224
|
microRNA 1224
|
increases expression
|
EXP
|
Bleomycin results in increased expression of MIR1224 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr11:93,811,291...93,811,375
|
|
G
|
Mir1249
|
microRNA 1249
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR1249 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 7:117,955,517...117,955,636
|
|
G
|
Mir125a
|
microRNA 125a
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR125A mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 1:67,350,675...67,350,759
Ensembl chr 1:67,350,675...67,350,759
|
|
G
|
Mir126a
|
microRNA 126a
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR126 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 3:29,813,150...29,813,267
|
|
G
|
Mir130a
|
microRNA 130a
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR130A mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 3:90,229,228...90,229,315
|
|
G
|
Mir133a1
|
microRNA 133a-1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR133A1 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr18:2,157,872...2,157,958
|
|
G
|
Mir133b
|
microRNA 133b
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR133B mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 9:30,594,582...30,594,665
Ensembl chr 9:30,594,582...30,594,665
|
|
G
|
Mir140
|
microRNA 140
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR140 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr19:52,375,293...52,375,391
Ensembl chr19:52,375,293...52,375,391
|
|
G
|
Mir141
|
microRNA 141
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR141 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 4:159,209,525...159,209,618
|
|
G
|
Mir142
|
microRNA 142
|
decreases expression increases expression
|
EXP
|
Bleomycin results in decreased expression of MIR142 mRNA Bleomycin results in increased expression of MIR142 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr10:73,055,104...73,055,190
Ensembl chr10:73,055,097...73,055,207
|
|
G
|
Mir143
|
microRNA 143
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR143 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr18:57,371,349...57,371,453
|
|
G
|
Mir144
|
microRNA 144
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR144 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr10:63,459,397...63,459,479
Ensembl chr10:63,459,397...63,459,479
|
|
G
|
Mir145
|
microRNA 145
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR145 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr18:57,369,983...57,370,070
|
|
G
|
Mir146a
|
microRNA 146a
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR146A mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr10:28,349,996...28,350,090
|
|
G
|
Mir146b
|
microRNA 146b
|
increases expression
|
EXP
|
Bleomycin results in increased expression of MIR146B mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 1:255,144,860...255,144,947
Ensembl chr 1:255,144,860...255,144,947
|
|
G
|
Mir148b
|
microRNA 148b
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR148B mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 7:136,299,870...136,299,966
Ensembl chr 7:136,299,870...136,299,966
|
|
G
|
Mir150
|
microRNA 150
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR150 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 1:104,741,487...104,741,571
Ensembl chr 1:104,741,487...104,741,571
|
|
G
|
Mir151
|
microRNA 151
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR151 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 7:107,061,380...107,061,476
|
|
G
|
Mir152
|
microRNA 152
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR152 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr10:82,329,383...82,329,467
Ensembl chr10:82,329,383...82,329,467
|
|
G
|
Mir15b
|
microRNA 15b
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR15B mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 2:155,555,178...155,555,275
Ensembl chr 2:155,555,178...155,555,275
|
|
G
|
Mir16-2
|
microRNA 16-2
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR16-2 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 2:155,555,327...155,555,421
Ensembl chr 2:155,555,327...155,555,421
|
|
G
|
Mir17
|
microRNA 17
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR17 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr15:98,587,848...98,587,931
Ensembl chr15:98,587,848...98,587,931
|
|
G
|
Mir181a-1
|
microRNA 181a-1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR181A-1 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr13:52,037,067...52,037,166
|
|
G
|
Mir181c
|
microRNA 181c
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR181C mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr19:40,888,291...40,888,396
Ensembl chr19:40,888,291...40,888,396
|
|
G
|
Mir181d
|
microRNA 181d
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR181D mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr19:40,888,474...40,888,556
Ensembl chr19:40,888,474...40,888,556
|
|
G
|
Mir182
|
microRNA 182
|
increases expression affects expression multiple interactions
|
ISO EXP
|
Bleomycin results in increased expression of MIR182 mRNA Bleomycin affects the expression of MIR182 mRNA MIR182 affects the reaction [Bleomycin results in decreased expression of SMAD7 protein]; MIR182 affects the reaction [Bleomycin results in increased expression of ACTA2 protein]; MIR182 affects the reaction [Bleomycin results in increased expression of FN1 protein]; MIR182 affects the reaction [Bleomycin results in increased expression of TGFB1 protein]; MIR182 affects the reaction [Bleomycin results in increased phosphorylation of SMAD2 protein]; MIR182 affects the reaction [Bleomycin results in increased phosphorylation of SMAD3 protein]
|
CTD |
PMID:25933445 PMID:31884830 |
|
NCBI chr 4:59,752,246...59,752,307
|
|
G
|
Mir183
|
microRNA 183
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR183 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 4:59,756,044...59,756,153
|
|
G
|
Mir185
|
microRNA 185
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR185 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr11:96,169,028...96,169,107
Ensembl chr11:96,169,028...96,169,107
|
|
G
|
Mir186
|
microRNA 186
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR186 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 2:249,241,650...249,241,735
Ensembl chr 2:249,241,650...249,241,735
|
|
G
|
Mir188
|
microRNA 188
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR188 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr X:17,919,585...17,919,664
Ensembl chr X:17,919,585...17,919,664
|
|
G
|
Mir18a
|
microRNA 18a
|
increases expression
|
EXP
|
Bleomycin results in increased expression of MIR18A mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr15:98,587,984...98,588,079
Ensembl chr15:98,587,984...98,588,079
|
|
G
|
Mir193
|
microRNA 193
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR193 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr10:65,170,317...65,170,402
|
|
G
|
Mir1949
|
microRNA 1949
|
increases expression
|
EXP
|
Bleomycin results in increased expression of MIR1949 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr18:27,429,688...27,429,784
Ensembl chr18:27,429,688...27,429,784
|
|
G
|
Mir195
|
microRNA 195
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR195 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr10:55,450,495...55,450,581
Ensembl chr10:55,450,495...55,450,581
|
|
G
|
Mir199a2
|
microRNA 199a-2
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR199A2 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr13:77,116,225...77,116,334
Ensembl chr13:77,116,225...77,116,334
|
|
G
|
Mir19a
|
microRNA 19a
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR19A mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr15:98,588,131...98,588,212
Ensembl chr15:98,588,131...98,588,212
|
|
G
|
Mir200a
|
microRNA 200a
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR200A mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 5:171,930,717...171,930,805
|
|
G
|
Mir200b
|
microRNA 200b
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR200B mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 5:171,931,495...171,931,589
|
|
G
|
Mir200c
|
microRNA 200c
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR200C mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 4:159,209,965...159,210,033
|
|
G
|
Mir203
|
microRNA 203
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR203 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 6:137,020,691...137,020,805
|
|
G
|
Mir204
|
microRNA 204
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR204 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 1:229,743,461...229,743,570
Ensembl chr 1:229,743,461...229,743,570
|
|
G
|
Mir20a
|
microRNA 20a
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR20A mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr15:98,588,303...98,588,387
Ensembl chr15:98,588,303...98,588,387
|
|
G
|
Mir20b
|
microRNA 20b
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR20B mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr X:137,343,197...137,343,268
|
|
G
|
Mir21
|
microRNA 21
|
increases expression
|
EXP
|
Bleomycin results in increased expression of MIR21 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr10:71,902,600...71,902,691
|
|
G
|
Mir210
|
microRNA 210
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR210 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 1:205,755,923...205,756,032
Ensembl chr 1:205,755,917...205,756,034
|
|
G
|
Mir211
|
microRNA 211
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR211 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 1:127,189,328...127,189,433
Ensembl chr 1:127,189,328...127,189,433
|
|
G
|
Mir212
|
microRNA 212
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR212 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr10:60,521,740...60,521,850
Ensembl chr10:60,521,740...60,521,850
|
|
G
|
Mir214
|
microRNA 214
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR214 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr13:77,121,645...77,121,752
Ensembl chr13:77,121,643...77,121,752
|
|
G
|
Mir22
|
microRNA 22
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR22 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr10:60,805,331...60,805,425
Ensembl chr10:60,805,331...60,805,425
|
|
G
|
Mir221
|
microRNA 221
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR221 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr X:6,023,182...6,023,290
Ensembl chr X:6,023,182...6,023,290
|
|
G
|
Mir222
|
microRNA 222
|
decreases expression affects expression
|
EXP
|
Bleomycin results in decreased expression of MIR222 mRNA Bleomycin affects the expression of MIR222 mRNA
|
CTD |
PMID:25933445 PMID:34425168 |
|
NCBI chr X:6,022,621...6,022,723
Ensembl chr X:6,022,621...6,022,723
|
|
G
|
Mir223
|
microRNA 223
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR223 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr X:65,151,383...65,151,492
Ensembl chr X:65,151,383...65,151,492
|
|
G
|
Mir23a
|
microRNA 23a
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR23A mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr19:40,859,769...40,859,843
|
|
G
|
Mir23b
|
microRNA 23b
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR23B mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr17:1,819,386...1,819,482
|
|
G
|
Mir24-2
|
microRNA 24-2
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR24-2 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr19:40,859,455...40,859,562
|
|
G
|
Mir25
|
microRNA 25
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR25 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr12:22,156,641...22,156,724
|
|
G
|
Mir26a1
|
microRNA 26a-1
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of MIR26A-1
|
CTD |
PMID:35785413 |
|
NCBI chr 8:127,633,048...127,633,137
Ensembl chr 8:127,633,048...127,633,137
|
|
G
|
Mir26b
|
microRNA 26b
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR26B mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 9:83,425,709...83,425,793
Ensembl chr 9:83,425,709...83,425,793
|
|
G
|
Mir27a
|
microRNA 27a
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR27A mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr19:40,859,603...40,859,689
|
|
G
|
Mir27b
|
microRNA 27b
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR27B mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr17:1,819,147...1,819,243
|
|
G
|
Mir28
|
microRNA 28
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR28 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr11:89,480,252...89,480,337
|
|
G
|
Mir290
|
microRNA 290
|
increases expression
|
EXP
|
Bleomycin results in increased expression of MIR290 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 1:74,880,055...74,880,135
|
|
G
|
Mir296
|
microRNA 296
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR296 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 3:183,470,069...183,470,146
|
|
G
|
Mir2985
|
microRNA 2985
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR2985 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 2:168,254,500...168,254,609
|
|
G
|
Mir29a
|
microRNA 29a
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR29A mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 4:60,617,955...60,618,042
|
|
G
|
Mir29c
|
microRNA 29c
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR29C mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr13:109,099,359...109,099,446
|
|
G
|
Mir301a
|
microRNA 301a
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR301A mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr10:72,422,599...72,422,698
Ensembl chr10:72,422,599...72,422,698
|
|
G
|
Mir3085
|
microRNA 3085
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR3085 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 1:251,038,184...251,038,272
|
|
G
|
Mir30a
|
microRNA 30a
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR30A mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 9:33,233,941...33,234,011
Ensembl chr 9:33,233,941...33,234,011
|
|
G
|
Mir30b
|
microRNA 30b
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR30B mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 7:102,021,543...102,021,629
|
|
G
|
Mir30c2
|
microRNA 30c-2
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR30C2 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 9:33,253,682...33,253,765
Ensembl chr 9:33,253,682...33,253,765
|
|
G
|
Mir30d
|
microRNA 30d
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR30D mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 7:102,025,345...102,025,426
|
|
G
|
Mir30e
|
microRNA 30e
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR30E mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 5:139,637,450...139,637,541
Ensembl chr 5:139,637,450...139,637,541
|
|
G
|
Mir31
|
microRNA 31
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR31 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 5:108,714,849...108,714,954
|
|
G
|
Mir32
|
microRNA 32
|
increases expression
|
EXP
|
Bleomycin results in increased expression of MIR32 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 5:76,391,285...76,391,354
|
|
G
|
Mir320a
|
microRNA 320a
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR320A mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr15:51,926,088...51,926,169
Ensembl chr15:51,926,088...51,926,169
|
|
G
|
Mir322
|
microRNA 322
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR322 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr X:137,726,147...137,726,241
|
|
G
|
Mir324
|
microRNA 324
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR324 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr10:55,233,363...55,233,445
Ensembl chr10:55,233,361...55,233,449
|
|
G
|
Mir326
|
microRNA 326
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR326 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 1:163,266,165...163,266,259
Ensembl chr 1:163,266,165...163,266,259
|
|
G
|
Mir328
|
microRNA 328
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR328 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr19:50,094,691...50,094,774
|
|
G
|
Mir33
|
microRNA 33
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR33 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 7:115,593,952...115,594,020
Ensembl chr 7:115,593,952...115,594,020
|
|
G
|
Mir330
|
microRNA 330
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR330 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 1:87,961,207...87,961,303
Ensembl chr 1:87,961,207...87,961,303
|
|
G
|
Mir331
|
microRNA 331
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR331 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 7:30,414,386...30,414,481
|
|
G
|
Mir338
|
microRNA 338
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR338 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr10:105,796,342...105,796,407
|
|
G
|
Mir340
|
microRNA 340
|
increases expression
|
EXP
|
Bleomycin results in increased expression of MIR340 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr10:34,894,650...34,894,747
Ensembl chr10:34,894,650...34,894,747
|
|
G
|
Mir342
|
microRNA 342
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR342 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 6:133,329,655...133,329,753
Ensembl chr 6:133,329,655...133,329,753
|
|
G
|
Mir345
|
microRNA 345
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR345 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 6:133,518,403...133,518,498
Ensembl chr 6:133,518,403...133,518,498
|
|
G
|
Mir347
|
microRNA mir-347
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR347 mRNA
|
CTD |
PMID:25933445 |
|
|
|
G
|
Mir3473
|
microRNA 3473
|
increases expression
|
EXP
|
Bleomycin results in increased expression of MIR3473 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr13:42,051,691...42,051,757
Ensembl chr13:42,051,691...42,051,757
|
|
G
|
Mir34a
|
microRNA 34a
|
affects expression decreases expression
|
EXP
|
Bleomycin affects the expression of MIR34A mRNA Bleomycin results in decreased expression of MIR34A mRNA
|
CTD |
PMID:25933445 PMID:34425168 |
|
NCBI chr 5:165,815,952...165,816,053
Ensembl chr 5:165,815,952...165,816,053
|
|
G
|
Mir34b
|
microRNA 34b
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR34B mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 8:60,306,609...60,306,692
|
|
G
|
Mir34c
|
microRNA 34c
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR34C mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 8:60,306,091...60,306,167
|
|
G
|
Mir352
|
microRNA mir-352
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR352 mRNA
|
CTD |
PMID:25933445 |
|
|
|
G
|
Mir3573
|
microRNA 3573
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR3573 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr X:68,299,274...68,299,345
Ensembl chr X:68,299,274...68,299,345
|
|
G
|
Mir3584
|
microRNA 3584
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR3584 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 1:256,727,531...256,727,611
|
|
G
|
Mir361
|
microRNA 361
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR361 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr X:82,438,463...82,438,532
|
|
G
|
Mir362
|
microRNA 362
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR362 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr X:17,926,485...17,926,549
Ensembl chr X:17,926,485...17,926,549
|
|
G
|
Mir365b
|
microRNA 365b
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR365B mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr10:65,184,217...65,184,302
Ensembl chr10:65,184,214...65,184,313
|
|
G
|
Mir374b
|
microRNA 374b
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR374B mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr X:72,657,495...72,657,562
|
|
G
|
Mir375
|
microRNA 375
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR375 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 9:83,906,582...83,906,656
|
|
G
|
Mir378
|
microRNA 378
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR378 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr18:57,128,922...57,128,986
|
|
G
|
Mir409
|
microRNA 409
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR409 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 6:134,579,185...134,579,261
|
|
G
|
Mir423
|
microRNA 423
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR423 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr10:62,412,272...62,412,350
|
|
G
|
Mir425
|
microRNA 425
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR425 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 8:118,143,084...118,143,166
Ensembl chr 8:118,143,084...118,143,166
|
|
G
|
Mir429
|
microRNA 429
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR429 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 5:171,929,682...171,929,766
|
|
G
|
Mir449a
|
microRNA 449a
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR449A mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 2:46,403,910...46,404,000
Ensembl chr 2:46,403,910...46,404,000
|
|
G
|
Mir450a1
|
microRNA 450a-1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR450A1 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr X:137,720,933...137,721,023
|
|
G
|
Mir451a
|
microRNA 451a
|
decreases expression
|
EXP ISO
|
Bleomycin results in decreased expression of MIR451A mRNA Bleomycin results in decreased expression of MIR451A protein
|
CTD |
PMID:25933445 PMID:34460027 |
|
NCBI chr10:63,459,569...63,459,640
Ensembl chr10:63,459,569...63,459,640
|
|
G
|
Mir466b-1
|
microRNA mir-466b-1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR466B-1 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr17:72,945,493...72,945,578
|
|
G
|
Mir483
|
microRNA 483
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR483 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 1:207,247,859...207,247,931
|
|
G
|
Mir494
|
microRNA 494
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR494 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 6:134,550,115...134,550,197
Ensembl chr 6:134,550,114...134,550,198
|
|
G
|
Mir497
|
microRNA 497
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR497 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr10:55,450,171...55,450,239
Ensembl chr10:55,450,162...55,450,241
|
|
G
|
Mir500
|
microRNA 500
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR500 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr X:17,930,647...17,930,726
Ensembl chr X:17,930,637...17,930,728
|
|
G
|
Mir503
|
microRNA 503
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR503 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr X:137,725,856...137,725,926
|
|
G
|
Mir511
|
microRNA 511
|
increases expression
|
EXP
|
Bleomycin results in increased expression of MIR511 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr17:82,187,953...82,188,031
Ensembl chr17:82,187,953...82,188,031
|
|
G
|
Mir532
|
microRNA 532
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR532 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr X:17,919,185...17,919,263
Ensembl chr X:17,919,185...17,919,263
|
|
G
|
Mir542
|
microRNA 542
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR542 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr X:137,722,176...137,722,254
|
|
G
|
Mir6215
|
microRNA 6215
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR6215 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 5:157,133,945...157,134,011
|
|
G
|
Mir6216
|
microRNA 6216
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR6216 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 3:65,165,553...65,165,630
|
|
G
|
Mir6328
|
microRNA 6328
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR6328 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr20:2,890,103...2,890,199
Ensembl chr20:2,890,103...2,890,199
|
|
G
|
Mir652
|
microRNA 652
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR652 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr X:111,140,079...111,140,159
Ensembl chr X:111,140,079...111,140,159
|
|
G
|
Mir672
|
microRNA 672
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR672 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr X:73,192,304...73,192,383
|
|
G
|
Mir674
|
microRNA 674
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR674 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 3:124,507,170...124,507,246
Ensembl chr 3:124,507,170...124,507,246
|
|
G
|
Mir702
|
microRNA 702
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR702 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr12:25,318,495...25,318,601
|
|
G
|
Mir872
|
microRNA 872
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR872 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 5:114,654,823...114,654,903
Ensembl chr 5:114,654,823...114,654,903
|
|
G
|
Mir93
|
microRNA 93
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR93 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr12:22,156,844...22,156,930
|
|
G
|
Mir96
|
microRNA 96
|
affects expression
|
EXP
|
Bleomycin affects the expression of MIR96 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 4:59,755,841...59,755,946
|
|
G
|
Mir98
|
microRNA 98
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR98 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr X:24,460,648...24,460,755
Ensembl chr X:24,460,648...24,460,755
|
|
G
|
Mir99a
|
microRNA 99a
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR99A mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr11:29,687,392...29,687,472
Ensembl chr11:29,687,392...29,687,472
|
|
G
|
Mir99b
|
microRNA 99b
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIR99B mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 1:67,350,064...67,350,133
Ensembl chr 1:67,350,060...67,350,139
|
|
G
|
Mirlet7b
|
microRNA let-7b
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIRLET7B mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 7:118,684,038...118,684,122
Ensembl chr 7:118,684,038...118,684,122
|
|
G
|
Mirlet7d
|
microRNA let-7d
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIRLET7D mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr17:16,322,260...16,322,357
Ensembl chr17:16,322,260...16,322,357
|
|
G
|
Mirlet7e
|
microRNA let-7e
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIRLET7E mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 1:67,350,229...67,350,321
|
|
G
|
Mirlet7i
|
microRNA let-7i
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MIRLET7I mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 7:60,527,877...60,527,961
|
|
G
|
Mkln1
|
muskelin 1
|
multiple interactions increases expression
|
ISO
|
MKLN1 mRNA alternative form affects the reaction [Bleomycin results in decreased expression of CDH1 protein]; MKLN1 mRNA alternative form affects the reaction [Bleomycin results in increased expression of ACTA2 protein]; MKLN1 mRNA alternative form affects the reaction [Bleomycin results in increased expression of CDK8 protein]; MKLN1 mRNA alternative form affects the reaction [Bleomycin results in increased expression of VIM protein] Bleomycin results in increased expression of MKLN1 mRNA alternative form
|
CTD |
PMID:38460002 |
|
NCBI chr 4:60,939,239...61,095,214
Ensembl chr 4:60,937,817...61,095,210
|
|
G
|
Mmp1
|
matrix metallopeptidase 1
|
increases expression
|
ISO
|
Bleomycin results in increased expression of MMP1 mRNA; Bleomycin results in increased expression of MMP1 protein
|
CTD |
PMID:18684396 |
|
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:12,943,453...12,963,964
|
|
G
|
Mmp2
|
matrix metallopeptidase 2
|
multiple interactions increases expression
|
EXP ISO
|
allyl sulfide inhibits the reaction [Bleomycin results in increased expression of MMP2 protein]; celastrol inhibits the reaction [Bleomycin results in increased expression of MMP2 protein] Bleomycin results in increased expression of MMP2 mRNA; Bleomycin results in increased expression of MMP2 protein Bleomycin results in increased expression of and results in increased secretion of MMP2 protein; Curcumin inhibits the reaction [Bleomycin results in increased expression of and results in increased secretion of MMP2 protein]; Curcumin inhibits the reaction [Bleomycin results in increased expression of MMP2 mRNA]
|
CTD |
PMID:23656969 PMID:26345256 PMID:26768587 PMID:29175452 PMID:35716765 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
G
|
Mmp23
|
matrix metallopeptidase 23
|
increases expression
|
ISO
|
Bleomycin results in increased expression of MMP23 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 5:171,521,905...171,525,007
Ensembl chr 5:171,520,494...171,524,695
|
|
G
|
Mmp3
|
matrix metallopeptidase 3
|
multiple interactions increases expression
|
ISO
|
[MMP3 protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of CCN2 mRNA]; [MMP3 protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; [MMP3 protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of TGFB2 mRNA]; [MMP3 protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of TGFBR1 mRNA]; [MMP3 protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of TGFBR2 mRNA]; Dinoprostone inhibits the reaction [Bleomycin results in increased expression of MMP3 mRNA]; MMP3 protein affects the reaction [Dinoprostone inhibits the reaction [Bleomycin results in increased expression of TGFB3 mRNA]] 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [Bleomycin results in increased expression of MMP3 mRNA]; Apigenin inhibits the reaction [Bleomycin results in increased expression of MMP3 mRNA]; methyl caffeate inhibits the reaction [Bleomycin results in increased expression of MMP3 mRNA]
|
CTD |
PMID:28299617 PMID:28434932 PMID:32554301 |
|
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:12,925,280...12,938,826
|
|
G
|
Mmp7
|
matrix metallopeptidase 7
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of MMP7 protein honokiol inhibits the reaction [Bleomycin results in increased expression of MMP7 protein]
|
CTD |
PMID:32032644 |
|
NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:13,133,043...13,140,755
|
|
G
|
Mmp9
|
matrix metallopeptidase 9
|
increases expression multiple interactions
|
EXP ISO
|
Bleomycin results in increased expression of MMP9 protein allyl sulfide inhibits the reaction [Bleomycin results in increased expression of MMP9 protein]; celastrol inhibits the reaction [Bleomycin results in increased expression of MMP9 protein] Bleomycin results in increased expression of MMP9 mRNA; Bleomycin results in increased expression of MMP9 protein 12-(3-adamantan-1-ylureido)dodecanoic acid inhibits the reaction [Bleomycin results in increased expression of MMP9 mRNA]; 12-(3-adamantan-1-ylureido)dodecanoic acid inhibits the reaction [Bleomycin results in increased expression of MMP9 protein]; Bleomycin results in increased expression of and results in increased secretion of MMP9 protein; Curcumin inhibits the reaction [Bleomycin results in increased expression of and results in increased secretion of MMP9 protein]; Curcumin inhibits the reaction [Bleomycin results in increased expression of MMP9 mRNA]; Dexamethasone inhibits the reaction [Bleomycin results in increased expression of MMP9 mRNA]; Dexamethasone inhibits the reaction [Bleomycin results in increased expression of MMP9 protein]; Grape Seed Extract inhibits the reaction [Bleomycin results in increased expression of MMP9 protein]; NOS2 protein affects the reaction [Bleomycin results in increased expression of MMP9 protein]
|
CTD |
PMID:23656969 PMID:26526764 PMID:26768587 PMID:28300665 PMID:28694203 PMID:35716765 More...
|
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
G
|
Mpo
|
myeloperoxidase
|
multiple interactions increases activity increases expression
|
ISO EXP
|
Oils, Volatile inhibits the reaction [Bleomycin results in increased activity of MPO protein]; pirinixic acid inhibits the reaction [Bleomycin results in increased activity of MPO protein]; verlukast inhibits the reaction [Bleomycin results in increased activity of MPO protein]; zileuton inhibits the reaction [Bleomycin results in increased activity of MPO protein] Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of MPO protein]; Phytochemicals inhibits the reaction [Bleomycin results in increased expression of MPO protein]; resveratrol inhibits the reaction [Bleomycin results in increased activity of MPO protein]
|
CTD |
PMID:16317386 PMID:17035056 PMID:17118201 PMID:26093215 PMID:28850077 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
|
|
G
|
Mrc1
|
mannose receptor, C type 1
|
increases expression
|
ISO
|
Bleomycin results in increased expression of MRC1 mRNA
|
CTD |
PMID:29033951 |
|
NCBI chr17:82,157,725...82,239,411
Ensembl chr17:82,157,705...82,239,410
|
|
G
|
Msn
|
moesin
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MSN protein
|
CTD |
PMID:25933445 |
|
NCBI chr X:65,005,546...65,073,512
Ensembl chr X:65,005,458...65,075,129
|
|
G
|
Muc5ac
|
mucin 5AC, oligomeric mucus/gel-forming
|
increases expression multiple interactions
|
ISO EXP
|
Bleomycin results in increased expression of MUC5AC mRNA Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of MUC5AC mRNA]; Phytochemicals inhibits the reaction [Bleomycin results in increased expression of MUC5AC mRNA]
|
CTD |
PMID:18684396 PMID:26093215 |
|
NCBI chr 1:206,293,717...206,326,006
Ensembl chr 1:206,293,869...206,326,006
|
|
G
|
Mucl3
|
mucin like 3
|
increases expression
|
ISO
|
Bleomycin results in increased expression of MUCL3 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr20:3,105,360...3,113,278
Ensembl chr20:3,105,360...3,113,278
|
|
G
|
Mug2
|
murinoglobulin 2
|
increases expression
|
EXP
|
Bleomycin results in increased expression of PZP protein
|
CTD |
PMID:25933445 |
|
NCBI chr 4:156,836,140...156,908,972
|
|
G
|
Mxi1
|
MAX interactor 1, dimerization protein
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of MXI1 mRNA
|
CTD |
PMID:33770205 |
|
NCBI chr 1:262,329,274...262,389,037
Ensembl chr 1:262,328,875...262,389,036
|
|
G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
increases response to substance
|
ISO
|
MYC protein results in increased susceptibility to Bleomycin
|
CTD |
PMID:10449034 |
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
|
|
G
|
Myh11
|
myosin heavy chain 11
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MYH11 protein
|
CTD |
PMID:25933445 |
|
NCBI chr10:1,250,554...1,345,681
Ensembl chr10:1,263,194...1,345,678
|
|
G
|
Myh6
|
myosin heavy chain 6
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MYH6 protein
|
CTD |
PMID:25933445 |
|
NCBI chr15:32,388,102...32,413,663
Ensembl chr15:32,387,487...32,411,333
|
|
G
|
Myl12b
|
myosin light chain 12B
|
increases expression
|
EXP
|
Bleomycin results in increased expression of MYL12B protein
|
CTD |
PMID:25933445 |
|
NCBI chr 9:118,320,479...118,334,810
Ensembl chr 9:118,320,489...118,324,418
|
|
G
|
Myl4
|
myosin, light chain 4
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MYL4 protein
|
CTD |
PMID:25933445 |
|
NCBI chr10:89,949,733...89,985,308
Ensembl chr10:89,949,404...89,985,308
|
|
G
|
Myl6
|
myosin light chain 6
|
increases expression
|
EXP
|
Bleomycin results in increased expression of MYL6 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 7:1,495,301...1,498,512
Ensembl chr 7:1,495,747...1,498,344
|
|
G
|
Myo1c
|
myosin 1C
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of MYO1C protein
|
CTD |
PMID:25933445 |
|
NCBI chr10:60,996,642...61,019,022
Ensembl chr10:60,996,638...61,019,022
|
|
G
|
Myo1e
|
myosin IE
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of MYO1E mRNA
|
CTD |
PMID:33770205 |
|
NCBI chr 8:79,768,828...79,961,048
Ensembl chr 8:79,753,596...79,961,045
|
|
G
|
Nap1l1
|
nucleosome assembly protein 1-like 1
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of NAP1L1 protein
|
CTD |
PMID:29733421 |
|
NCBI chr 7:48,819,464...48,844,108
Ensembl chr 7:48,819,477...48,844,104
|
|
G
|
Nfatc2
|
nuclear factor of activated T-cells 2
|
multiple interactions increases expression
|
ISO
|
MIR101-1 mRNA inhibits the reaction [Bleomycin results in increased expression of NFATC2 mRNA]
|
CTD |
PMID:28726637 |
|
NCBI chr 3:177,615,189...177,747,493
Ensembl chr 3:177,618,314...177,747,380
|
|
G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
affects localization increases phosphorylation decreases expression multiple interactions increases expression
|
ISO EXP
|
Bleomycin affects the localization of NFE2L2 protein Bleomycin results in increased phosphorylation of NFE2L2 protein Bleomycin results in decreased expression of NFE2L2 protein caffeic acid phenethyl ester inhibits the reaction [Bleomycin results in decreased expression of NFE2L2 protein]; U 0126 inhibits the reaction [Bleomycin affects the localization of NFE2L2 protein]; U 0126 inhibits the reaction [Bleomycin results in increased phosphorylation of NFE2L2 protein] Bleomycin results in increased expression of NFE2L2 protein Bleomycin results in decreased expression of NFE2L2 mRNA; Bleomycin results in decreased expression of NFE2L2 protein Berberine promotes the reaction [Bleomycin results in increased expression of NFE2L2 protein]; celastrol inhibits the reaction [Bleomycin results in decreased expression of NFE2L2 protein]; Methylprednisolone inhibits the reaction [Bleomycin results in decreased expression of NFE2L2 mRNA]; Phytochemicals inhibits the reaction [Bleomycin results in decreased expression of NFE2L2 mRNA] Ephedrine inhibits the reaction [Bleomycin results in decreased expression of NFE2L2 protein]
|
CTD |
PMID:23523906 PMID:23570914 PMID:26093215 PMID:26768587 PMID:37778983 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
G
|
Nfkb1
|
nuclear factor kappa B subunit 1
|
increases activity increases expression multiple interactions
|
ISO EXP
|
Bleomycin results in increased activity of NFKB1 protein Bleomycin results in increased expression of NFKB1 mRNA Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of NFKB1 mRNA]; Phytochemicals inhibits the reaction [Bleomycin results in increased expression of NFKB1 mRNA] NOS2 protein affects the reaction [Bleomycin results in increased activity of NFKB1 protein]
|
CTD |
PMID:12003776 PMID:26093215 PMID:26526764 |
|
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
|
|
G
|
Nfkbia
|
NFKB inhibitor alpha
|
multiple interactions
|
ISO
|
[Bleomycin results in increased phosphorylation of GSK3B protein] inhibits the reaction [GSK3B protein binds to and results in increased stability of NFKBIA protein]
|
CTD |
PMID:19429264 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
G
|
Nfkbiz
|
NFKB inhibitor zeta
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of NFKBIZ mRNA; Bleomycin results in increased expression of NFKBIZ protein 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [Bleomycin results in increased expression of NFKBIZ mRNA]; methyl caffeate inhibits the reaction [Bleomycin results in increased expression of NFKBIZ protein]
|
CTD |
PMID:28299617 PMID:32554301 |
|
NCBI chr11:58,251,720...58,279,767
Ensembl chr11:58,251,721...58,279,767
|
|
G
|
Nherf1
|
NHERF family PDZ scaffold protein 1
|
increases expression
|
EXP
|
Bleomycin results in increased expression of NHERF1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr10:100,902,165...100,919,265
Ensembl chr10:100,901,227...100,919,579
|
|
G
|
Nherf2
|
NHERF family PDZ scaffold protein 2
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of NHERF2 protein
|
CTD |
PMID:25933445 |
|
NCBI chr10:14,167,005...14,177,519
Ensembl chr10:14,167,005...14,177,593
|
|
G
|
Nit2
|
nitrilase family, member 2
|
multiple interactions
|
ISO
|
[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of NIT2 protein
|
CTD |
PMID:29733421 |
|
NCBI chr11:56,832,957...56,844,142
Ensembl chr11:56,832,558...56,844,141
|
|
G
|
Nlrp10
|
NLR family, pyrin domain containing 10
|
increases expression
|
ISO
|
Bleomycin results in increased expression of NLRP10 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 1:172,357,648...172,365,205
Ensembl chr 1:172,357,648...172,365,205
|
|
G
|
Nmbr
|
neuromedin B receptor
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of NMBR mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr 1:10,942,476...10,966,174
Ensembl chr 1:10,954,916...10,965,555
|
|
G
|
Nme2
|
NME/NM23 nucleoside diphosphate kinase 2
|
increases expression
|
EXP
|
Bleomycin results in increased expression of NME2 protein
|
CTD |
PMID:25933445 |
|
NCBI chr10:79,394,999...79,400,418
Ensembl chr20:11,179,066...11,179,497 Ensembl chr10:11,179,066...11,179,497
|
|
G
|
Nos2
|
nitric oxide synthase 2
|
increases expression multiple interactions increases secretion
|
ISO EXP
|
Bleomycin results in increased expression of NOS2 protein 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [Bleomycin results in increased expression of NOS2 protein]; 2-((dimethylamino)methyl)-9-hydroxythieno(2,3-c)isoquinolin-5(4H)-one inhibits the reaction [Bleomycin results in increased expression of NOS2 protein]; NOS2 protein affects the reaction [Bleomycin results in increased activity of NFKB1 protein]; NOS2 protein affects the reaction [Bleomycin results in increased expression of LGALS3 protein]; NOS2 protein affects the reaction [Bleomycin results in increased expression of MMP9 protein]; NOS2 protein affects the reaction [Bleomycin results in increased expression of RETNLA protein]; rosiglitazone inhibits the reaction [Bleomycin results in increased expression of NOS2 protein] Bleomycin results in increased expression of NOS2 mRNA; Bleomycin results in increased expression of NOS2 protein Berberine inhibits the reaction [Bleomycin results in increased expression of NOS2 protein]; Curcumin inhibits the reaction [Bleomycin results in increased expression of NOS2 mRNA]; Curcumin inhibits the reaction [Bleomycin results in increased expression of NOS2 protein]; Hydrocortisone inhibits the reaction [Bleomycin results in increased expression of NOS2 mRNA]; Hydrocortisone inhibits the reaction [Bleomycin results in increased expression of NOS2 protein]; Taurine inhibits the reaction [Bleomycin results in increased expression of NOS2 protein] Bleomycin results in increased secretion of NOS2 protein yupingfeng inhibits the reaction [Bleomycin results in increased secretion of NOS2 protein]
|
CTD |
PMID:15684285 PMID:17434272 PMID:19362168 PMID:23523906 PMID:26526764 PMID:27704718 PMID:33647319 PMID:37898439 More...
|
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
G
|
Notch4
|
notch receptor 4
|
increases expression
|
ISO
|
Bleomycin results in increased expression of NOTCH4 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr20:4,164,969...4,189,072
Ensembl chr20:4,161,730...4,189,072
|
|
G
|
Nox4
|
NADPH oxidase 4
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of NOX4 mRNA geranylgeranylacetone inhibits the reaction [Bleomycin results in increased expression of NOX4 mRNA]; Thioctic Acid inhibits the reaction [Bleomycin results in increased expression of NOX4 mRNA]
|
CTD |
PMID:35187969 PMID:37307957 |
|
NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:150,313,728...150,491,483
|
|
G
|
Npm1
|
nucleophosmin 1
|
increases expression
|
EXP
|
Bleomycin results in increased expression of NPM1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr10:18,245,739...18,255,913
Ensembl chr10:18,245,740...18,256,024 Ensembl chr X:18,245,740...18,256,024
|
|
G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
decreases activity multiple interactions
|
EXP
|
Bleomycin results in decreased activity of NQO1 protein celastrol inhibits the reaction [Bleomycin results in decreased activity of NQO1 protein]
|
CTD |
PMID:26768587 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
G
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of NR3C1 mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843
|
|
G
|
Nr3c2
|
nuclear receptor subfamily 3, group C, member 2
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of NR3C2 mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr19:47,619,853...47,964,089
Ensembl chr19:47,619,853...47,964,078
|
|
G
|
Nucb2
|
nucleobindin 2
|
increases expression
|
EXP
|
Bleomycin results in increased expression of NUCB2 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 1:180,185,121...180,221,644
Ensembl chr 1:180,199,551...180,230,116
|
|
G
|
Oat
|
ornithine aminotransferase
|
multiple interactions
|
ISO
|
[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of OAT protein
|
CTD |
PMID:29733421 |
|
NCBI chr 1:196,777,973...196,797,754
Ensembl chr 1:196,777,975...196,797,754
|
|
G
|
Ogg1
|
8-oxoguanine DNA glycosylase
|
increases expression affects response to substance multiple interactions
|
ISO
|
Bleomycin results in increased expression of OGG1 protein OGG1 protein affects the susceptibility to Bleomycin OGG1 protein affects the reaction [Bleomycin results in decreased expression of CDH1 protein]; OGG1 protein affects the reaction [Bleomycin results in increased expression of CCN2 protein]; OGG1 protein affects the reaction [Bleomycin results in increased expression of CDH2 protein]; OGG1 protein affects the reaction [Bleomycin results in increased expression of FN1 protein]; OGG1 protein inhibits the reaction [TH5487 inhibits the reaction [Bleomycin results in decreased expression of CDH1 protein]]; OGG1 protein inhibits the reaction [TH5487 inhibits the reaction [Bleomycin results in increased expression of CCN2 protein]]; OGG1 protein inhibits the reaction [TH5487 inhibits the reaction [Bleomycin results in increased expression of CDH2 protein]]; OGG1 protein inhibits the reaction [TH5487 inhibits the reaction [Bleomycin results in increased expression of FN1 protein]]; OGG1 protein promotes the reaction [Bleomycin results in increased expression of CCN2 protein]; OGG1 protein promotes the reaction [Bleomycin results in increased expression of FN1 protein]; pirfenidone inhibits the reaction [Bleomycin results in increased expression of OGG1 protein]; TH5487 inhibits the reaction [Bleomycin results in increased expression of OGG1 protein]
|
CTD |
PMID:35654123 |
|
NCBI chr 4:148,030,237...148,037,599
Ensembl chr 4:148,030,349...148,037,604
|
|
G
|
Osr1
|
odd-skipped related transcription factor 1
|
increases expression
|
ISO
|
Bleomycin results in increased expression of OSR1 protein
|
CTD |
PMID:34460027 |
|
NCBI chr 6:38,088,688...38,100,010
Ensembl chr 6:38,093,011...38,100,021
|
|
G
|
Ostf1
|
osteoclast stimulating factor 1
|
increases expression
|
EXP
|
Bleomycin results in increased expression of OSTF1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 1:225,428,661...225,475,851
Ensembl chr 1:225,428,661...225,541,027
|
|
G
|
P4hb
|
prolyl 4-hydroxylase subunit beta
|
increases expression
|
EXP
|
Bleomycin results in increased expression of P4HB protein
|
CTD |
PMID:25933445 |
|
NCBI chr10:106,335,300...106,346,911
Ensembl chr10:106,335,300...106,346,911
|
|
G
|
Pabpc1
|
poly(A) binding protein, cytoplasmic 1
|
increases expression
|
EXP
|
Bleomycin results in increased expression of PABPC1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 7:69,662,513...69,674,806
Ensembl chr 7:69,663,068...69,675,050
|
|
G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
increases expression increases cleavage multiple interactions
|
ISO EXP
|
Bleomycin results in increased expression of PARP1 protein Bleomycin results in increased cleavage of PARP1 protein Bleomycin inhibits the reaction [Azacitidine results in increased cleavage of PARP1 protein]
|
CTD |
PMID:15371238 PMID:16317386 PMID:32278510 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
G
|
Pcbp2
|
poly(rC) binding protein 2
|
multiple interactions
|
ISO
|
[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of PCBP2 protein
|
CTD |
PMID:29733421 |
|
NCBI chr 7:135,483,702...135,508,254
Ensembl chr 7:135,483,856...135,509,412
|
|
G
|
Pdia3
|
protein disulfide isomerase family A, member 3
|
multiple interactions
|
EXP
|
[Bleomycin co-treated with Cisplatin co-treated with Etoposide] results in increased expression of PDIA3 protein
|
CTD |
PMID:24478030 |
|
NCBI chr 3:128,841,781...128,865,733
Ensembl chr 3:128,841,917...128,867,327
|
|
G
|
Pdlim1
|
PDZ and LIM domain 1
|
increases expression
|
EXP
|
Bleomycin results in increased expression of PDLIM1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 1:248,991,818...249,040,409
Ensembl chr 1:248,991,818...249,047,379
|
|
G
|
Pdlim5
|
PDZ and LIM domain 5
|
increases expression
|
EXP
|
Bleomycin results in increased expression of PDLIM5 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 2:233,625,478...233,793,582
Ensembl chr 2:233,628,503...233,793,528
|
|
G
|
Pecam1
|
platelet and endothelial cell adhesion molecule 1
|
multiple interactions decreases expression
|
ISO
|
Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of PECAM1 protein]
|
CTD |
PMID:30825431 |
|
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:92,090,235...92,151,839
|
|
G
|
Plau
|
plasminogen activator, urokinase
|
increases expression decreases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of PLAU mRNA; Bleomycin results in increased expression of PLAU protein Bleomycin results in decreased expression of PLAU mRNA; Bleomycin results in decreased expression of PLAU protein Curcumin inhibits the reaction [Bleomycin results in decreased expression of PLAU mRNA]; Curcumin inhibits the reaction [Bleomycin results in decreased expression of PLAU protein]
|
CTD |
PMID:25648892 PMID:35716765 |
|
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
|
|
G
|
Plaur
|
plasminogen activator, urokinase receptor
|
decreases expression multiple interactions
|
ISO
|
Bleomycin results in decreased expression of PLAUR mRNA; Bleomycin results in decreased expression of PLAUR protein Curcumin inhibits the reaction [Bleomycin results in decreased expression of PLAUR mRNA]; Curcumin inhibits the reaction [Bleomycin results in decreased expression of PLAUR protein]
|
CTD |
PMID:35716765 |
|
NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:89,178,453...89,198,130
|
|
G
|
Pml
|
PML nuclear body scaffold
|
multiple interactions increases expression
|
ISO
|
arsenic trioxide inhibits the reaction [Bleomycin results in increased expression of PML protein]
|
CTD |
PMID:24762191 |
|
NCBI chr 8:67,523,164...67,557,801
Ensembl chr 8:67,523,164...67,576,083
|
|
G
|
Pnp
|
purine nucleoside phosphorylase
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of PNP protein
|
CTD |
PMID:25933445 |
|
NCBI chr15:26,644,147...26,651,808
Ensembl chr15:26,643,858...26,678,162
|
|
G
|
Podxl
|
podocalyxin-like
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of PODXL protein
|
CTD |
PMID:25933445 |
|
NCBI chr 4:61,102,434...61,149,131
Ensembl chr 4:61,102,419...61,149,789
|
|
G
|
Polb
|
DNA polymerase beta
|
decreases response to substance
|
ISO
|
POLB results in decreased susceptibility to Bleomycin
|
CTD |
PMID:21251944 |
|
NCBI chr16:76,081,903...76,105,174
Ensembl chr16:76,081,864...76,108,180
|
|
G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
multiple interactions decreases response to substance
|
ISO
|
PPARA protein affects the reaction [Bleomycin results in increased expression of HMOX1 protein]; PPARA protein affects the reaction [Bleomycin results in increased expression of IL1B protein]; PPARA protein affects the reaction [Bleomycin results in increased expression of TNF protein] PPARA protein results in decreased susceptibility to Bleomycin
|
CTD |
PMID:16317386 |
|
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
|
|
G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
decreases expression multiple interactions
|
ISO
|
Bleomycin results in decreased expression of PPARG mRNA; Bleomycin results in decreased expression of PPARG protein lenabasum inhibits the reaction [Bleomycin results in decreased expression of PPARG protein]; Rosiglitazone inhibits the reaction [Bleomycin results in decreased expression of PPARG mRNA] Berberine inhibits the reaction [Bleomycin binds to PPARG protein]
|
CTD |
PMID:19147827 PMID:27153807 PMID:29408570 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
G
|
Ppfia4
|
PTPRF interacting protein alpha 4
|
multiple interactions increases expression
|
ISO
|
Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of PPFIA4 mRNA]; lenabasum inhibits the reaction [Bleomycin results in increased expression of PPFIA4 mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr13:48,305,844...48,354,329
Ensembl chr13:48,305,848...48,354,279
|
|
G
|
Ppia
|
peptidylprolyl isomerase A
|
increases expression
|
EXP
|
Bleomycin results in increased expression of PPIA protein
|
CTD |
PMID:25933445 |
|
NCBI chr14:85,491,223...85,496,884
Ensembl chr14:85,492,484...85,497,115
|
|
G
|
Prdx2
|
peroxiredoxin 2
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of PRDX2 protein
|
CTD |
PMID:25933445 |
|
NCBI chr19:40,085,788...40,091,083
Ensembl chr19:40,084,430...40,091,006
|
|
G
|
Prdx6
|
peroxiredoxin 6
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of PRDX6 protein
|
CTD |
PMID:25933445 |
|
NCBI chr13:76,062,082...76,072,631
Ensembl chr13:76,061,554...76,072,657
|
|
G
|
Prelp
|
proline and arginine rich end leucine rich repeat protein
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of PRELP protein
|
CTD |
PMID:25933445 |
|
NCBI chr13:47,920,480...47,943,547
Ensembl chr13:47,922,590...47,932,324
|
|
G
|
Psmd13
|
proteasome 26S subunit, non-ATPase 13
|
multiple interactions
|
ISO
|
[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of PSMD13 protein
|
CTD |
PMID:29733421 |
|
NCBI chr 1:205,394,248...205,406,525
Ensembl chr 1:205,393,746...205,411,651
|
|
G
|
Psme1
|
proteasome activator subunit 1
|
increases expression
|
EXP
|
Bleomycin results in increased expression of PSME1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr15:33,038,962...33,041,849
Ensembl chr15:33,038,597...33,041,848
|
|
G
|
Psme2
|
proteasome activator subunit 2
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of PSME2 protein
|
CTD |
PMID:25933445 |
|
NCBI chr15:33,048,452...33,053,055
Ensembl chr15:33,048,457...33,053,102
|
|
G
|
Ptafr
|
platelet-activating factor receptor
|
multiple interactions increases expression
|
ISO
|
Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of PTAFR mRNA]; lenabasum inhibits the reaction [Bleomycin results in increased expression of PTAFR mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr 5:150,049,322...150,079,060
Ensembl chr 5:150,049,460...150,079,408
|
|
G
|
Ptbp1
|
polypyrimidine tract binding protein 1
|
increases expression
|
EXP
|
Bleomycin results in increased expression of PTBP1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 7:10,493,199...10,502,957
Ensembl chr 7:10,493,200...10,502,957
|
|
G
|
Pten
|
phosphatase and tensin homolog
|
multiple interactions decreases expression
|
ISO
|
((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide) inhibits the reaction [Berberine inhibits the reaction [Bleomycin results in decreased expression of PTEN mRNA]]; Berberine inhibits the reaction [Bleomycin results in decreased expression of PTEN mRNA]; Berberine inhibits the reaction [Bleomycin results in decreased expression of PTEN protein] Bleomycin results in decreased expression of PTEN mRNA; Bleomycin results in decreased expression of PTEN protein
|
CTD |
PMID:29408570 |
|
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330
|
|
G
|
Ptgdr
|
prostaglandin D2 receptor
|
increases expression
|
ISO
|
Bleomycin results in increased expression of PTGDR mRNA
|
CTD |
PMID:20719937 |
|
NCBI chr15:19,790,499...19,797,873
Ensembl chr15:19,790,499...19,797,873
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of PTGS2 mRNA; Bleomycin results in increased expression of PTGS2 protein 2-((dimethylamino)methyl)-9-hydroxythieno(2,3-c)isoquinolin-5(4H)-one inhibits the reaction [Bleomycin results in increased expression of PTGS2 protein]; N-((3-(aminomethyl)phenyl)methyl)ethanimidamide inhibits the reaction [Bleomycin results in increased expression of PTGS2 mRNA]
|
CTD |
PMID:26526764 PMID:27704718 PMID:32828905 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
G
|
Ptms
|
parathymosin
|
increases expression
|
EXP
|
Bleomycin results in increased expression of PTMS protein
|
CTD |
PMID:25933445 |
|
NCBI chr 4:159,408,647...159,412,837
Ensembl chr 4:159,408,649...159,415,212
|
|
G
|
Rab1b
|
RAB1B, member RAS oncogene family
|
increases expression
|
EXP
|
Bleomycin results in increased expression of RAB1B protein
|
CTD |
PMID:25933445 |
|
NCBI chr 1:211,835,133...211,843,408
Ensembl chr 1:211,835,073...211,843,337 Ensembl chr X:211,835,073...211,843,337
|
|
G
|
Rac2
|
Rac family small GTPase 2
|
multiple interactions increases expression
|
ISO
|
Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of RAC2 mRNA]; lenabasum inhibits the reaction [Bleomycin results in increased expression of RAC2 mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr 7:111,981,825...112,009,201
Ensembl chr 7:111,996,742...112,009,267
|
|
G
|
Rad51ap1
|
RAD51 associated protein 1
|
decreases expression multiple interactions
|
ISO
|
Bleomycin results in decreased expression of RAD51AP1 mRNA Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of RAD51AP1 mRNA]; lenabasum inhibits the reaction [Bleomycin results in decreased expression of RAD51AP1 mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr 4:161,445,610...161,458,661
Ensembl chr 4:161,445,512...161,458,680
|
|
G
|
Ralb
|
RAS like proto-oncogene B
|
increases expression
|
EXP
|
Bleomycin results in increased expression of RALB protein
|
CTD |
PMID:25933445 |
|
NCBI chr13:33,140,834...33,176,997
Ensembl chr13:33,140,835...33,176,998
|
|
G
|
Rap1b
|
RAP1B, member of RAS oncogene family
|
increases expression
|
EXP
|
Bleomycin results in increased expression of RAP1B protein
|
CTD |
PMID:25933445 |
|
NCBI chr 7:55,308,922...55,342,217
Ensembl chr 7:55,308,922...55,342,217
|
|
G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions increases expression decreases expression increases phosphorylation increases activity
|
ISO EXP
|
Calcitriol inhibits the reaction [Bleomycin results in increased expression of RELA protein]; geranylgeranylacetone inhibits the reaction [Bleomycin results in increased expression of RELA mRNA]; honokiol inhibits the reaction [Bleomycin results in increased expression of RELA protein modified form]; methyl palmitate inhibits the reaction [Bleomycin results in increased expression of RELA protein] Berberine inhibits the reaction [Bleomycin affects the localization of and results in increased expression of RELA protein]; Bleomycin affects the localization of and results in increased expression of RELA protein; thymoquinone inhibits the reaction [Bleomycin results in increased expression of RELA protein] Bleomycin results in increased expression of RELA mRNA; Bleomycin results in increased expression of RELA protein; Bleomycin results in increased expression of RELA protein modified form Bleomycin results in decreased expression of RELA mRNA Bleomycin results in increased phosphorylation of RELA protein Ephedrine inhibits the reaction [Bleomycin results in increased phosphorylation of RELA protein]; methyl caffeate inhibits the reaction [Bleomycin results in increased activity of RELA protein]
|
CTD |
PMID:21575650 PMID:22982510 PMID:23523906 PMID:26520185 PMID:28299617 PMID:29720568 PMID:32032644 PMID:37307957 PMID:37778983 More...
|
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
G
|
Relb
|
RELB proto-oncogene, NF-kB subunit
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of RELB mRNA
|
CTD |
PMID:29720568 |
|
NCBI chr 1:88,385,717...88,413,380
Ensembl chr 1:88,385,717...88,413,420
|
|
G
|
Robo1
|
roundabout guidance receptor 1
|
decreases expression multiple interactions
|
ISO
|
Bleomycin results in decreased expression of ROBO1 mRNA Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of ROBO1 mRNA]; lenabasum inhibits the reaction [Bleomycin results in decreased expression of ROBO1 mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr11:24,067,869...25,108,694
Ensembl chr11:24,067,878...25,108,694
|
|
G
|
Rpl12
|
ribosomal protein L12
|
increases expression
|
EXP
|
Bleomycin results in increased expression of RPL12 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 3:36,661,940...36,664,314
Ensembl chr 3:36,661,939...36,664,306
|
|
G
|
Rpl13
|
ribosomal protein L13
|
increases expression
|
EXP
|
Bleomycin results in increased expression of RPL13 protein
|
CTD |
PMID:25933445 |
|
NCBI chr19:68,062,442...68,065,065
Ensembl chr19:68,062,493...68,065,059
|
|
G
|
Rpl4
|
ribosomal protein L4
|
increases expression
|
EXP
|
Bleomycin results in increased expression of RPL4 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 8:73,566,477...73,571,600
Ensembl chr 8:73,566,466...73,571,788
|
|
G
|
Rpl5
|
ribosomal protein L5
|
increases expression
|
EXP
|
Bleomycin results in increased expression of RPL5 protein
|
CTD |
PMID:25933445 |
|
NCBI chr14:1,988,792...1,995,236
Ensembl chr14:1,988,793...1,995,225
|
|
G
|
Rpl6
|
ribosomal protein L6
|
affects expression
|
EXP
|
Bleomycin affects the expression of RPL6 protein
|
CTD |
PMID:25933445 |
|
NCBI chr12:41,008,142...41,012,756
Ensembl chr12:41,008,142...41,025,733
|
|
G
|
Rps3a
|
ribosomal protein S3a
|
increases expression
|
EXP
|
Bleomycin results in increased expression of RPS3A1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 2:173,822,673...173,827,042
Ensembl chr 2:173,822,488...173,827,043
|
|
G
|
S100a11
|
S100 calcium binding protein A11
|
increases expression
|
EXP
|
Bleomycin results in increased expression of S100A11 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 2:181,875,132...181,880,542
Ensembl chr 2:181,875,130...181,880,541
|
|
G
|
S100a4
|
S100 calcium-binding protein A4
|
increases expression multiple interactions
|
EXP
|
Bleomycin results in increased expression of S100A4 protein andrographolide inhibits the reaction [Bleomycin results in increased expression of S100A4 protein]
|
CTD |
PMID:25933445 PMID:31706003 |
|
NCBI chr 2:178,388,529...178,390,838
Ensembl chr 2:178,388,526...178,390,837
|
|
G
|
S100a6
|
S100 calcium binding protein A6
|
affects expression
|
EXP
|
Bleomycin affects the expression of S100A6 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 2:178,398,189...178,399,763
Ensembl chr 2:178,398,481...178,399,762
|
|
G
|
S100a8
|
S100 calcium binding protein A8
|
increases expression
|
EXP
|
Bleomycin results in increased expression of S100A8 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 2:178,464,095...178,465,223
Ensembl chr 2:178,464,702...178,465,221
|
|
G
|
S1pr1
|
sphingosine-1-phosphate receptor 1
|
multiple interactions
|
ISO
|
[S1PR5 protein affects the susceptibility to Bleomycin] which affects the expression of S1PR1 protein
|
CTD |
PMID:29033951 |
|
NCBI chr 2:206,309,715...206,314,070
Ensembl chr 2:205,900,836...206,328,689
|
|
G
|
S1pr3
|
sphingosine-1-phosphate receptor 3
|
multiple interactions increases expression
|
ISO
|
S1PR5 protein affects the reaction [Bleomycin results in increased expression of S1PR3 mRNA]
|
CTD |
PMID:29033951 |
|
NCBI chr17:13,932,773...13,946,213
Ensembl chr17:13,928,444...13,947,197
|
|
G
|
S1pr5
|
sphingosine-1-phosphate receptor 5
|
multiple interactions affects response to substance
|
ISO
|
[S1PR5 protein affects the susceptibility to Bleomycin] which affects the expression of COMP protein; [S1PR5 protein affects the susceptibility to Bleomycin] which affects the expression of S1PR1 protein; S1PR5 protein affects the reaction [Bleomycin results in increased expression of COL1A1 mRNA]; S1PR5 protein affects the reaction [Bleomycin results in increased expression of GATA3 mRNA]; S1PR5 protein affects the reaction [Bleomycin results in increased expression of S1PR3 mRNA]; S1PR5 protein affects the reaction [Bleomycin results in increased expression of SMAD7 mRNA]
|
CTD |
PMID:29033951 |
|
NCBI chr 8:28,062,841...28,068,013
Ensembl chr 8:28,061,752...28,068,389
|
|
G
|
Scarna15
|
small Cajal body-specific RNA 15
|
affects expression
|
EXP
|
Bleomycin affects the expression of SCARNA15 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 1:144,893,856...144,893,919
Ensembl chr 1:144,893,795...144,893,921
|
|
G
|
Scgb1a1
|
secretoglobin family 1A member 1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of SCGB1A1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 1:215,406,138...215,409,686
Ensembl chr 1:215,406,138...215,409,686
|
|
G
|
Scp2
|
sterol carrier protein 2
|
increases expression
|
EXP
|
Bleomycin results in increased expression of SCP2 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 5:128,035,714...128,110,015
Ensembl chr 5:128,008,125...128,110,043
|
|
G
|
Scpep1
|
serine carboxypeptidase 1
|
increases expression
|
EXP
|
Bleomycin results in increased expression of SCPEP1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr10:74,200,491...74,230,107
Ensembl chr10:74,200,491...74,230,241
|
|
G
|
Scube3
|
signal peptide, CUB domain and EGF like domain containing 3
|
multiple interactions decreases expression
|
ISO
|
Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of SCUBE3 mRNA]; lenabasum inhibits the reaction [Bleomycin results in decreased expression of SCUBE3 mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr20:6,200,891...6,232,848
Ensembl chr20:6,200,178...6,233,051
|
|
G
|
Sec14l3
|
SEC14-like lipid binding 3
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of SEC14L3 protein
|
CTD |
PMID:25933445 |
|
NCBI chr14:83,168,154...83,181,240
Ensembl chr14:83,168,208...83,179,654
|
|
G
|
Selenbp1
|
selenium binding protein 1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of SELENBP1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 2:185,183,022...185,193,612
Ensembl chr 2:185,183,004...185,194,295
|
|
G
|
Serpinb2
|
serpin family B member 2
|
multiple interactions increases expression
|
ISO
|
Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of SERPINB2 mRNA]; lenabasum inhibits the reaction [Bleomycin results in increased expression of SERPINB2 mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr13:24,051,933...24,065,032
Ensembl chr13:24,056,021...24,065,031
|
|
G
|
Serpine1
|
serpin family E member 1
|
increases expression decreases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of SERPINE1 mRNA; Bleomycin results in increased expression of SERPINE1 protein Bleomycin results in decreased expression of SERPINE1 protein Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of SERPINE1 protein]; Curcumin inhibits the reaction [Bleomycin results in increased expression of SERPINE1 mRNA]; Curcumin inhibits the reaction [Bleomycin results in increased expression of SERPINE1 protein]; lenabasum inhibits the reaction [Bleomycin results in decreased expression of SERPINE1 protein]
|
CTD |
PMID:29175452 PMID:30825431 PMID:35716765 |
|
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
|
|
G
|
Serpinh1
|
serpin family H member 1
|
multiple interactions increases expression
|
EXP
|
allyl sulfide inhibits the reaction [Bleomycin results in increased expression of SERPINH1 protein]
|
CTD |
PMID:23656969 PMID:25933445 |
|
NCBI chr 1:163,055,630...163,063,177
Ensembl chr 1:163,055,630...163,062,976
|
|
G
|
Sfrp1
|
secreted frizzled-related protein 1
|
increases expression
|
ISO
|
Bleomycin results in increased expression of SFRP1 mRNA
|
CTD |
PMID:26345256 |
|
NCBI chr16:75,278,325...75,316,736
Ensembl chr16:75,278,325...75,316,736
|
|
G
|
Sftpa1
|
surfactant protein A1
|
multiple interactions decreases expression increases expression
|
ISO EXP
|
[Bleomycin co-treated with SFTPA1 protein polymorphism] results in increased expression of CXCL8 protein; [Bleomycin co-treated with SFTPA1 protein polymorphism] results in increased expression of TNF protein; Bleomycin promotes the reaction [[SFTPA1 protein binds to SFTPA2 protein] which results in increased expression of TNF protein]; calfactant inhibits the reaction [Bleomycin promotes the reaction [[SFTPA1 protein binds to SFTPA2 protein] which results in increased expression of TNF protein]] Bleomycin results in decreased expression of SFTPA1 mRNA Bleomycin results in increased expression of SFTPA1 protein
|
CTD |
PMID:14617519 PMID:15782499 PMID:25933445 |
|
NCBI chr16:17,042,264...17,045,770
Ensembl chr16:17,042,255...17,045,769
|
|
G
|
Sftpb
|
surfactant protein B
|
decreases expression multiple interactions
|
EXP ISO
|
Bleomycin results in decreased expression of SFTPB mRNA [TNF protein affects the susceptibility to Bleomycin] which affects the expression of SFTPB protein
|
CTD |
PMID:15782499 PMID:33647319 |
|
NCBI chr 4:105,917,495...105,926,631
Ensembl chr 4:105,917,578...105,927,646
|
|
G
|
Sftpc
|
surfactant protein C
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of SFTPC mRNA; Bleomycin results in decreased expression of SFTPC protein
|
CTD |
PMID:34425168 |
|
NCBI chr15:52,006,274...52,009,324
Ensembl chr15:52,006,283...52,009,475
|
|
G
|
Sftpd
|
surfactant protein D
|
increases expression increases metabolic processing multiple interactions
|
EXP ISO
|
Bleomycin results in increased expression of SFTPD mRNA; Bleomycin results in increased expression of SFTPD protein Bleomycin results in increased metabolism of SFTPD protein [TNF protein affects the susceptibility to Bleomycin] which affects the expression of SFTPD protein; Bleomycin promotes the reaction [SFTPD protein binds to SFTPD protein binds to SFTPD protein]; N-((3-(aminomethyl)phenyl)methyl)ethanimidamide inhibits the reaction [Bleomycin results in increased metabolism of SFTPD protein]
|
CTD |
PMID:11880309 PMID:25933445 PMID:26526764 PMID:33647319 |
|
NCBI chr16:17,080,575...17,093,047
Ensembl chr16:17,080,567...17,094,036
|
|
G
|
Sirt1
|
sirtuin 1
|
decreases expression multiple interactions
|
ISO
|
Bleomycin results in decreased expression of SIRT1 mRNA; Bleomycin results in decreased expression of SIRT1 protein resveratrol inhibits the reaction [Bleomycin results in decreased expression of SIRT1 mRNA]; resveratrol inhibits the reaction [Bleomycin results in decreased expression of SIRT1 protein]
|
CTD |
PMID:25707573 |
|
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
|
|
G
|
Slc12a1
|
solute carrier family 12 member 1
|
increases expression
|
EXP
|
Bleomycin results in increased expression of SLC12A1 mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr 3:132,859,581...132,936,354
Ensembl chr 3:132,859,590...132,936,340
|
|
G
|
Slc1a2
|
solute carrier family 1 member 2
|
increases expression
|
EXP
|
Bleomycin results in increased expression of SLC1A2 mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr 3:109,460,109...109,590,445
Ensembl chr 3:109,459,630...109,605,249
|
|
G
|
Slc25a4
|
solute carrier family 25 member 4
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of SLC25A4 protein
|
CTD |
PMID:25933445 |
|
NCBI chr16:52,805,521...52,809,316
Ensembl chr16:52,805,523...52,811,700
|
|
G
|
Slc25a5
|
solute carrier family 25 member 5
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of SLC25A5 protein
|
CTD |
PMID:25933445 |
|
NCBI chr X:120,897,616...120,900,683
Ensembl chr X:120,897,563...120,900,688
|
|
G
|
Slc6a12
|
solute carrier family 6 member 12
|
increases expression
|
EXP
|
Bleomycin results in increased expression of SLC6A12 mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr 4:156,257,518...156,275,870
Ensembl chr 4:156,254,208...156,275,879
|
|
G
|
Slc6a15
|
solute carrier family 6 member 15
|
decreases expression multiple interactions
|
ISO
|
Bleomycin results in decreased expression of SLC6A15 mRNA Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of SLC6A15 mRNA]; lenabasum inhibits the reaction [Bleomycin results in decreased expression of SLC6A15 mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr 7:40,439,607...40,493,788
Ensembl chr 7:40,439,658...40,493,786
|
|
G
|
Slc7a1
|
solute carrier family 7 member 1
|
decreases expression multiple interactions
|
ISO
|
Bleomycin results in decreased expression of SLC7A1 mRNA Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of SLC7A1 mRNA]; lenabasum inhibits the reaction [Bleomycin results in decreased expression of SLC7A1 mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr12:11,664,488...11,740,030
Ensembl chr12:11,664,399...11,740,030
|
|
G
|
Slco2a1
|
solute carrier organic anion transporter family, member 2a1
|
increases response to substance multiple interactions
|
ISO
|
SLCO2A1 gene mutant form results in increased susceptibility to Bleomycin [SLCO2A1 gene mutant form results in increased susceptibility to Bleomycin] which results in increased expression of TNF mRNA; SLCO2A1 gene mutant form promotes the reaction [Bleomycin results in increased expression of CCL5 mRNA]; SLCO2A1 gene mutant form promotes the reaction [Bleomycin results in increased expression of IL1B mRNA]
|
CTD |
PMID:32828905 |
|
NCBI chr 8:112,467,739...112,551,923
Ensembl chr 8:112,467,160...112,551,921
|
|
G
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1
|
multiple interactions
|
ISO
|
Bleomycin inhibits the reaction [SLCO2B1 protein results in increased uptake of Cascade Blue]
|
CTD |
PMID:30863990 |
|
NCBI chr 1:163,371,410...163,419,412
Ensembl chr 1:163,371,410...163,419,279
|
|
G
|
Slpi
|
secretory leukocyte peptidase inhibitor
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of SLPI mRNA; Bleomycin results in increased expression of SLPI protein Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of SLPI mRNA]; lenabasum inhibits the reaction [Bleomycin results in increased expression of SLPI mRNA]
|
CTD |
PMID:26345256 PMID:30825431 |
|
NCBI chr 3:173,501,573...173,503,822
Ensembl chr 3:173,501,573...173,503,822
|
|
G
|
Smad2
|
SMAD family member 2
|
increases phosphorylation multiple interactions increases expression
|
ISO
|
Bleomycin results in increased phosphorylation of SMAD2 protein camostat inhibits the reaction [Bleomycin results in increased phosphorylation of SMAD2 protein]; honokiol inhibits the reaction [Bleomycin results in increased phosphorylation of SMAD2 protein]; MIR182 affects the reaction [Bleomycin results in increased phosphorylation of SMAD2 protein]; Thioctic Acid inhibits the reaction [Bleomycin results in increased phosphorylation of SMAD2 protein] yupingfeng inhibits the reaction [Bleomycin results in increased expression of SMAD2 mRNA]; yupingfeng inhibits the reaction [Bleomycin results in increased phosphorylation of SMAD2 protein]
|
CTD |
PMID:26599507 PMID:31884830 PMID:32032644 PMID:35187969 PMID:37898439 |
|
NCBI chr18:72,124,792...72,193,345
Ensembl chr18:72,124,863...72,187,388
|
|
G
|
Smad3
|
SMAD family member 3
|
multiple interactions increases expression increases phosphorylation
|
EXP ISO
|
Phytochemicals inhibits the reaction [Bleomycin results in increased expression of SMAD3 mRNA] 2-((dimethylamino)methyl)-9-hydroxythieno(2,3-c)isoquinolin-5(4H)-one inhibits the reaction [Bleomycin results in increased phosphorylation of SMAD3 protein]; honokiol inhibits the reaction [Bleomycin results in increased phosphorylation of SMAD3 protein]; MIR182 affects the reaction [Bleomycin results in increased phosphorylation of SMAD3 protein]; Thioctic Acid inhibits the reaction [Bleomycin results in increased phosphorylation of SMAD3 protein]
|
CTD |
PMID:26093215 PMID:27704718 PMID:31884830 PMID:32032644 PMID:35187969 |
|
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:73,024,760...73,132,324
|
|
G
|
Smad7
|
SMAD family member 7
|
decreases expression increases expression multiple interactions
|
EXP ISO
|
Bleomycin results in decreased expression of SMAD7 mRNA Bleomycin results in increased expression of SMAD7 mRNA MIR182 affects the reaction [Bleomycin results in decreased expression of SMAD7 protein]; S1PR5 protein affects the reaction [Bleomycin results in increased expression of SMAD7 mRNA]
|
CTD |
PMID:26093215 PMID:29033951 PMID:31884830 |
|
NCBI chr18:71,263,508...71,291,849
Ensembl chr18:71,263,508...71,291,849
|
|
G
|
Smc1a
|
structural maintenance of chromosomes 1A
|
increases phosphorylation
|
ISO
|
Bleomycin results in increased phosphorylation of SMC1A protein
|
CTD |
PMID:24933654 |
|
NCBI chr X:24,582,732...24,627,462
Ensembl chr X:24,582,690...24,627,462
|
|
G
|
Smim14
|
small integral membrane protein 14
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of SMIM14 mRNA
|
CTD |
PMID:33770205 |
|
NCBI chr14:43,136,754...43,180,622
Ensembl chr14:43,136,867...43,183,416
|
|
G
|
Smtn
|
smoothelin
|
decreases expression multiple interactions
|
ISO
|
Bleomycin results in decreased expression of SMTN mRNA Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of SMTN mRNA]; lenabasum inhibits the reaction [Bleomycin results in decreased expression of SMTN mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr14:82,622,223...82,644,525
Ensembl chr14:82,621,375...82,644,514
|
|
G
|
Snora58
|
small nucleolar RNA, H/ACA box 58
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of SNORA58 mRNA
|
CTD |
PMID:25933445 |
|
NCBI chr 6:112,811,875...112,811,950
|
|
G
|
Socs1
|
suppressor of cytokine signaling 1
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of SOCS1 mRNA
|
CTD |
PMID:17374387 |
|
NCBI chr10:5,389,574...5,391,265
Ensembl chr10:5,389,334...5,391,847
|
|
G
|
Sod1
|
superoxide dismutase 1
|
increases expression multiple interactions decreases expression decreases activity
|
ISO EXP
|
Bleomycin results in increased expression of SOD1 protein IL1A protein promotes the reaction [Bleomycin results in increased expression of SOD1 protein]; IL1B protein promotes the reaction [Bleomycin results in increased expression of SOD1 protein]; TNF protein promotes the reaction [Bleomycin results in increased expression of SOD1 protein] Bleomycin results in decreased expression of SOD1 protein Bleomycin results in decreased activity of SOD1 protein
|
CTD |
PMID:8317554 PMID:25933445 PMID:30106319 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
G
|
Sod2
|
superoxide dismutase 2
|
increases expression multiple interactions decreases activity
|
ISO EXP
|
Bleomycin results in increased expression of SOD2 protein IL1A protein promotes the reaction [Bleomycin results in increased expression of SOD2 protein]; IL1B protein promotes the reaction [Bleomycin results in increased expression of SOD2 protein]; TNF protein promotes the reaction [Bleomycin results in increased expression of SOD2 protein] Bleomycin results in decreased activity of SOD2 protein celastrol inhibits the reaction [Bleomycin results in decreased activity of SOD2 protein]
|
CTD |
PMID:8317554 PMID:26768587 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
G
|
Sparc
|
secreted protein acidic and cysteine rich
|
increases response to substance
|
ISO
|
SPARC protein results in increased susceptibility to Bleomycin
|
CTD |
PMID:19446018 |
|
NCBI chr10:40,017,065...40,038,816
Ensembl chr10:40,017,075...40,039,268
|
|
G
|
Sparcl1
|
SPARC like 1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of SPARCL1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr14:5,937,484...5,968,532
Ensembl chr14:5,914,535...5,969,120
|
|
G
|
Spc25
|
SPC25 component of NDC80 kinetochore complex
|
increases expression
|
ISO
|
Bleomycin results in increased expression of SPC25 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 3:74,337,872...74,396,825
Ensembl chr 3:74,383,548...74,396,718
|
|
G
|
Spp1
|
secreted phosphoprotein 1
|
increases expression
|
ISO
|
Bleomycin results in increased expression of SPP1 mRNA; Bleomycin results in increased expression of SPP1 protein
|
CTD |
PMID:26345256 PMID:29175452 |
|
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820
|
|
G
|
Sptan1
|
spectrin, alpha, non-erythrocytic 1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of SPTAN1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 3:33,639,020...33,703,890
Ensembl chr 3:33,607,210...33,703,889
|
|
G
|
Srxn1
|
sulfiredoxin 1
|
increases expression
|
ISO
|
Bleomycin results in increased expression of SRXN1 mRNA
|
CTD |
PMID:22003191 |
|
NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:161,059,931...161,088,765
|
|
G
|
Sstr1
|
somatostatin receptor 1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of SSTR1 mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr 6:81,567,237...81,571,759
Ensembl chr 6:81,566,850...81,571,992
|
|
G
|
Sstr2
|
somatostatin receptor 2
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of SSTR2 mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr10:99,163,353...99,170,519
Ensembl chr10:99,162,740...99,183,863
|
|
G
|
Sstr3
|
somatostatin receptor 3
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of SSTR3 mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr 7:111,973,049...111,980,250
Ensembl chr 7:111,972,811...111,997,368
|
|
G
|
St14
|
ST14 transmembrane serine protease matriptase
|
multiple interactions
|
ISO
|
Bleomycin results in increased expression of and results in increased activity of ST14 protein
|
CTD |
PMID:26599507 |
|
NCBI chr 8:37,798,994...37,839,881
Ensembl chr 8:37,798,995...37,855,652
|
|
G
|
St3gal5
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 5
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of ST3GAL5 mRNA
|
CTD |
PMID:33770205 |
|
NCBI chr 4:105,692,840...105,750,774
Ensembl chr 4:105,692,840...105,750,775
|
|
G
|
Stat3
|
signal transducer and activator of transcription 3
|
multiple interactions increases expression
|
ISO
|
honokiol inhibits the reaction [Bleomycin results in increased expression of STAT3 protein modified form]
|
CTD |
PMID:32032644 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
G
|
Stat6
|
signal transducer and activator of transcription 6
|
multiple interactions decreases response to substance
|
ISO
|
STAT6 protein affects the reaction [Bleomycin results in increased expression of RETNLA mRNA] STAT6 gene mutant form results in decreased susceptibility to Bleomycin
|
CTD |
PMID:15322207 |
|
NCBI chr 7:65,365,505...65,382,825
Ensembl chr 7:65,365,306...65,383,795
|
|
G
|
Stk11
|
serine/threonine kinase 11
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of STK11 protein Soot inhibits the reaction [Bleomycin results in increased expression of STK11 protein]
|
CTD |
PMID:31302203 |
|
NCBI chr 7:10,225,204...10,241,965
Ensembl chr 7:10,225,204...10,241,965
|
|
G
|
Stk26
|
serine/threonine kinase 26
|
increases expression
|
EXP
|
Bleomycin results in increased expression of PDXK protein
|
CTD |
PMID:25933445 |
|
NCBI chr X:135,195,176...135,259,994
Ensembl chr X:135,195,204...135,259,993
|
|
G
|
Stmn1
|
stathmin 1
|
increases expression
|
EXP
|
Bleomycin results in increased expression of STMN1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 5:151,964,308...151,970,843
Ensembl chr 5:151,964,351...151,970,842
|
|
G
|
Sv2b
|
synaptic vesicle glycoprotein 2b
|
increases expression
|
EXP
|
Bleomycin results in increased expression of SV2B mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr 1:138,388,268...138,562,635
Ensembl chr 1:138,388,266...138,562,258
|
|
G
|
Tacr2
|
tachykinin receptor 2
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of TACR2 mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr20:30,751,645...30,766,181
Ensembl chr20:30,751,557...30,766,180
|
|
G
|
Tagln
|
transgelin
|
increases expression
|
EXP
|
Bleomycin results in increased expression of TAGLN protein
|
CTD |
PMID:25933445 |
|
NCBI chr 8:55,121,647...55,127,121
Ensembl chr 8:55,121,301...55,127,563
|
|
G
|
Tagln2
|
transgelin 2
|
increases expression
|
EXP
|
Bleomycin results in increased expression of TAGLN2 protein
|
CTD |
PMID:25933445 |
|
NCBI chr13:87,499,350...87,506,328
Ensembl chr13:87,499,394...87,506,330
|
|
G
|
Taldo1
|
transaldolase 1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of TALDO1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 1:205,923,196...205,933,526
Ensembl chr 1:205,923,165...205,933,535
|
|
G
|
Tapbp
|
TAP binding protein
|
affects response to substance
|
ISO
|
TAPBP protein affects the susceptibility to Bleomycin
|
CTD |
PMID:38992170 |
|
NCBI chr20:4,958,821...4,967,958
Ensembl chr20:4,959,926...4,971,834
|
|
G
|
Tbx21
|
T-box transcription factor 21
|
increases expression
|
ISO
|
Bleomycin results in increased expression of TBX21 mRNA
|
CTD |
PMID:29033951 |
|
NCBI chr10:82,578,751...82,595,253
Ensembl chr10:82,578,751...82,595,253
|
|
G
|
Tcp1
|
t-complex 1
|
multiple interactions
|
ISO
|
[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of TCP1 protein
|
CTD |
PMID:29733421 |
|
NCBI chr 1:50,376,848...50,384,527
Ensembl chr 1:50,376,848...50,384,527
|
|
G
|
Tent4b
|
terminal nucleotidyltransferase 4B
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of TENT4B mRNA
|
CTD |
PMID:33770205 |
|
NCBI chr19:34,984,244...35,042,423
Ensembl chr19:34,980,296...35,042,399
|
|
G
|
Tert
|
telomerase reverse transcriptase
|
decreases response to substance
|
ISO
|
TERT gene mutant form results in decreased susceptibility to Bleomycin
|
CTD |
PMID:18008008 |
|
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:31,466,056...31,488,111
|
|
G
|
Tf
|
transferrin
|
increases expression
|
EXP
|
Bleomycin results in increased expression of TF protein
|
CTD |
PMID:25933445 |
|
NCBI chr 8:112,668,667...112,695,376
Ensembl chr 8:112,647,642...112,695,400
|
|
G
|
Tgfb1
|
transforming growth factor, beta 1
|
multiple interactions increases secretion increases expression
|
ISO EXP
|
(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone inhibits the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; 12-(3-adamantan-1-ylureido)dodecanoic acid inhibits the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; 12-(3-adamantan-1-ylureido)dodecanoic acid inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]; 2-((dimethylamino)methyl)-9-hydroxythieno(2,3-c)isoquinolin-5(4H)-one inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]; 5-hydroxydecanoic acid inhibits the reaction [baicalein inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]]; 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]]; [Bleomycin co-treated with Cannabidiol analog] results in decreased expression of TGFB1 mRNA; [Bleomycin co-treated with Rosiglitazone] results in decreased expression of TGFB1 mRNA; [CCL12 protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; [HIF1A protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; [MMP3 protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; bufotalin inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]; Calcitriol inhibits the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; camostat inhibits the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; CCL11 protein promotes the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; CCR2 gene mutant form inhibits the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; CEBPB protein affects the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; Dexamethasone inhibits the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; Dexamethasone inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]; Diazoxide inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]; Grape Seed Extract inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]; honokiol inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]; lenabasum inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]; loganin inhibits the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; MIR182 affects the reaction [Bleomycin results in increased expression of TGFB1 protein]; morroniside inhibits the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; N-((3-(aminomethyl)phenyl)methyl)ethanimidamide promotes the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; Rosiglitazone inhibits the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; Simvastatin inhibits the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; Simvastatin inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]; SPL-334 inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]; tetrathiomolybdate inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]; Thioctic Acid inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein] 1-hydroxyalantolactone inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]; andrographolide inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]; angiotensin I (1-7) inhibits the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; Berberine inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]; Curcumin inhibits the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; Curcumin inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]; Hydrocortisone inhibits the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; Hydrocortisone inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]; Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; pachymic acid inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]; Phytochemicals inhibits the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; Resveratrol inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]; Valsartan inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein] Bleomycin results in increased secretion of TGFB1 protein Bleomycin results in increased expression of TGFB1 mRNA; Bleomycin results in increased expression of TGFB1 protein yupingfeng inhibits the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; yupingfeng inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]
|
CTD |
PMID:14609568 PMID:15541506 PMID:16115399 PMID:16314464 PMID:17035056 PMID:17177178 PMID:17434272 PMID:19080365 PMID:19112509 PMID:19147827 PMID:20581171 PMID:22687607 PMID:23523906 PMID:26093215 PMID:26209236 PMID:26520185 PMID:26526764 PMID:26599507 PMID:27153807 PMID:27704718 PMID:28300665 PMID:28434932 PMID:28694203 PMID:29033951 PMID:29720568 PMID:30033591 PMID:30106319 PMID:31706003 PMID:31884830 PMID:31901889 PMID:32032644 PMID:34758440 PMID:35187969 PMID:35267148 PMID:35279615 PMID:35785413 PMID:37163307 PMID:37783230 PMID:37898439 PMID:38158113 More...
|
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
G
|
Tgfb1i1
|
transforming growth factor beta 1 induced transcript 1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of TGFB1I1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 1:192,258,992...192,265,903
Ensembl chr 1:192,258,598...192,265,903
|
|
G
|
Tgfb2
|
transforming growth factor, beta 2
|
multiple interactions
|
ISO
|
[CCL12 protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of TGFB2 mRNA]; [HIF1A protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of TGFB2 mRNA]; [MMP3 protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of TGFB2 mRNA]
|
CTD |
PMID:28434932 |
|
NCBI chr13:100,691,540...100,793,227
Ensembl chr13:100,692,953...100,792,856
|
|
G
|
Tgfb3
|
transforming growth factor, beta 3
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of TGFB3 mRNA CCL12 protein affects the reaction [Dinoprostone inhibits the reaction [Bleomycin results in increased expression of TGFB3 mRNA]]; Dinoprostone inhibits the reaction [Bleomycin results in increased expression of TGFB3 mRNA]; HIF1A protein affects the reaction [Dinoprostone inhibits the reaction [Bleomycin results in increased expression of TGFB3 mRNA]]; MMP3 protein affects the reaction [Dinoprostone inhibits the reaction [Bleomycin results in increased expression of TGFB3 mRNA]]
|
CTD |
PMID:28434932 |
|
NCBI chr 6:111,435,170...111,457,646
Ensembl chr 6:111,435,170...111,456,946
|
|
G
|
Tgfbr1
|
transforming growth factor, beta receptor 1
|
multiple interactions increases expression
|
ISO
|
[CCL12 protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of TGFBR1 mRNA]; [HIF1A protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of TGFBR1 mRNA]; [MMP3 protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of TGFBR1 mRNA] MIR101-1 mRNA inhibits the reaction [Bleomycin results in increased expression of TGFBR1 mRNA]
|
CTD |
PMID:28434932 PMID:28726637 |
|
NCBI chr 5:66,449,348...66,506,371
Ensembl chr 5:66,449,293...66,527,260
|
|
G
|
Tgfbr2
|
transforming growth factor, beta receptor 2
|
multiple interactions
|
ISO
|
[CCL12 protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of TGFBR2 mRNA]; [HIF1A protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of TGFBR2 mRNA]; [MMP3 protein co-treated with Dinoprostone] affects the reaction [Bleomycin results in increased expression of TGFBR2 mRNA]
|
CTD |
PMID:28434932 |
|
NCBI chr 8:124,672,677...124,761,741
Ensembl chr 8:124,674,986...124,761,469
|
|
G
|
Tgif2
|
TGFB-induced factor homeobox 2
|
increases expression
|
ISO
|
Bleomycin results in increased expression of TGIF2 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 3:165,791,101...165,808,669
Ensembl chr 3:165,793,480...165,808,666
|
|
G
|
Thbs1
|
thrombospondin 1
|
increases expression
|
ISO
|
Bleomycin results in increased expression of THBS1 mRNA
|
CTD |
PMID:29720568 |
|
NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:125,510,250...125,525,402
|
|
G
|
Thbs2
|
thrombospondin 2
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of THBS2 protein Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of THBS2 protein]; lenabasum inhibits the reaction [Bleomycin results in increased expression of THBS2 protein]
|
CTD |
PMID:30825431 |
|
NCBI chr 1:64,343,523...64,372,918
Ensembl chr 1:64,343,523...64,372,918
|
|
G
|
Thop1
|
thimet oligopeptidase 1
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of THOP1 protein
|
CTD |
PMID:29733421 |
|
NCBI chr 7:9,283,617...9,295,957
Ensembl chr 7:9,283,617...9,295,957
|
|
G
|
Thrb
|
thyroid hormone receptor beta
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of THRB mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr15:10,115,954...10,465,231
Ensembl chr15:10,115,954...10,313,680
|
|
G
|
Timp1
|
TIMP metallopeptidase inhibitor 1
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of TIMP1 mRNA; Bleomycin results in increased expression of TIMP1 protein Dexamethasone inhibits the reaction [Bleomycin results in increased expression of TIMP1 protein]; Grape Seed Extract inhibits the reaction [Bleomycin results in increased expression of TIMP1 protein]; honokiol inhibits the reaction [Bleomycin results in increased expression of TIMP1 protein]
|
CTD |
PMID:26345256 PMID:28300665 PMID:32032644 |
|
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:3,766,510...3,771,135
|
|
G
|
Tlr1
|
toll-like receptor 1
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of TLR1 mRNA
|
CTD |
PMID:29720568 |
|
NCBI chr14:43,737,761...43,750,389
Ensembl chr14:43,740,379...43,756,243
|
|
G
|
Tmcc3
|
transmembrane and coiled-coil domain family 3
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of TMCC3 mRNA
|
CTD |
PMID:33770205 |
|
NCBI chr 7:30,781,452...31,058,888
Ensembl chr 7:30,897,991...31,058,889
|
|
G
|
Tmem250
|
transmembrane protein 250
|
increases expression
|
ISO
|
Bleomycin results in increased expression of TMEM250 mRNA
|
CTD |
PMID:33770205 |
|
NCBI chr 3:29,360,770...29,364,756
Ensembl chr 3:29,360,770...29,364,462
|
|
G
|
Tmem87a
|
transmembrane protein 87A
|
increases expression
|
ISO
|
Bleomycin results in increased expression of TMEM87A mRNA
|
CTD |
PMID:33770205 |
|
NCBI chr 3:127,761,490...127,807,314
Ensembl chr 3:127,761,490...127,807,314
|
|
G
|
Tnc
|
tenascin C
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of TNC mRNA; Bleomycin results in increased expression of TNC protein Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of TNC protein]; lenabasum inhibits the reaction [Bleomycin results in increased expression of TNC protein]
|
CTD |
PMID:26345256 PMID:30825431 |
|
NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:82,391,340...82,476,131
|
|
G
|
Tnf
|
tumor necrosis factor
|
multiple interactions increases expression increases secretion affects response to substance
|
ISO EXP
|
[Bleomycin co-treated with SFTPA1 protein polymorphism] results in increased expression of TNF protein; [Bleomycin co-treated with SFTPA2 protein polymorphism] results in increased expression of TNF protein; Bleomycin promotes the reaction [[SFTPA1 protein binds to SFTPA2 protein] which results in increased expression of TNF protein]; calfactant inhibits the reaction [Bleomycin promotes the reaction [[SFTPA1 protein binds to SFTPA2 protein] which results in increased expression of TNF protein]]; Ephedrine inhibits the reaction [Bleomycin results in increased secretion of TNF protein]; Ozone inhibits the reaction [[Bleomycin co-treated with SFTPA2 protein polymorphism] results in increased expression of TNF protein]; TNF protein promotes the reaction [Bleomycin results in increased expression of CAT protein]; TNF protein promotes the reaction [Bleomycin results in increased expression of SOD1 protein]; TNF protein promotes the reaction [Bleomycin results in increased expression of SOD2 protein]; yupingfeng inhibits the reaction [Bleomycin results in increased expression of TNF mRNA] (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone inhibits the reaction [Bleomycin results in increased expression of TNF mRNA]; 2-((dimethylamino)methyl)-9-hydroxythieno(2,3-c)isoquinolin-5(4H)-one inhibits the reaction [Bleomycin results in increased expression of TNF protein]; [SLCO2A1 gene mutant form results in increased susceptibility to Bleomycin] which results in increased expression of TNF mRNA; [TNF protein affects the susceptibility to Bleomycin] which affects the expression of SFTPB protein; [TNF protein affects the susceptibility to Bleomycin] which affects the expression of SFTPD protein; Calcitriol inhibits the reaction [Bleomycin results in increased expression of TNF mRNA]; CCR2 gene mutant form inhibits the reaction [Bleomycin results in increased expression of TNF mRNA]; CEBPB protein affects the reaction [Bleomycin results in increased expression of TNF mRNA]; Curcumin inhibits the reaction [Bleomycin results in increased expression of TNF mRNA]; Curcumin inhibits the reaction [Bleomycin results in increased expression of TNF protein]; Enalapril inhibits the reaction [Bleomycin results in increased expression of TNF mRNA]; honokiol inhibits the reaction [Bleomycin results in increased expression of TNF protein]; Oils, Volatile inhibits the reaction [Bleomycin results in increased expression of TNF protein]; pirinixic acid inhibits the reaction [Bleomycin results in increased expression of TNF protein]; PPARA protein affects the reaction [Bleomycin results in increased expression of TNF protein]; Simvastatin inhibits the reaction [Bleomycin results in increased expression of TNF protein]; tetrathiomolybdate inhibits the reaction [Bleomycin results in increased expression of TNF mRNA]; Thioctic Acid inhibits the reaction [Bleomycin results in increased expression of TNF mRNA]; TRPM2 gene mutant form inhibits the reaction [Bleomycin results in increased secretion of TNF protein]; verlukast inhibits the reaction [Bleomycin results in increased expression of TNF protein]; zileuton inhibits the reaction [Bleomycin results in increased expression of TNF protein] 1-hydroxyalantolactone inhibits the reaction [Bleomycin results in increased secretion of TNF protein]; [Bleomycin co-treated with Tobacco Smoke Pollution] results in increased expression of TNF protein; Berberine inhibits the reaction [Bleomycin results in increased expression of TNF protein]; celastrol inhibits the reaction [Bleomycin results in increased expression of TNF protein]; Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of TNF mRNA]; Phytochemicals inhibits the reaction [Bleomycin results in increased expression of TNF mRNA]; Resveratrol inhibits the reaction [Bleomycin results in increased expression of TNF protein]; Taurine inhibits the reaction [Bleomycin results in increased expression of TNF protein] Bleomycin results in increased expression of TNF mRNA; Bleomycin results in increased expression of TNF protein
|
CTD |
PMID:8317554 PMID:8473757 PMID:11350791 PMID:12003776 PMID:14609568 PMID:14617519 PMID:15541506 PMID:16317386 PMID:17035056 PMID:17118201 PMID:17177178 PMID:19080365 PMID:19362168 PMID:22687607 PMID:23523906 PMID:26093215 PMID:26520185 PMID:26600069 PMID:26768587 PMID:27704718 PMID:28850077 PMID:31901889 PMID:32032644 PMID:32828905 PMID:33516805 PMID:33647319 PMID:34758440 PMID:35187969 PMID:35716765 PMID:37778983 PMID:37898439 More...
|
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
G
|
Tnfrsf1a
|
TNF receptor superfamily member 1A
|
increases response to substance increases expression
|
ISO
|
TNFRSF1A results in increased susceptibility to Bleomycin Bleomycin results in increased expression of TNFRSF1A mRNA
|
CTD |
PMID:12003776 PMID:36087614 |
|
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:159,837,032...159,849,816
|
|
G
|
Tnfrsf1b
|
TNF receptor superfamily member 1B
|
increases expression increases response to substance
|
EXP ISO
|
Bleomycin results in increased expression of TNFRSF1B protein TNFRSF1B results in increased susceptibility to Bleomycin
|
CTD |
PMID:12003776 PMID:15371238 |
|
NCBI chr 5:162,356,250...162,387,411
Ensembl chr 5:162,353,848...162,387,411
|
|
G
|
Tnfsf11
|
TNF superfamily member 11
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of TNFSF11 mRNA
|
CTD |
PMID:29720568 |
|
NCBI chr15:60,083,008...60,114,479
Ensembl chr15:60,083,008...60,114,479
|
|
G
|
Tnfsf4
|
TNF superfamily member 4
|
increases expression
|
ISO
|
Bleomycin results in increased expression of TNFSF4 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr13:76,256,654...76,280,133
Ensembl chr13:76,256,654...76,280,133
|
|
G
|
Tp53
|
tumor protein p53
|
increases expression increases response to substance increases phosphorylation multiple interactions
|
ISO
|
Bleomycin results in increased expression of TRP53 protein TP53 protein results in increased susceptibility to Bleomycin Bleomycin results in increased phosphorylation of TP53 protein 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Bleomycin promotes the reaction [Resveratrol results in increased phosphorylation of TP53 protein]]; 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Bleomycin results in increased phosphorylation of TP53 protein]; 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Resveratrol promotes the reaction [Bleomycin results in increased phosphorylation of TP53 protein]]; Bleomycin promotes the reaction [Polyphenols results in increased expression of TP53 mRNA]; Bleomycin promotes the reaction [Resveratrol results in increased phosphorylation of TP53 protein]; Bleomycin promotes the reaction [Tea results in increased expression of TP53 mRNA]; Polyphenols promotes the reaction [Bleomycin results in increased expression of TP53 mRNA]; Resveratrol promotes the reaction [Bleomycin results in increased phosphorylation of TP53 protein]; Tea promotes the reaction [Bleomycin results in increased expression of TP53 mRNA]
|
CTD |
PMID:9683175 PMID:20135637 PMID:24933654 PMID:26800624 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
G
|
Tpm1
|
tropomyosin 1
|
increases expression
|
EXP
|
Bleomycin results in increased expression of TPM1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 8:76,516,654...76,543,661
Ensembl chr 8:76,511,871...76,543,468
|
|
G
|
Tpm3
|
tropomyosin 3
|
increases expression
|
EXP
|
Bleomycin results in increased expression of TPM3 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 2:177,812,534...177,842,661
Ensembl chr 2:177,814,883...177,842,660
|
|
G
|
Tpm4
|
tropomyosin 4
|
increases expression
|
EXP
|
Bleomycin results in increased expression of TPM4 protein
|
CTD |
PMID:25933445 |
|
NCBI chr16:17,718,442...17,732,483
Ensembl chr16:17,717,230...17,732,494
|
|
G
|
Tppp3
|
tubulin polymerization-promoting protein family member 3
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of TPPP3 protein
|
CTD |
PMID:25933445 |
|
NCBI chr19:50,255,809...50,259,655
Ensembl chr19:50,255,810...50,259,489
|
|
G
|
Traf2
|
Tnf receptor-associated factor 2
|
decreases expression increases expression
|
EXP ISO
|
Bleomycin results in decreased expression of TRAF2 protein Bleomycin results in increased expression of TRAF2 mRNA
|
CTD |
PMID:15371238 PMID:36087614 |
|
NCBI chr 3:28,740,098...28,764,752
Ensembl chr 3:28,740,098...28,764,691
|
|
G
|
Traf3ip2
|
Traf3 interacting protein 2
|
multiple interactions
|
ISO
|
Calcitriol inhibits the reaction [Bleomycin results in increased phosphorylation of ACT1 protein]
|
CTD |
PMID:26520185 |
|
NCBI chr20:44,565,992...44,609,240
Ensembl chr20:44,517,242...44,609,618
|
|
G
|
Trim28
|
tripartite motif-containing 28
|
increases phosphorylation
|
ISO
|
Bleomycin results in increased phosphorylation of TRIM28 protein
|
CTD |
PMID:24933654 |
|
NCBI chr 1:82,724,842...82,731,566
Ensembl chr 1:82,724,838...82,731,572
|
|
G
|
Trpm2
|
transient receptor potential cation channel, subfamily M, member 2
|
multiple interactions
|
ISO
|
TRPM2 gene mutant form inhibits the reaction [Bleomycin results in increased secretion of CXCL1 protein]; TRPM2 gene mutant form inhibits the reaction [Bleomycin results in increased secretion of CXCL2 protein]; TRPM2 gene mutant form inhibits the reaction [Bleomycin results in increased secretion of IL1B protein]; TRPM2 gene mutant form inhibits the reaction [Bleomycin results in increased secretion of TNF protein]
|
CTD |
PMID:26600069 |
|
NCBI chr20:10,703,190...10,752,795
Ensembl chr20:10,704,482...10,752,802
|
|
G
|
Tshr
|
thyroid stimulating hormone receptor
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of TSHR mRNA
|
CTD |
PMID:15808516 |
|
NCBI chr 6:116,072,321...116,206,009
Ensembl chr 6:116,072,281...116,206,010
|
|
G
|
Tuba1c
|
tubulin, alpha 1C
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of TUBA1C protein
|
CTD |
PMID:25933445 |
|
NCBI chr 7:131,636,974...132,078,589
Ensembl chr 7:132,070,536...132,079,311
|
|
G
|
Tubb2a
|
tubulin, beta 2A class IIa
|
decreases expression
|
EXP ISO
|
Bleomycin results in decreased expression of TUBB2A protein Bleomycin results in decreased expression of TUBB2A mRNA
|
CTD |
PMID:25933445 PMID:33770205 |
|
NCBI chr17:31,002,186...31,006,057
Ensembl chr17:30,983,387...31,006,838
|
|
G
|
Tubb4b
|
tubulin, beta 4B class IVb
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of TUBB4B protein
|
CTD |
PMID:25933445 |
|
NCBI chr 3:28,435,999...28,438,455
Ensembl chr 3:28,435,148...28,439,719
|
|
G
|
Twist1
|
twist family bHLH transcription factor 1
|
increases expression
|
ISO
|
Bleomycin results in increased expression of TWIST1 protein
|
CTD |
PMID:37126650 |
|
NCBI chr 6:56,402,309...56,404,303
Ensembl chr 6:56,398,061...56,404,965
|
|
G
|
Tymp
|
thymidine phosphorylase
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of TYMP protein Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of TYMP protein]
|
CTD |
PMID:30825431 |
|
NCBI chr 7:122,318,396...122,323,716
Ensembl chr 7:122,316,520...122,324,003
|
|
G
|
Ugcg
|
UDP-glucose ceramide glucosyltransferase
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of UGCG mRNA
|
CTD |
PMID:33770205 |
|
NCBI chr 5:78,828,006...78,860,725
Ensembl chr 5:78,828,006...78,860,417
|
|
G
|
Ulk1
|
unc-51 like autophagy activating kinase 1
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of ULK1 protein modified form Soot inhibits the reaction [Bleomycin results in increased expression of ULK1 protein modified form]
|
CTD |
PMID:31302203 |
|
NCBI chr12:51,511,492...51,537,746
Ensembl chr12:51,511,492...51,537,746
|
|
G
|
Uqcrc1
|
ubiquinol-cytochrome c reductase core protein 1
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of UQCRC1 protein
|
CTD |
PMID:25933445 |
|
NCBI chr 8:118,468,223...118,479,968
Ensembl chr 8:118,468,200...118,479,964
|
|
G
|
Uqcrh
|
ubiquinol-cytochrome c reductase hinge protein
|
increases expression
|
EXP
|
Bleomycin results in increased expression of UQCRHL protein
|
CTD |
PMID:25933445 |
|
NCBI chr 5:134,782,687...134,790,882
Ensembl chr 5:134,782,255...134,790,926
|
|
G
|
Vav1
|
vav guanine nucleotide exchange factor 1
|
multiple interactions increases expression
|
ISO
|
Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of VAV1 mRNA]; lenabasum inhibits the reaction [Bleomycin results in increased expression of VAV1 mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr 9:2,248,856...2,295,905
Ensembl chr 9:2,248,914...2,296,922
|
|
G
|
Vcl
|
vinculin
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of VCL protein
|
CTD |
PMID:25933445 |
|
NCBI chr15:3,315,069...3,404,891
Ensembl chr15:3,315,069...3,405,163
|
|
G
|
Vegfa
|
vascular endothelial growth factor A
|
increases expression
|
EXP
|
Bleomycin results in increased expression of VEGFA mRNA
|
CTD |
PMID:26093215 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
G
|
Vegfb
|
vascular endothelial growth factor B
|
increases expression multiple interactions
|
ISO
|
Bleomycin results in increased expression of VEGFB protein Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of VEGFB protein]; lenabasum inhibits the reaction [Bleomycin results in increased expression of VEGFB protein]
|
CTD |
PMID:30825431 |
|
NCBI chr 1:213,601,570...213,607,254
Ensembl chr 1:213,600,966...213,607,152
|
|
G
|
Vim
|
vimentin
|
increases expression decreases expression affects expression multiple interactions
|
EXP ISO
|
Bleomycin results in increased expression of VIM protein Bleomycin results in decreased expression of VIM mRNA Bleomycin affects the expression of VIM protein Bleomycin results in increased expression of VIM mRNA; Bleomycin results in increased expression of VIM protein geranylgeranylacetone inhibits the reaction [Bleomycin results in increased expression of VIM mRNA]; geranylgeranylacetone inhibits the reaction [Bleomycin results in increased expression of VIM protein]; MIR100HG mRNA affects the reaction [Bleomycin results in increased expression of VIM mRNA]; MIR100HG mRNA affects the reaction [Bleomycin results in increased expression of VIM protein]; MKLN1 mRNA alternative form affects the reaction [Bleomycin results in increased expression of VIM protein] Ephedrine inhibits the reaction [Bleomycin results in increased expression of VIM mRNA]; Ephedrine inhibits the reaction [Bleomycin results in increased expression of VIM protein]
|
CTD |
PMID:25933445 PMID:34425168 PMID:35267148 PMID:35472619 PMID:37126650 PMID:37307957 PMID:37778983 PMID:38460002 More...
|
|
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746
|
|
G
|
Vwf
|
von Willebrand factor
|
multiple interactions decreases expression
|
ISO
|
Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of VWF protein]
|
CTD |
PMID:30825431 |
|
NCBI chr 4:160,042,900...160,177,757
Ensembl chr 4:160,047,982...160,177,757
|
|
G
|
Wif1
|
Wnt inhibitory factor 1
|
multiple interactions decreases expression
|
ISO
|
Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of WIF1 mRNA]; lenabasum inhibits the reaction [Bleomycin results in decreased expression of WIF1 mRNA]
|
CTD |
PMID:30825431 |
|
NCBI chr 7:58,433,326...58,503,853
Ensembl chr 7:58,384,643...58,503,852
|
|
G
|
Wnt1
|
Wnt family member 1
|
increases expression
|
ISO
|
Bleomycin results in increased expression of WNT1 mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 7:131,817,558...131,821,605
Ensembl chr 7:131,817,558...131,821,605
|
|
G
|
Wnt10a
|
Wnt family member 10A
|
increases expression
|
ISO
|
Bleomycin results in increased expression of WNT10A mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr 9:83,798,594...83,811,060
Ensembl chr 9:83,798,594...83,811,067
|
|
G
|
Wnt9a
|
Wnt family member 9A
|
increases expression
|
ISO
|
Bleomycin results in increased expression of WNT9A mRNA
|
CTD |
PMID:36087614 |
|
NCBI chr10:44,593,691...44,620,682
Ensembl chr10:44,593,691...44,620,682
|
|
G
|
Xrcc1
|
X-ray repair cross complementing 1
|
affects response to substance decreases response to substance
|
ISO
|
XRCC1 gene polymorphism affects the susceptibility to Bleomycin XRCC1 results in decreased susceptibility to Bleomycin
|
CTD |
PMID:12082022 PMID:20705543 |
|
NCBI chr 1:89,268,721...89,296,619
Ensembl chr 1:89,268,644...89,296,613
|
|
G
|
Xrcc5
|
X-ray repair cross complementing 5
|
affects response to substance
|
ISO
|
XRCC5 protein affects the susceptibility to Bleomycin
|
CTD |
PMID:12384553 |
|
NCBI chr 9:81,404,507...81,493,293
Ensembl chr 9:81,375,863...81,493,293
|
|
G
|
Yes1
|
YES proto-oncogene 1, Src family tyrosine kinase
|
decreases expression
|
ISO
|
Bleomycin results in decreased expression of YES1 mRNA
|
CTD |
PMID:33770205 |
|
NCBI chr 9:120,646,657...120,753,880
Ensembl chr 9:120,646,838...120,746,441
|
|
G
|
Ywhab
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
|
decreases expression
|
EXP
|
Bleomycin results in decreased expression of YWHAB protein
|
CTD |
PMID:25933445 |
|
NCBI chr 3:173,078,904...173,101,508
Ensembl chr 3:173,079,041...173,101,854
|
|
G
|
Zfx
|
zinc finger protein X-linked
|
increases expression
|
ISO
|
Bleomycin results in increased expression of ZFX mRNA
|
CTD |
PMID:33770205 |
|
NCBI chr X:62,798,483...62,847,068
Ensembl chr X:62,798,483...62,875,309
|
|